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Human longevity refers to individuals who live exceptionally long compared to other 
members of the populations from which they stem. They belong to a selective group 
of individuals who have been able to withstand the test of time successfully. Although 
the exact definition of longevity often differs across (study)populations and over time, 
longevity is mostly defined as reaching a specific age that exceeds the life expectancy 
(e.g. age 85 or 90 years), or by exceeding a survival percentile threshold (e.g. top 
10%) of their birth cohort (1-5). There is increasing evidence that in those who reach 
exceptional ages, the development of chronic diseases is also delayed (6, 7). As a 
result, there is a growing research interest in factors that characterize this group of 
exceptional survivors (1, 8). Although a longer lifespan is generally positive, reaching 
longevity might also be accompanied by some negative side effects. For instance, 
because people live longer than the average life expectancy they might outlive their 
resources, family and friends, which could lead to poverty and feelings of loneliness. 
Additionally, the very old often need structural assistance with activities of daily 
living (ADL), which is a major healthcare cost for both society and the individual. 
Human lifespan
There is much variation in the duration of lifespan (the time between birth and death) 
within and between species. Evolutionary, organisms have evolved by optimizing the 
reproductive capabilities of their species. Organisms had to find a balance between 
growth, reproduction and DNA repair maintenance. A well-developed repair and 
maintenance mechanism only evolves when a longer lifespan optimizes the reproductive 
capabilities of the species. This balance depends heavily on the level of environmental 
hazards to which the organism is exposed. Longevity could be beneficial in a stable 
environment with little external threats. If there are a lot of external threats that lead 
to early mortality, it is not beneficial to invest heavily in maintenance. Instead, it would 
be more beneficial to invest in rapid growth and reproduction as an optimal strategy for 
ensuring offspring. Evolutionary, early mammals have experienced many environmental 
hazards that led to early mortality of individuals. As a result, most modern mammals, 
including humans, have only a limited repair capacity. Consequently, damaged somatic 
cells will go into senescence and accumulate over time, which results in aging of 
the body (9). It has been hypothesized that by natural selection the human body has 
evolved to maximize its fitness until the end of its reproductive lifespan. 
Several evolutionary theories have been proposed to explain why humans tend to age 
when their sexual maturity ends, a period that is often referred to as the “selection 
shadow” (10). In 1952, the mutation accumulation theory was proposed (11). This 
theory stated that mutations that affect health are selected against during the reproductive 
lifespan. However, mutations that affect health at a later age (during the selection 
shadow) are not selected against, and these late-acting mutations accumulate in the 
population (11). Building on this theory, Williams (1957) formulated the antagonistic 
pleiotropy theory (12). This theory describes a phenomenon where one gene controls 
for more than one genetic trait (pleiotropy), of which at least one is beneficial and 
at least one is detrimental (antagonistic). The theory states that genes are selected 
by their beneficial effect to the reproduction and fitness in an organism’s early life, 
despite their potential detrimental effect in later life (12). This theory is often used as 
General introduction
 
9
1
an explanation for the survival of non-optimal alleles that increase the rate of aging 
and/or the risk for certain genetic disorders (e.g. Huntington’s disease) in later life. In 
line with these evolutionary theories, the disposable-soma theory was proposed in 1991 
(9). This theory describes that somatic cells are maintained for reproductive success 
and that they become disposable after the reproductive lifespan. 
In humans, the exposure to external lethal hazards in early life has been reduced 
in the last two centuries. As a result, the average lifespan has increased and factors 
influencing the rate of somatic senescence beyond the reproductive lifespan became 
increasingly important. The most commonly used measure to estimate the average 
lifespan in a human population is the period life expectancy at birth (period LEB). 
This measure expresses the average duration of life of a hypothetical cohort in a given 
year (13). Period life expectancies use the age-specific probabilities of death (mortality 
rates) of a single calendar year (or group of years) and project these probabilities 
on the life course of the hypothetical cohort. This also means that future changes in 
mortality rates are not taken into account.  
Worldwide, the LEB has been increasing substantially since the start of the twentieth 
century. In 1900, the LEB was 32.0 years, which increased to 71.4 years in 2015 (14). 
In developed countries, the LEB showed an even stronger increase. For instance, in 
1900, the LEB in Europe was 42.7 years (14). This has increased to age 62 years in 
1950, and to age 78.5 years in 2019 (14, 15). In the United States the LEB increased 
from 49.2 years in 1900 to 78.8 years in 2015 (16, 17). The strongest increase in 
LEB occurred in Japan, with 38.6 years in 1900 to 83.8 years in 2015 (15). In the 
Netherlands, the LEB was 48.0 years in 1900 and 81.8 years in 2018 (18, 19). 
In the first half of the twentieth century, the growing LEB among humans could be 
attributed to reduction of mortality in early life (20). Improved personal hygiene and the 
implementation of vaccination reduced premature deaths caused by air- and waterborne 
infectious diseases (21). It is estimated that the reduction of infection diseases has 
contributed to 55-80% of the total mortality decline observed between 1875 and 1970 
in the Netherlands (20). Improved nutrition and increased food availability by improved 
storage and transportation, have led to further reductions in childhood mortality (21). 
Although the largest reduction of mortality was observed in early life, the remaining 
life expectancy at older ages has also increased. In the Netherlands, the life expectancy 
at age 65 has increased from 14.7 years in 1950 to 20.3 years in 2018 (18). After 
1970, reduction in cardiovascular deaths and reduced deaths by external causes (e.g. 
traffic accidents contributed 74% of the total decline in mortality, because the number 
of deaths due to infection diseases was already low (20, 22). 
Due to the reduction of infectious diseases, more people are reaching the “selection 
shadow”. Still, there is a lot of variation in the lifespan between people after their 
reproductive lifespan. Exposure to accidental traumas resulting in death will explain 
a part of the variation, but still some people seem to age faster than others. Several 
theories have been proposed to explain how people age. In general, these theories 
can be classified in one of two overarching categories, namely programmed- or error-
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theories of aging (10, 23). Programmed theories assume that aging is an active process, 
that depends on biological clocks that regulate gene-signaling to the nervous, endocrine 
and immune systems depending on the stage of life (24-27). On the other hand, error 
theories state that aging is a (passive) process of error accumulation (e.g. free radical 
theory, accumulation of (mitochondrial) DNA damage, and protein cross-linking (28-
31)). Aging is most likely not explained by a single theory, but rather a multifactorial 
process that incorporates several elements of the above mentioned programmed and 
error theories. 
Together with an increasing life expectancy, reaching an exceptionally old age seems to 
become more common in recent decades as well. People who have reached longevity 
seem to have a decreased rate of aging compared to the population from which they 
stem. For women aged 65 years in the Netherlands, the probability of reaching the age 
of 90 years was 9.4% in 1950, and increased to 27.9% in 2000 (Table 1). For men, 
this probability increased from 8.3% to 12.8% (Table 1). These figures indicate that 
the increased probability of reaching old ages during the second half of the twentieth 
century is mainly attributable to the increased probabilities in women. Worldwide, it 
is expected that the absolute number of persons reaching the age of 90 years will 
quadruple by the year 2060 (32). Historically, human longevity has fascinated humanity, 
and many researchers have tried to identify factors that might prolong the lifespan.  
Table 1. Sex-specific percentages of survival to the age of 90 years at the age 
of 65 years in the Netherlands (1950-2000), Statistics Netherlands (CBS)(18). 
 
 
Methods studying determinants of reaching human longevity
Apart from anecdotal case reports about the lifestyle of centenarians, several researchers 
have tried to investigate determinants of reaching human longevity using a population-
based study approach. Some studies have studied longevity using a retrospective or 
case-control design (e.g. (33-37)).  However, these studies are often hampered by recall-
bias of the exposure or inappropriate selection of deceased and/or younger controls. 
Sometimes, historical data can be used to determine the exposure status or certain 
demographic characteristics of an individual in the past e.g. (38-40). Although these 
data are often a valuable and reliable source of information, data on other relevant 
confounding factors are not available which might lead to confounding bias.     
Likelihood of survival to age 90 years at age 65 years (%)
Year Men Women
1950 8.3 9.4
1960 9.3 12.5
1970 9.1 15.8
1980 10.6 24.1
1990 10.8 26.7
2000 12.8 27.9
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Due to the rise of large prospective cohort studies to study the etiology of chronic 
diseases since the mid-twentieth century, prospectively collected individual data of those 
who became very old are becoming increasingly available (41). As a result, researchers 
have recently gained new possibilities to investigate how baseline characteristics of 
those who reached an exceptional lifespan differ from those who had a shorter lifespan. 
In a prospective cohort study, a random cohort of individuals is sampled from a target 
population of a certain age range. After recruitment of the cohort, exposure information 
of the participants is collected by questionnaires, diaries, interviews and/or by the 
collection of biological samples (e.g. blood, nails, saliva). These participants are then 
followed over time (which might take several decades) to observe the incidence of 
diseases, mortality, and/or other outcomes of interest. Statistical analyses techniques 
can then be used to evaluate the relationship between an exposure and the outcome 
under study, while accounting for other potential relevant variables that might explain 
the association. For studies on longevity, reaching a certain longevity cut-off age (e.g. 
reaching 90 years (yes/no)) is used as the main outcome variable. The main advantage 
of this study design is that selection of participants and data collection is independent 
of the outcome, reducing the risk for selection and information bias. Furthermore, the 
amount of detailed information that is collected from the participant makes it possible 
to reduce the risk for potential confounding bias.
Because of the long follow-up time, and the large numbers of participants that are 
required to examine the etiology of rare diseases, prospective cohort studies are costly 
and require labor-intensive data processing and maintenance. Because of this, the 
number of cohort studies that have a sufficiently long follow-up to study participants 
who could have reached an exceptionally high age is still limited. Nevertheless, their 
number is growing. Most analyses defined longevity as reaching the age of 85 or 90 
years, because a longer follow-up is often not possible (42-52). Reaching longevity 
is determined by a combination of inherited/genetic factors and environmental factors. 
Inheritance of longevity
Because longevity is partially determined by genes, it has been observed that 
longevity often clusters within families (53, 54). Several studies have investigated the 
heritability of longevity with varying study designs and results. Most studies used 
cross-sectional analyses comparing multiple cohorts, or cases to younger controls 
using historical genealogical data, as summarized in (2). Van den Berg et.al. (2017) 
stated that parental lifespan was positively associated with offspring lifespan in all 
twelve studies investigating this relationship, with most evidence for a mother-daughter 
longevity relationship (2). Other studies used a prospective cohort approach to study 
the relationship between parental longevity and offspring longevity , which we reviewed 
in 2016 at the start of the PhD trajectory. This is described in chapter 2. These 
studies have shown inconsistent results. Therefore, replication of these findings in other 
cohorts is needed. It is estimated that approximately 20-30% of human longevity can 
be attributed to genetic factors (55, 56). To date, single nucleotide polymorphisms 
(SNPs) in the Apolipoprotein E (ApoE) gene, and the forkhead box O3A (FOXO3A) 
gene are the most important genetic alterations associated with longevity (56, 57). The 
presence of the ApoE ԑ4 allele has been negatively associated with longevity, while 
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the presence of the ApoE ԑ2 allele has been positively associated  with longevity, 
compared to the presence of the ApoE ԑ3 allele (57-59). Several SNPs in the FOXO3A 
gene, which is linked to the insulin/insulin growth factor-1 (IGF-1) signaling pathway, 
have been positively associated with longevity and healthy aging (57, 60-62). Several 
other genes have been suggested to be associated with longevity, including Sirtuin 1 
(SIRT1), target of rapamycin (mTOR), angiotensin converting enzyme (ACE), nitric 
oxide synthase (NOS) gene, but these have shown inconsistent results (56).
(Modifiable) lifestyle factors and longevity
The findings regarding genetic factors and longevity indicate that human longevity 
is mainly determined by non-genetic, and potentially modifiable factors. It is known 
that exposure to certain environmental factors could lead to somatic cell damage and 
an increased amount of DNA damage, protein cross-linking, and accumulation of 
free radicals. Exposure to harmful or protective environmental factors might therefore 
influence the rate of aging, and could potentially influence the likelihood of reaching 
exceptional ages. Several lifestyle factors have been associated with reaching longevity, 
which we reviewed more elaborately in Chapter 2. Based on this review, we concluded 
that smoking status, and physical activity were the most important factors that are 
associated with longevity. Alcohol intake, BMI, marital status and educational level 
have shown limited and/or contradictory associations. Still, the absolute number of 
studies investigating the relationship between non-genetic factors and longevity is 
limited. 
Reproductive factors and longevity
Several evolutionary theories have argued that increased investments in growth and 
reproduction in early life come at the expense of repair mechanisms in later life (9, 
12). Based on these theories, there seems to be an antagonistic relationship between 
reproduction and longevity. The lack of prospective cohort studies on the association 
between reproductive factors and longevity, which we described in chapter 2, was 
therefore surprising. More recently, some studies have started to assess the relationship 
between female reproductive factors and reaching longevity, defined as reaching the 
age of 90 years (52, 63). In these analyses, a later age at menarche, a later age at 
menopause, and a longer reproductive lifespan were associated with an increased odds 
of reaching 90 years (52). Furthermore, parity, and a later age at first childbirth were 
also associated with an increased odds of reaching 90 years (63).
  
The potential role of psychosocial factors
Although most theories of aging focus on biological mechanisms, several psychosocial 
factors have been associated with an increased or decreased risk for premature mortality 
(64-66). However, the potential relationship between psychosocial factors and longevity 
has received little attention thus far.  Recently, two prospective cohort studies observed 
that optimism, and social integration were associated with an increased odds of reaching 
the age of 85 years (67, 68). This indicates that an increased subjective well-being 
might postpone aging and increase the lifespan. Therefore, it would be interesting to 
examine the relationship between psychosocial factors and reaching longevity. 
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Longevity vs. mortality
Although the number of studies on longevity is limited, more research has been 
performed to investigate non-genetic factors that are associated with short- and long-
term mortality. The concept longevity and mortality are closely related. Therefore, 
studies on mortality are a valuable source for identifying potentially interesting factors 
that could be associated with reaching longevity as well. While studies on longevity 
estimate the probability of reaching an exceptionally high age, studies on mortality 
estimate an average risk probability of mortality for a certain time-period. This means 
that studies on mortality hold a strong assumption that the estimated risk is similar 
over the examined time-period, independent of individual differences during the aging 
process. During the aging process, different contextual conditions might influence the 
survival curve, the effect of relevant factors on mortality might converge or crossover 
across different stages of life, and the role of chance is substantial (69, 70). Therefore, 
studies on mortality are more suitable for identifying factors that are associated with 
premature death, which occurs at every stage of the life course, rather than identifying 
factors that are associated with reaching exceptionally high ages. In terms of causality, 
inspired by the causal pie model of Rothman (71, 72), studies on mortality might hint 
towards factors that act as a component cause for reaching longevity. However, these 
factors do not necessarily add up to a sufficient cause for reaching longevity, because 
the outcome (longevity) is not yet known. As a result, a factor might be associated 
with premature mortality and not with longevity, and vice versa. By estimating the 
risk of reaching an exceptionally high age, a natural selection takes place by which 
we are able to select those who fit the robust description of an “exceptional survivor”. 
As a result, we can investigate how their characteristics differ from those who died 
at earlier ages in the same population.
Rationale and aim 
Using a prospective cohort approach, we aimed to identify particular characteristics 
that are associated with a decreased or increased probability of reaching longevity. For 
the analyses in this dissertation, we defined reaching longevity as reaching the age of 
90 years. Furthermore, our review (chapter 2) has addressed several knowledge gaps, 
and found inconsistencies between findings, which we have tried to accommodate in 
this PhD thesis. 
Study design
For the analyses in this thesis, data from two prospective cohorts was used, namely 
the Netherlands Cohort Study (NLCS) for the analyses on parental, lifestyle and 
reproductive factors, and the Longitudinal Aging Study Amsterdam (LASA) for the 
analyses on loneliness.  
The Netherlands Cohort Study (NLCS)
The NLCS was set up in 1986 as a large prospective cohort study, which aimed 
to investigate the relationship between diet and the development of multiple cancers 
in the Netherlands (73). The NLCS collected data from 120,852 men and women 
(aged 55-69 years) using an 11-page self-administrated questionnaire. This questionnaire 
contained questions on demographic factors, dietary habits, smoking habits, physical 
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activity, alcohol consumption, anthropometry, medical information, and family history. 
To increase efficiency in the data processing and follow-up, a case-cohort design was 
used. Here, a random subcohort of 5,000 people (2,411 men and 2,589 women) was 
sampled from the total cohort at baseline and followed up for vital status information. 
Furthermore, the total cohort has been monitored for cancer incidence by record linkage 
to the cancer registry annually, since the onset of the study (74). As a result of 
the case-cohort approach, only the questionnaire data from the subcohort members 
and incident cancer cases have been entered into the database. In addition to cancer 
incidence, the full cohort has been followed-up for mortality. This was done by record 
linkage to the Central Bureau for Genealogy (CBG) from September 1986 until 1995, 
and to the municipal population registries (GBA) from 1995 until 2011. 
NLCS Longevity cohort
Because only a part of the subcohort was at risk to reach the age of 90 years at 
the onset of this longevity project, we were forced to look beyond the subcohort 
and select those participants in the full cohort who were able to reach the age of 
90 years in 2011. Because most of the questionnaires from these participants still 
needed to be entered (given the case-cohort design aimed at cancer incidence), the 
data entry was restricted to the oldest birth cohorts (1916, and 1917) of the NLCS 
cohort. The participants from these two birth years form the longevity cohort for the 
current longevity analyses in the NLCS (i.e. aged 68-70 years at baseline). Follow-
up for vital status of the longevity cohort until the age of 90 was 99.9% complete. 
Seven participants were lost to follow-up due to migration before reaching the age 
of 90. As a result, the study population of the longevity cohort consisted of 7,807 
participants (3,646 men and 4,161 women). Our mortality follow-up showed that among 
these participants 565 men (15.5%) and 1388 women (33.4%) have survived to the 
age of 90 years. 
Longitudinal Aging Study Amsterdam (LASA)
The Longitudinal Aging Study Amsterdam (LASA) is a prospective cohort study 
initiated in 1992 to study the physical, emotional, cognitive, and social functioning 
of older adults (aged 55-84 years) in the Netherlands (75). In 1992, a sample was 
recruited from 11 municipal registries within three representative geographic regions 
in the Netherlands for the Living Arrangements and Social Networks of Older Adults 
programme (LSN). These regions were chosen to represent the protestant north, and 
the catholic south, in both urban and rural areas. Participants recruited for this study 
were born between 1908 and 1937, with an oversampling of older individuals and 
males. The initial response rate was 62% (n=3,805). From this sample, 3677 surviving 
participants were contacted for the first LASA cycle (1992-1993) on average 11 months 
after the LSN interview, with a response rate of 85%. Examinations were performed at 
the participants’ homes, and re-examinations took place about every three years. Trained 
interviewers held the home interviews, and additional data was obtained using a self-
administered questionnaire. During the home interviews, participants were also asked 
for consent to participate in a separate medical interview. During the medical interview, 
clinical measurements were taken, and the interviewer asked additional questions.  
Loneliness has been assessed during the home interviews using a validated 11-item 
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De Jong-Gierveld scale (76). Mortality follow-up was done by record linkage to the 
municipal population registries, Gemeentelijk Basisadministratie Persoonsgegevens 
(GBA). The last date of mortality follow-up for this study was August 1st, 2018. 
Because only a part of the full cohort was “at risk”of reaching the age of 90 years 
at this date, the analyses were restricted to participants born before August 2nd, 1928. 
Of these, follow-up for mortality was 99.5% complete. After exclusion of participants 
with missing data information on loneliness (n=62), 1,032 men and 1,078 women 
were included for these analyses. Our mortality follow-up showed that among these 
participants 252 men (24.4%) and 413 women (38.3%) have survived to the age of 
90 years.  
Thesis outline
The studies of this thesis aimed to identify potential non-genetic determinants that are 
associated with reaching longevity. The thesis starts with a literature review (chapter 
2), in which we provided an overview of prospective cohort studies that have aimed 
to assess the relationship between parental, lifestyle and reproductive factors and the 
chance/odds of reaching longevity defined as reaching a certain longevity cut-off age 
(75-100 years). In chapter 3 we describe inheritance patterns of longevity between 
parents and their offspring within the NLCS. In chapter 4, 5, and 6 we describe 
how several lifestyle factors in later life are associated with reaching the age of 90 
years. These lifestyle factors include several smoking habits (chapter 4), body size and 
non-occupational physical activity (chapter 5), and alcohol consumption (chapter 6). 
In chapter 7 we describe how several reproductive factors in women are associated 
with the probability of reaching 90 years of age. In Chapter 8 we describe whether 
loneliness is related with the probability of reaching 90 years of age, using data from 
the LASA study. Lastly, in Chapter 9, the findings of this thesis are discussed, and 
put into perspective. 
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Abstract 
Background
With an increasingly aging population, societies need to adapt to the challenges 
and issues associated with it. Therefore, extending our knowledge on (modifiable) 
factors that may contribute to an increase or decline in human longevity is very 
important in order to predict future trends in aging. This paper aimed to summarize 
the available data on lifestyle, parental and reproductive factors and their association 
with longevity. 
Methods 
A literature search was conducted using PubMed to identify publications assessing 
the association of these factors with longevity. Study results were summarized 
and assessed for differences due to the longevity cut-off age, age at baseline 
measurement, and subgroup if possible. Furthermore, we identified gaps in the 
available data. 
Results 
Thirteen publications on cohort studies were included for this review. Differences 
were found across studies regarding longevity cut-off age and age at baseline. 
Among the factors of interest, smoking and physical activity seem to be important 
factors associated with longevity. Alcohol consumption, coffee consumption, Body 
Mass Index, education, marital status, and parental longevity show limited and/or 
contradictory results and need further assessment. In addition, there are almost no 
data regarding the association of dietary and reproductive factors with longevity. 
Conclusions 
This review highlights the current knowledge and gaps in longevity research. Given 
the limited number of publications on this topic, more research on longevity among 
men and women should be done to gain insight into the epidemiology of longevity. 
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Introduction 
One of the biggest developments that will confront us in the future is the changing 
demographic composition of the human population. The absolute number of elderly 
reaching 90 years of age is expected to quadruple by 2060 (1). However, some 
speculate that the rise in life expectancy might flatten or even decline in the future, 
due to an increasing proportion of obese, and physically inactive individuals (2, 
3). Because demographic changes have huge implications for societal policies, it is 
important to understand the underlying determinants of longevity.
There are various theories on how longevity is attained but most researchers agree 
that aging is a multifactorial process that is subject to hereditary and environmental 
influences (4-6). It is estimated that genetic influences account for 25% in the 
process of reaching longevity (7, 8). This indicates that the remaining influences 
are largely environmental and therefore potentially modifiable. Multiple studies have 
tried to assess determinants of longevity using various approaches. Rizzuto and 
Fratiglioni (9) have reviewed the relationship between potentially modifiable factors 
and mortality risk in elderly. Based on multiple studies and systematic reviews, they 
found that smoking, body mass index (BMI), social networks, physical activity, and 
leisure time activity were the most important predictors for mortality in elderly (9). 
Another review suggested reproductive phenotypes, including age at menarche and 
age at menopause, to be important factors explaining the longevity advantage in 
women (10). Most of these findings were based on short- and long term mortality 
analyses in elderly populations. However, a variable could show an association with 
short term mortality, while not with longevity, leading to inconclusive interpretations 
of the results and their relevance to longevity. When assessing longevity the 
outcome should be defined as reaching a specific old age. Factors with stronger 
associations to longevity could otherwise be missed if the focus is on mortality over 
a certain follow-up period. In addition, many researchers conducted cross-sectional 
analyses comparing groups from different birth cohorts or different populations 
instead (11-14). As a result, the observed effects could be due to generational or 
group differences that are almost impossible to account for. 
We aimed to summarize the available publications on determinants of longevity, 
defined as reaching a certain age compared with not reaching that age. The 
criteria for defining longevity have evolved throughout the years because of an 
increasing life expectancy worldwide (15). The cut-off age for defining longevity 
varies between studies, but is often between 75 and 100 years of age. (16-19). 
Furthermore, some studies use age categories (e.g. octogenarians (80-89 years), 
nonagenarians (90-99 years), and centenarians (100+ years)) to specify longevity 
(20). For this review, studies with longevity cut-off points from 75 years of age and 
over were used. Moreover, the focus is on studies assessing lifestyle, parental and 
reproductive factors, instead of genetic markers and their association to longevity, as 
these have been recently reviewed (8). Although parental longevity and reproductive 
factors are not necessarily modifiable, they may help to understand the aging 
process and can be easily assessed in an observational setting. Furthermore, growing 
evidence suggests an association between parental influences and the health of 
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subsequent generations (21-23). With this paper we provide a literature review with 
available data on the relationship between lifestyle, parental and reproductive factors, 
and longevity.
Methods 
A literature search was conducted using PubMed. The final search algorithm was 
created out of five building blocks to identify publications using MESH terms 
and keywords in titles and abstracts. We aimed to identify publications relating 
modifiable lifestyle, parental or reproductive factors with longevity. The search 
was further restricted to publications between 01 January 1990 and 31 October 
2016 in human species. The final search term was as follows: “(((“Aged, 80 and 
over”[MeSH Terms]OR “Aged”[MeSH Terms]) AND (“Cohort Studies”[MeSH 
Terms] OR (Reach*[tiab] AND age[tiab])) AND (“Longevity”[MAJR] OR “Life 
Expectancy”[MAJR] OR (“Aging/physiology”[MAJR]) OR “Aging/genetics”[MeSH 
Terms])) AND (“Life Style”[MeSH Terms] OR “Risk Factors”[MeSH Terms] OR 
“Behavior”[MeSH Terms] OR “Diet”[MeSH Terms] OR “Body Constitution”[MeSH 
Terms] OR “Family characteristics”[MeSH Terms] OR “Socioeconomic 
factors”[MeSH Terms])) OR ((longevity[tiab] OR Life Expectanc*[tiab] OR 
octogen*[tiab] OR nonagen*[tiab] OR centen*[tiab]) AND Surviv*[tiab] ) AND 
(lifestyle[tiab] OR (modifi*[tiab] AND factor*[tiab]) OR (reproductive[tiab] AND 
factor*[tiab]) OR (parental[tiab] AND factor*[tiab]) OR (exceptional[tiab] AND 
surviv*[tiab]))”.
In addition to searching the database for publications, we checked the references 
of the publications included in this review and in reviews published earlier. We 
included studies that defined longevity as reaching a certain cut-off age, with a 
prospective cohort design, and that assessed the effects of lifestyle, parental, or 
reproductive factors on longevity. We excluded: studies that assessed mortality over 
a certain follow-up period, studies that investigated longevity cut-off ages below 75 
years, studies with a cross-sectional design, or studies that investigated longevity 
within cohorts of patient groups.
After identification of the publications, the studied lifestyle, parental and reproductive 
factors were identified and the respective results summarized. The included 
studies were heterogeneous in terms of the outcome (cut-off age), baseline age, 
population used, and length of follow-up. In addition, some variation was present 
in categorizing levels of exposure. Therefore, no statistical pooling methods were 
used for this review. We presented study specific results, yet we aimed to identify 
patterns across studies that are related to the longevity cut-off age, differences in the 
start of the baseline period, or the definition of the factors of interest. The effect 
estimates including 95% confidence intervals (95% CI) were used to describe the 
direction of associations between the factor of interest and the chance of reaching 
longevity. As some studies assessed survival to a longevity cut-off age and others 
mortality to a longevity cut-off age, the inverse of the effect ratio was calculated 
if needed, to make effect estimates comparable. Many publications did not present 
effect estimates if no association was found, therefore these estimates could not be 
presented (16-18, 24, 25). 
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Results
From the 511 records found in PubMed, twelve articles were found eligible based 
on our in- and exclusion criteria (16-20, 24-30) (Figure 1). In addition, one article 
was identified when references were checked (31). The longevity cut-off points 
that were used in these studies ranged from 75 years of age to 100 years of age. 
Age at baseline ranged from age 40 to 72 years (Figure 2). The average follow-up 
period was 31.6 years (range, 15-45 years). Furthermore, seven studies included both 
men and women (16-18, 25, 29-31), and six only included men (19, 20, 24, 26-28).
 
Figure 1: Flowchart of search strategy results, additional results and number of excluded publications.
Description of cohort studies 
Among the thirteen included articles, nine separate cohorts were identified of 
which five originated from Europe (17, 18, 25, 27, 28, 30) and four from the 
United States (US) (16, 19, 20, 24, 26, 29, 31). Two articles used data from 
the Framingham Heart Study (FHS) (16, 31). Set up in 1948, the FHS aimed to 
identify risk factors for cardiovascular disease. The FHS longevity publications 
assessed factors measured in around 2,500 healthy middle-aged adults of 50 years 
who were followed up until they reached 75 years of age (16), or 85 years of 
age (31). Another publication used data from the Physicians’ Health Study (PHS), 
and was started in Massachusetts, USA in 1982 to test the benefits and risks of 
aspirin and beta-carotene (19). The authors assessed the association between factors 
measured in 2,357 healthy men of at least 66 years of age (mean age 72) and 
longevity (90 years) (19). 
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Figure 2: Study follow-up time from age at baseline to longevity cut-off point. Studies sorted by longev-
ity cut-off age, and then by baseline age.
 
There were three US publications based on data from the Honolulu Heart Program 
(HHP) (20, 24, 26). Originally, the HHP aimed to investigate the aetiology of 
coronary heart disease and stroke among healthy American men of Japanese ancestry 
who were living on the island of Oahu in 1965. They measured the participants’ 
baseline characteristics twice, once at mid-life (45-68 years) and once in late life 
(72-82 years). The three selected HHP publications had a different focus: The 
first one quantified the association between factors measured in mid-life(mean age 
54) and survival to 85 years of age in 5,820 healthy men (26). The second used 
factors measured in 2,239 healthy older adults (mean age 76) and also studied their 
association with survival to the age of 85 years (24). The third study included those 
with the potential to reach 100 years within the considered follow-up period, leaving 
1,292 healthy men aged 56-68 years (mean age 62), and analysed the association 
between factors measured at that age and the chance of reaching octogen-, nonagen- 
or centenarian status (20). The last publication originating from the US used data 
from the Iowa-Established Populations for Epidemiologic Study of the Elderly 
(Iowa-ESEPE) (29). This prospective cohort study was initially set up to identify 
risk factors for mortality, institutional admissions, and changes in functional abilities. 
They analysed 2,890 community-dwelling citizens, who were between 65 and 85 
years of age at baseline (November 1981-January 1983), and followed them up to 
death. Separate analyses were performed within men, and women using the top 
10th percentile survivors cut-off age as an outcome (94 years for men, 97 years for 
women).
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There were six European studies (17, 18, 25, 27, 28, 30), five of which were 
based on existing cohort studies (18, 25, 27, 28, 30), and one based on data from 
a standard examination program (17). The first used data from the Oslo Ischemia 
Study (OIS) (28). The OIS aimed to detect unsuspected coronary heart disease. 
For the publication of Heir et al. (2013), 821 men were followed up from 51-
59 years to 85 years of age. The analyses were conducted separately for smokers 
and non-smokers (28). The second study was based on the Rotterdam study (18). 
The main objectives of the Rotterdam Study were to investigate the risk factors 
of cardiovascular, neurological, ophthalmological, and endocrine diseases in the 
elderly. For this study, they followed up 2,008 men and women from 68 -84 
years and assessed their survival to at least 85 years of age (18). The third study 
was based on the existing PAQUID cohort, which is a French study initiated to 
better understand dementia in the elderly (25). 2,578 participants were followed up 
to assess the association between risk factors measured at age 70 years or older 
and survival to 90 years of age. Another French study used national standard 
examination data from IPC centers (Centre d’Investigations Préventives et Cliniques) 
and followed 7,467 participants from 60-70 years of age to 80 years (men) and 
85 years (women) (17). They assessed the association between factors measured at 
baseline and reaching longevity. The authors analysed males and females separately 
and together (17). Finally, two studies used data from the Swedish Gothenburg 
cohort (27, 30). One study assessed determinants of longevity to the age of 90 
in 855 men measured at 50, 54, 60 and 67 years of age (27). The other study 
analysed both men (n=1,225) and women (n=1,403) from 70 years until 85 years of 
age (30). A summary of the studies described above can be found in Table 1.
Table 1: Overview of identified publications sorted by publication year.
Reference Design Follow-up Age at 
baseline
Outcome Analysis
Goldberg, 
1996 (16)
Cohort: 
Framingham 
Heart 
Study(FHS), 
Framingham, 
USA
Sample size: 
1,720 men, 
and women 
free of certain 
diseasesa
1948-52 
to early 
1990s
50 years Survival to the 
age of ≥75 years
•	 Males and Females were 
analysed separately
•	 Adjustment factors 
considered were 
Italian ancestry, 
education, marital 
status, occupation, 
alcohol intake, smoking, 
hypertension, level of 
systolic and diastolic 
blood pressure (SBP, 
DBP), Body Mass Index 
(BMI), current heart rate,  
forced vital capacity 
(FVC), Parent’s  survival 
to 75
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Dey, 2001 
(30) 
Cohort: 
Gothenburg, 
Sweden. 
Sample size: 
2,628 men and 
women
1971-81 to 
1996 
70 years Survival to the 
age of 85 years
•	 Males and Females were 
analysed separately
•	 Adjustment factors 
considered were birth 
cohort, smoking habits 
at age 70, and weight 
change between 70 and 
75 years.
Benetos, 2005 
(17)
Cohort:
Participants 
of standard 
IPC Center 
examinations 
in Paris area, 
France
Sample size: 
7,467 men and 
women
1972-81 to 
1997
60-70 
years
Men:
Survival to the 
age of ≥ 80 years
Women:
Survival to the 
age of  ≥85 years
•	 Males and Females were 
analysed together and 
separately
•	 Adjustment factors 
considered were age, 
gender, personal history 
of diseases, Forced 
expiratory volume (FEV) 
ratio, SBP, DBP, pulse 
pressure (PP), total 
cholesterol, glycaemia, 
smoking, BMI, 
triglycerides, heart rate, 
physical activity and left 
ventricular hypertrophy 
(LVH)
Terry , 2005 
(31)
Cohort:
GFramingham 
Heart 
Study(FHS), 
Framingham, 
USA
Sample size: 
2,531 men 
and women 
free of certain 
diseasesa; all 
born before Jan 
1st 1919
1948-52 to 
2004
40-50 
years
Survival to the 
age of ≥85 years
•	 Adjustment factors 
considered were 
sex, SBP, DBP, PP, 
antihypertensive 
medication use, total 
serum cholesterol, BMI, 
glucose intolerance, 
LVH, smoking, education 
and physical activity 
index, calendar decade
Willcox,  2006 
(26)
Cohort: 
Honolulu 
Heart Program 
(HHP), Oahu, 
Hawaii, USA
Sample size: 
5,820 Japanese 
American men 
free of certain 
diseasesa; all 
born between 
1900 -19
1965-68 to 
2005
45-68 
years 
(mean 
age 54)
Survival to the 
age of ≥85 years
•	 Adjustment factors 
considered were 
BMI, grip strength, 
hypertension, 
hyperglycaemia, 
triglycerides level, 
haematocrit level, uric 
acid levels, smoking, 
alcohol, education, 
marital status, FEV
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Yates, 2008 
(19)
Cohort:
Physician’s 
Health Study 
(PHS), MA, 
USA
Sample size: 
2,357 men 
free of certain 
diseasesa; all 
born on or 
before Dec 31, 
1915
1981-84 to 
2006
≥66  
years 
(mean 
age 72)
Survival to the 
age of ≥90 years
•	 Adjustment factors 
considered were age, 
BMI, smoking status, 
alcohol intake, exercise 
frequency, history of 
hypertension, diabetes, 
high cholesterol level, 
angina, and treatment 
assignment at baseline
Newson, 2010 
(18)
Cohort: 
Rotterdam 
Study, 
Rotterdam, The 
Netherlands
Sample size: 
2,008 men 
and women 
free of certain 
diseasesa all 
born on or 
before Jan 1, 
1922
1990-93 to 
2007
68 - <85 
years
(mean 
age 75.8)
Survival to the 
age of ≥ 85 years
•	 Adjustment factors 
considered were age, 
sex, number of relatives, 
living status, income, 
health insurance, self-
rated health, smoking, 
education, spousal death, 
BMI, energy intake, fruit 
and vegetable intake, 
alcohol intake, diabetes, 
atrial fibrillation, family 
history of morbidities, 
depression history, 
hospitalization, cognitive 
status, hip fracture, 
vertebral fracture, 
glucose, high density 
lipoprotein (HDL), 
cholesterol, lumbar spine 
bone mineral density 
(BMD), (instrumental) 
activities of daily living 
(I)ADL, C-reactive 
protein (CRP), creatinine, 
uric acid, albumin, 
femoral neck BMD, 
DBP, heart rate, ankle 
brachial index, aortic 
calcification, intima 
media thickness, carotid 
plaques, leucocytes, LVH
•	 Effect modification by 
gender assessed
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Wilhelmsen, 
2010 (27)
Cohort: 
Gothenburg, 
Sweden 
 
Sample size: 
855 men born 
in Gothenburg 
in 1913 on 
dates divisible 
by 3 and who 
responded to 
the invitation 
to participate
1963 to 
2003
50 years;
factors 
also 
measured 
at 54, 60 
and 67
Survival to the 
age of ≥ 90 years
•	 Adjustment factors 
considered were 
smoking, coffee 
consumption, alcohol-
related problems, socio-
economic status (SES), 
dyspnoea on exertion, 
psychological stress, 
presence of diabetes 
mellitus, early death or 
myocardial infarction 
(MI) in parents, 
blood pressure, BMI, 
waist circumference, 
blood levels of lipids 
and glucose, plasma 
fibrinogen, lung 
function, maximum 
working capacity and 
heart volume. The 
following factors were 
also considered but not 
measured at each time 
point: physical activity, 
mental stress, diabetes, 
height, weight and 
marital status
Dutta, 2011 
29) 
Cohort: 
Iowa, 
Established 
Populations for 
Epidemiologic 
Study of the 
Elderly (Iowa-
EPESE), IA, 
USA.
 
Sample size: 
2,890 
community-
dwelling 
citizens.  
1981-1983 
to cohort 
‘death’
65-85 
years at 
baseline. 
(mean 
age 72 
for men, 
74 for 
women)
Survival to the 
top 10% longest 
survivors for 
their gender. (94 
years males, 97 
years females)
•	 Analyses were performed 
separate for men and 
women and combined.
•	 Adjustment factors 
considered were age at 
baseline, sex, smoking-, 
attitude towards life-, 
self-reported health-, 
chronic medical 
condition-, systolic blood 
pressure-, numbers of 
words recalled-, and 
gross mobility & physical 
ability at baseline.
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Rantanen, 
2012 (20)
Cohort: 
Honolulu 
Heart Program 
(HHP), Oahu, 
Hawaii, USA
Sample size: 
2,239  Japanese 
American men 
free of certain 
diseasesa; all 
born between 
1900 -09
Subgroups: 
Males only
1965-68 to 
2009
56-68 
years 
(mean 
age 62)
Survival 
categorized as;  
56-68 to < 79 = 
reference,
80-89 years = 
octogenarian,
90-99 years = 
nonagenarian,  
100 years= 
centenarians
•	 Models repeated 
to assess odds of 
becoming centenarian, 
nonagenarian or 
octogenarian compared 
to dying by 79 years in 
tertiles of baseline grip 
strength
•	 Adjustment factors 
considered were diabetes, 
high blood pressure, 
physical activity, 
mother’s age and 
smoking
Edjolo, 2013 
(25)
Cohort:
PAQUID 
prospective 
cohort on brain 
and functional 
ageing, South-
West France
Sample size:
2,578 men and 
women
1988 to 
2008
≥70- <90 
years
Survival to the 
age of ≥ 90 years
•	 Analysis conducted 
separately for men and 
women
•	 Adjustment factors 
considered were 
lifestyle factors, such 
as physical activity, 
smoking, alcohol intake, 
BMI, diet; material 
environment factors 
such as occupation, 
education; social 
environment factors 
such as marital status, 
living arrangement; 
current health status 
including cognition, 
depressive symptoms and 
impairment, self-reported 
history of health, 
perceived health and 
satisfaction of life, family 
background of siblings 
and parental age at death 
and age at birth
Heir,  2013 
(28)
Cohort:
Oslo ischemia 
study, Oslo, 
Norway
Sample size:
821 men born 
no later than 
Dec 31, 1921, 
free of certain 
diseasesa and 
without regular 
drug intake
1972-75 to 
2006
51-59 
years
Survival to the 
age of ≥ 85 years
•	 Analysis was performed 
separately for smokers 
and non-smokers
•	 Adjustment factors 
considered were  age, 
BMI, physical fitness, 
cholesterol level, systolic 
blood pressure, and daily 
number of cigarettes
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Bell, 2014 
(24)
Cohort:
Honolulu 
Heart Program 
(HHP), Oahu, 
Hawaii, USA
Sample size:
1,292 Japanese 
American men 
participants 
free of certain 
diseasesa; all 
born between 
1900 -19; 
excluded those 
who did not 
participate 
in second 
examination in 
1991-93
1991-93 to 
2012
72-82 
years
(mean 
age 76)
Survival to the 
age of ≥ 85 years
•	 Adjustment factors 
considered were age, 
education , unmarried in 
late life, BMI, waist hip 
ratio, FEV, SBP, DBP, 
hypertension, cognitive 
abilities, ankle-brachial 
index, depression, 
self-rated health, 
triglycerides, HDL, 
glucose,  fibrinogen, 
white blood cell count, 
insulin, total cholesterol, 
smoking, alcohol use, 
physical activity, blocks 
waked per day
a Diseases can vary from study to study, but usually include chronic diseases, such as cardiovascular 
diseases, respiratory diseases, cancer, liver and or kidney disease.
Lifestyle factors and longevity
Smoking 
Twelve of the thirteen included studies estimated the association between smoking 
and longevity (16-20, 24-29, 31). Nine studies performed analyses within male 
participants (16, 19, 20, 24-29), three studies analysed female participants (16, 
25, 29), and four studies combined gender in their analyses (17, 18, 29, 31). Ten 
studies categorized smoking in either current-/ ever- /never smoker or ever-/ never 
smoker (17-20, 24-27, 29, 31). In males, being an ever- or current smoker at 
baseline seems to be significant negatively associated with surviving to exceptional 
ages compared with never smokers (Table 2) (19, 20, 24-27). When both genders 
were combined in the analyses, three studies did find similar significant negative 
associations between smoking status and longevity (18, 29, 31), while one did not 
(17). Two publications investigated longevity in women, and both did not find a 
significant association between smoking status and longevity (Table 2) (25, 29). 
Two studies assessed the association between the numbers of cigarettes smoked 
per day and the odds for reaching the age of 75 years (16), and 85 years (28) 
respectively. Within the FHS cohort they found an odds ratio (OR) of 0.72 (95% 
CI, 0.62- 0.85) and 0.63 (95% CI, 0.55- 0.74) for males and females respectively 
per increase of 1-SD cigarettes consumed per day and reaching 75 years of age 
(16). Another study, which investigated men included in the OIS cohort, found 
ORs of 0.68 (95% CI, 0.45-1.02) and 0.39 (95% CI, 0.26-0.58) for 1-9, and ≥10 
cigarettes per day, respectively, compared to non-smokers (28). This indicates an 
inverse dose-response relationship between the number of cigarettes smoked per day 
and the odds for reaching longevity. One study within the HHP cohort investigated 
the association between smoking status and longevity using different longevity cut-
off ages (20). For ever smokers they observed an increasing strength in ORs, 0.74 
(95% CI, 0.59-0.92), 0.47 (95% CI, 0.37- 0.60), and 0.17 (95% CI, 0.09-0.33) 
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for ever smokers, for reaching octogenarian, nonagenarian, and centenarian status 
respectively, compared to never smokers. This indicates that smokers are less likely 
to survive to older ages. Additionally, in the Gothenburg study, never smoking was 
significantly associated with reaching longevity (90 years) when assessed at age 50 
years. However, no significant association was found between being an ex-smoker at 
ages 50-67 years and reaching longevity, compared to current smokers (27). 
Alcohol consumption
Four studies selected for this review investigated the association between alcohol 
consumption and longevity in men (16, 19, 24, 26), and one in women (16) 
(Table 2). In the FHS cohort, they compared alcohol consumers with non-alcohol 
consumers and different alcohol quantities in millilitres of alcohol per week 
on longevity (16). They did not find a significant association between alcohol 
consumption and the odds for reaching 75 years of age for both sexes. In the HHP 
cohort, they investigated the association between drinking  ≥3 alcoholic beverages 
a day and survival to 85 years of age (26). They found that participants drinking 
≥3 beverages a day had an OR of 0.63 (95% CI, 0.53- 0.75) (inversed from 
original article), for surviving to 85 years of age compared with participants who 
consumed less alcohol. Another study in the HHP compared participants consuming 
>15 ounces of alcohol per month with participants consuming less, and found an 
OR of 0.66 (95% CI, 0.48- 0.91) for surviving to 85 years of age (24). Finally, in 
the PHS cohort they investigated the association between different levels of alcohol 
intake and survival to 90 years (19). Alcohol consumption was defined as ‘drinking 
rarely or never’ versus ‘drinking 1-3 drinks per month’, ‘1-6 drinks per week’, or 
‘≥1 drink(s) per day’. No significant associations were found when the groups were 
compared. 
Coffee consumption
One publication from the Gothenburg cohort was found that investigated the 
association between coffee consumption and longevity. They found a significant OR 
of 0.88 (95% CI, 0.80-0.96) per increase of one cup of coffee per day for reaching 
90 years of age (Table 2) (27). No studies on other dietary factors were found.
Physical activity
Six of the selected publications investigated the association between physical activity 
and longevity (17, 19, 20, 24, 25, 28). All studies did show a significant positive 
association between elevated levels of physical activity and reaching longevity 
compared to participants with low levels of physical activity for both sexes (Table 
3) (17, 19, 20, 24, 25, 28). In addition, one study in the PHS cohort investigated 
a dose-response relationship between different levels of physical activity (1-4 times 
a month, 2-4 times per week, and ≥ 5 times a week vs. rarely or never) and the 
chance for reaching longevity (90 years) (19). No dose-response relationship was 
found across different levels of physical activity, with corresponding hazard ratios 
(HR) of 1.28 (95% CI, 1.10-1.49), 1.39 (95% CI, 1.20-1.61), and 1.23 (95% CI, 
1.04-1.45) respectively (19). However, they found a significant positive association 
with longevity even at a minimal level of physical activity (1-4 times a month) 
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compared to those with a lower level of physical activity. In the HHP cohort, 
they investigated whether an increase of one hour of physical activity per day 
was associated with the odds of reaching different age categories (octogenarian, 
nonagenarian, and centenarian) (20). The effect of physical activity on reaching 
longevity seemed to increase with advanced ages ranging from 1.03 (95% CI, 0.99-
1.06) to 1.13 (95% CI, 1.02-1.25) (20). Finally, one study that used data from the 
OIS cohort stratified their analyses based on smoking status (28). They found a 
significant association with physical activity only in non-smoking men (28). 
Body Mass Index and weight change
Six studies examined the relationship between BMI (in kg/m2) and the chance 
for reaching a defined longevity cut-off (19, 24, 26, 28-30). Overall, these studies 
show varying results as presented in Table 3. All studies used different BMI cut-off 
points to investigate the association between BMI and longevity, which makes it 
difficult to formulate clear-cut conclusions. However, in general the effect estimate 
on longevity seems only to be significantly negatively associated in both extremes 
of the BMI spectrum (BMI <20, and >30) (19, 24, 28-30). Another observation 
is that (unintentional) weight loss, in addition to low BMI (<20), is negatively 
associated to longevity (18, 24, 30). Within the OIS cohort Heir et al. (28) stratified 
for smoking status in their analysis. They found that men with overweight (25.5-
29.9 kg/m2) or obesity (>30 kg/m2) had a statistically significant lower chance for 
reaching the age of 85 compared to lower weight (BMI <25 kg/m2) men, but only 
in the non-smoking population (28). No clear differences were found between men 
and women. 
Table 2: Associations of smoking, alcohol and diet with longevity across studies.
Reference  Cohort Age at 
base-
line
Longevity cut-off 
point
Sub-
group
n Exposure contrast 
definition
Effect estimate + 95% CI
Smoking
Goldberg, 
1996
FHS 50 75 Men 733 Increase of 1-sd in 
cigarettes smoked 
per daya
OR: 0.72 (0.62 – 0.85)a
Women 946 OR: 0.63 (0.55 – 0.74)a
Heir, 2013 OIS 51 85 Men 821 1-9 vs. 0 cigarettes 
per day
OR: 0.68 (0.45-1.02)
≥10 vs. 0 cigarettes 
per day
OR: 0.39 (0.26-0.58)
Terry, 2005 FHS 40 88 - 1,445 Yes (if in last year) 
vs. No
OR: 0.47 (0.39-0.57)
Willcox, 2006 HHP 45 85 Men 5,525 Ever vs. never OR: 0.52 (0.46 – 0.58)a
Rantanen, 
2012
HHP 56 80-89 Men 1,647 Ever vs. never a OR: 0.74 (0.59 – 0.92)a
56 90-99 Men 1,346 Ever vs. nevera OR: 0.47 (0.37 -0.60)a
56 100 Men 848 Ever vs. nevera OR: 0.17 (0.09 – 0.33)a
Benetos, 2005 IPC 60 80 (♂)/ 85 (♀) - 7,467 Current smoking of 
more than 10 ciga-
rettes a day vs. not 
smoking
“No significant associ-
ation”
Newson, 2010 Rotterdam 55 85 - 2,008 Ever vs. nevera OR: 0.74 (0.57 - 0.94)a
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Bell, 2014 HHP 72 85 Men 1,292 Current vs. never OR: 0.43 (0.24 – 0.77)a
Past vs. never OR: 0.68 (0.49 – 0.68)a
Wilhelmsen, 
2010
Gothenburg 50 90 Men 855 Never-smoker at 
age 50b
OR: 2.79 (1.75-4.44) 
Ex-smoker at age 50b “No significant associ-
ation”
Stopped smoking at 
age 54b
“No significant associ-
ation”
Stopped smoking at 
age 60b
“No significant associ-
ation”
Stopped smoking at 
age 67b
“No significant associ-
ation”
Dutta, 2011 Iowa- ESEPE 65 94 Men 1,080 Current vs. nevera OR: 0.11 (0.03-0.46)a
Current vs. ex-smo-
kera
OR: 0.22 (0.05-0.93)a
65 97 Women 1,683 Current vs. nevera OR: 0.39 (0.09-1.67)a
Current vs. ex-smo-
kera
OR: 1.25 (0.19-7.69)a
Yates, 2008 PHS 66 90 Men 2,280 Past vs. never HR: 0.77 (0.68- 0.86)a
Current vs. never HR: 0.48 (0.40 – 0.57)a
Edjolo, 2013 PAQUID 70 90 Men 1,025 Ever vs. never HR: 0.85 (0.74- 0.99)a
Women 1,492 “No significant associ-
ation”
Alcohol intake
Goldberg, 
1996
FHS 50 75 Men 700 1-sd increase in alco-
hol intake (ml/wk)a
“No significant associ-
ation”
Women 916 “No significant associ-
ation”
Willcox, 2006 HHP 45 85 Men 5,525 ≥ 3 drinks/day vs. less OR: 0.63 (0.53-0.75)a
Bell, 2014 HHP 72 85 Men 1,292 >15 vs. ≤ 15 ounces 
per month
OR: 0.66 (0.48-0.91)a
Yates, 2008 PHS 66 90 Men 2,280 1-3drinks/month vs. 
rarely/never
HR: 1.12 (0.90 -1.41)a
1-6drinks/week vs. 
rarely/never
HR: 1.05 (0.90-1.23)a
≥1 drink/day vs. 
rarely/never
HR: 1.01 (0.86-1.19)a
Coffee consumption
Wilhelmsen, 
2010
Gothenburg 50 90 Men 855 Increase of 1 cup of 
coffee per day 
OR: 0.88 (0.80-0.96)
a Value or contrast definition inverted from published results. b Reference group is unclear in original publication.
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Table 3: Associations of physical activity and body mass with longevity across studies.
Reference Cohort Age at 
base-
line 
Longevity cut-
off point
Subgroup n Exposure contrast 
definition
Effect estimate + 
95% CI
Physical activity 
Heir, 2013 Oslo 51 85 Non- smoking 
men
452 Medium vs. low OR: 1.18 (0.71-1.98)
High vs. low OR: 1.88 (1.12-3.13)
Smoking men 369 Medium vs. low OR: 1.31 (0.72-2.39)
High vs. low OR: 1.80 (0.95-3.39)
Rantanen, 
2012
HHP 56 80-89 Men 1,647 Increasing h/day OR: 1.03 (0.99-1.06)
56 90-99 Men 1,346 Increasing h/day OR: 1.04 (1.00-1.09)
56 100 Men 848 Increasing h/day OR: 1.13 (1.02-1.25)
Benetos, 2005 IPC 60 80 (♂)/ 85 (♀) - 7,467 Yes (>2h per week)  
vs. No
OR: 1.52 (1.27-1.83)
Bell, 2014 HHP 72 85 Men 1,292 High vs. low a OR: 1.41 (1.04-1.91)
Yates, 2008 PHS 66 90 Men 2,280 1-4 times/mo vs. 
rarely/never
HR: 1.28 (1.10-1.49)a
2-4 times/wk vs. rarely/
never
HR: 1.39 (1.20-1.61)a
≥5 times/wk vs. rarely/
never
HR: 1.23 (1.04-1.45)a
Edjolo, 2013 PAQUID 70 90 Men 1,025 Regular vs. Not regular HR: 1.35 (1.15–1.56)a
Women 1,492 HR: 1.12 (1.04–1.47)a
BMI (kg/m2)
Heir, 2013 Oslo 51 85 Non-smoking 
men
452 25–29.9 vs. <25 OR: 0.54 (0.36-0.82)
≥30 vs. <25 OR: 0.21 (0.05-0.96)
Smoking men 369 25–29.9 vs. <25 OR: 0.92 (0.53–1.59)
≥30 vs. <25 OR: 0.84 (0.17–4.12)
Willcox, 2006 HHP 45 85 Men 5,525 ≥ 25 vs. <25 OR: 0.88 (0.78-1.00)a
Bell, 2014 HHP 72 85 Men 1,292 ≥ 19 vs. <19a OR: 2.25 (1.12-4.51)
≥ 25 vs. <25a “No significant asso-
ciation”
Yates, 2008 PHS 66 90 Men 2,280 25-29.9 vs. <25 HR:  1.03 (0.93-1.16)a
>30 vs. <25 HR: 0.69 (0.53-0.91)a
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Dutta, 2011 Iowa-ESEPE 50 94 Men 1,092 <20 vs. 20-25 OR: 0.68 (0.14-3.29) 
25-29.9 vs. 20-25 OR: 0.73 (0.43-1.24)
>30 vs. 20-25 OR: 0.64 (0.27-1.52)
50 97 Women 1,698 <20 vs. 20-25 OR: 1.12 (0.52-2.43)
25-29.9 vs. 20-25 OR: 0.87 (0.56-1.34)
>30 vs. 20-25 OR: 0.44 (0.18-1.07)
Combined 2,790 <20 vs. 20-25 OR: 1.00 (0.51-1.98)
25-29.9 vs. 20-25 OR: 0.81 (0.58-1.13)
>30 vs. 20-25 OR: 0.52 (0.28-0.96)
Dey, 2001 Gothenburg 70 85 Men 1,225 14.0-22.6 vs. 24.7-26.4 RR: 0.83 (0.66-1.04)a
22.7-24.6 vs. 24.7-26.4 RR: 0.93 (0.75-1.18)a
26.5-28.5 vs. 24.7-26.4 RR: 0.99 (0.79-1.23)a
28.6-39.2 vs. 24.7-26.4 RR: 0.84 (0.67-1.05)a
Women 1,403 14.1-22.5 vs. 24.6-26.5 RR: 0.67 (0.51-0.88)a
22.6-24.5 vs. 24.6-26.5 RR: 0.86 (0.65-1.14)a
26.6-29.2 vs. 24.6-26.5 RR: 0.86 (0.66-1.14)a
29.3-39.8 vs. 24.6-26.5 RR: 0.8 (0.61-1.05)a
Weight loss 
Newson, 2010 Rotterdam 55 85 - 2,008 Unintentional weight 
loss (3kg in 3 months) 
absent vs. present
OR: 1.42 (1.04-1.94)
Dey, 2001 Gothenburg 70 85 Men 1,225 ≥10% lost vs. 0-4.9% 
lostb 
RR: 0.62 (0.46-0.83)a
5-9.9% lost vs. 0-4.9% 
lostb 
RR: 0.90 (0.63-1.30)a
0-4.9% gained vs. 
0-4.9% lostb 
RR: 0.97 (0.65-1.45)a
≥5% gained vs. 0-4.9% 
lostb
RR: 0.99 (0.70-1.39)a
Women 1,403 ≥10% lost vs. 0-4.9% 
lostb 
RR: 0.47 (0.32-0.68)a
5-9.9% lost vs. 0-4.9% 
lostb 
RR: 0.75 (0.46-1.23)a
0-4.9% gained vs. 
0-4.9% lostb 
RR: 0.88 (0.54-1.43)a
≥5% gained vs. 0-4.9% 
lostb 
RR: 0.70 (0.46-1.05)a
a Value or definition inverted from published results. b Weight difference percentage between age 70 and 75 years.
Education 
The relationship between education and longevity was assessed in four studies 
(Table 4) (16, 18, 26, 31). One study of the FHS compared participants who 
received a college education or higher with lower educated participants (16). 
They did not find a significant association between educational level and reaching 
longevity. Another study in the HHP cohort also found no significant association 
when they compared men who graduated high school to less educated men on 
reaching longevity (85 years) (26). Two other studies, from the FHS cohort and the 
Rotterdam study, evaluated whether an increase per education level category might 
lead to a higher odds for reaching exceptional age (18, 31). The FHS study did 
find a significant OR of 1.25 (95% CI, 1.12-1.39) after adjustment for potential 
confounding factors (31), while the other did not (18). 
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Marital status 
Two studies from the HHP investigated the association between unmarried men and 
the chance for reaching longevity (85 years), compared to married men (24, 26). 
Both studies found significant negative ORs of 0.64 (95% CI, 0.52-0.78) (26), and 
0.44 (95% CI, 0.22-0.89) (24) (Table 4). In addition to marital status, the Rotterdam 
study investigated the association between spousal death and the odds for reaching 
85 years of age (18). No significant associations between a deceased spouse and 
reaching longevity were found in men and women (Table 4) (18).
Table 4: Associations of education and marital status with longevity across studies. 
Reference Cohort Age 
at 
base-
line 
Longevity cut-
off point
Subgroup n Exposure contrast 
definition
Effect estimate + 
95% CI
Education
Goldberg, 
1996
FHS 50 75 Men 723 College education or 
higher vs. lower
“No significant asso-
ciation”
“No significant asso-
ciation”
Women 953 College education or 
higher vs. lower
“No significant asso-
ciation”
“No significant asso-
ciation”
Terry, 2005 FHS 40 85 - 1,445 One increase in 
category from not 
graduating high 
school, to graduating 
high school and then 
having education 
beyond high school
OR: 1.25 (1.12-1.39)
Willcox, 2006 HHP 45 85 Men 5,525 Graduating high 
school vs. less educa-
tion (=  <12 years)1
“No significant asso-
ciation”
Newson, 2010 Rotterdam 55 85 - 2,008 One increase in cat-
egory (from primary 
education to universi-
ty level)
“No significant asso-
ciation”
Marital Status
Willcox, 2006 HHP 45 85 Men 5,525 Unmarried vs. 
married 
OR:  0.64 (0.52-0.78)a
Bell, 2014 HHP 55 85 Men 1,292 Unmarried vs. 
married 
OR: 0.44 (0.22-0.89)a
Newson, 2010 Rotterdam 72 85 - 2,008 Spousal death present 
vs. absenta 
“No significant asso-
ciation”
aValue or definition inverted from published results.
Parental longevity and reproductive factors 
We aimed to assess whether offspring of long-lived parents are long-lived as 
well, and whether this is mediated through the mother, the father or both (Table 
5). Furthermore, we aimed to identify studies which investigated the association 
between reproductive factors and the chance of reaching longevity. We found one 
study which investigated the association of parental age at birth, and the number of 
siblings with longevity (Table 5) (25). No studies were found on other reproductive 
factors of interest, including the number of children, breast-feeding, age at menarche, 
and age at menopause in relation to longevity.
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Parental longevity 
Two studies, one within the FHS, and one within the IOWA-ESEPE, quantified 
parental longevity by looking if one, two or none of the parents reached the age 
of 75 or 85 years respectively. Both studies found that per one parent increase in 
longevity, the odds for reaching longevity in participants was increased, but only 
in women (16, 29). Two other studies investigated whether the mother’s age and/
or the father’s age at death was associated with reaching longevity (20, 25). In the 
PAQUID study it was observed that only the mother’s age at death was associated 
with longevity, but only in women (25). In the HHP they found that maternal 
longevity to at least 80 years was significantly associated with the chance for their 
male offspring to become a nonagenarian (OR 1.84, 95% CI 1.37-2.47) and/or 
centenarian (OR 2.26, 95% CI 1.04-4.90), compared to maternal survival until 60 
years (20).  No significant associations were found between paternal ages at death 
and offspring’s longevity (20). Overall, these studies suggest that parental longevity 
is associated with reaching longevity, and that this association is primarily associated 
with maternal longevity. Whether parental longevity affects the chance of reaching 
longevity in both male and female offspring, remains unclear.  
Parental age at birth and number of siblings 
Only one study assessed the relationship between reproductive factors and longevity 
(25). In the PAQUID longevity study they assessed parental age at participant’s birth 
separately for both biological parents  in five years categories starting from below 
25 years (reference group) to above 40 years (25). According to the authors, none 
of the comparisons yielded any significant associations between the parental age 
at birth and offspring longevity (Table 5). Although not necessarily a reproductive 
factor, the authors also assessed number of siblings and found no association in 
relation to longevity (25).
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Table 5: Associations of parental longevity and reproductive factors with longevity 
across studies.
Reference Cohort
Age at 
base-
line
Longevity cut-
off point Subgroup n
Exposure contrast 
definition
Effect estimate + 
95% CI
Parental longevity
Goldberg, 
1996
FHS 50 75 Men 733 Per one parent increase 
in survival to 75 years
“No significant 
association”
Women 946 OR: 1.39 (1.10-1.75)
Rantanen, 
2012
HHP 56 80-89 Men 1,647 Maternal age at death
61-79 vs. ≤60 OR: 1.01 (0.78 – 1.31)
≥80 vs. ≤60 OR: 1.18 (0.92 – 1.52)
Paternal age at death “No significant 
association”
90-99 Men 1,346 Maternal age at death
61-79 vs. ≤60 OR: 1.30 (0.96 – 1.76)
≥80 vs. ≤60 OR: 1.84 (1.37 – 2.47)
Paternal age at death “No significant 
association”
100 Men 848 Maternal age at death
61-79 vs. ≤60 OR: 0.82 (0.33 – 2.05)
≥80 vs. ≤60 OR: 2.26 (1.04 – 4.90)
Paternal age at death “No significant 
association”
Edjolo, 2013 PAQUID 70 90 Men 1,060 Maternal age at death “No significant 
associations”
Paternal age at death “No significant 
association”
Women 1,580 Maternal age at death
≥85 vs. <65a HR: 1.36 (1.17-1.58)
≥85vs. 65-79a HR: 1.32 (1.11-1.57)
≥85 vs. 80-84a HR: 1.15 (0.98-1.35)
Paternal age at death “No significant 
association”
Dutta, 2011 Iowa-ESEPE 65 94 Men 1,092 One parent living ≥85 
years vs Parents not 
living ≥85
OR: 1.22 (0.73-2.04)
Two parents living ≥85 
years vs Parents not 
living ≥85
OR: 1.16 (0.45-2.98)
65 97 Women 1,698 One parent living ≥85 
years vs Parents not 
living ≥85
OR: 1.80 (1.20-2.74)
Two parents living ≥85 
years vs Parents not 
living ≥85
OR: 2.44 (1.48-4.01)
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Parental age at participant’s birth and number of siblings
Edjolo, 2013 PAQUID 70 90 Men 1,060 Maternal age at partici-
pant’s birth 
“No significant 
association”
Paternal age at partici-
pant’s birth 
“No significant 
association”
1-5 siblings vs 0 siblings “No significant 
association”
>6 siblings vs. 0 siblings “No significant 
association”
Women 1,580 Maternal age at partici-
pant’s birth 
“No significant 
association”
Paternal age at partici-
pant’s birth 
“No significant 
association”
1-5 siblings vs 0 siblings “No significant 
association”
>6 siblings vs. 0 siblings “No significant 
association”
aValue or definition inverted from published results.
Discussion 
This review aimed to summarize the available evidence on the association of 
lifestyle, parental and reproductive factors with reaching longevity (defined as 
reaching a certain age) from cohort studies. Based on the presented results for 
lifestyle factors with longevity, smoking status and physical activity seem to be 
the most important factors that are associated with longevity, whereas alcohol 
intake, BMI, marital status and educational level show limited and/or contradictory 
associations. Furthermore, parental longevity seems to be significantly associated 
with reaching longevity, primarily through maternal longevity, and some studies 
indicate a stronger effect of parental longevity in female offspring compared 
to male offspring (16, 20, 25). Only one study investigated trends in effect 
estimates due to differences in the longevity cut-off age (20). They found that 
the association of smoking and parental longevity with longevity became stronger 
the higher the longevity cut-off age was. Other main findings of this review are 
the limited number of available studies (n=13) investigating lifestyle, and parental 
factors on longevity using a defined cut-off age, and the sheer lack of data on 
dietary and reproductive factors on longevity. Furthermore, across these studies 
substantial heterogeneity in baseline and longevity cut-off ages was found. Therefore, 
conducting a formal meta-analysis was not possible. 
Being an (ex) smoker appears to decrease the chance of survival to old ages 
compared to non-smokers.  This association seems to strengthen with the number 
of cigarettes smoked per day (16, 28). Furthermore, the effect of smoking status 
becomes stronger the higher the longevity cut-off age is (20). In addition, it was 
observed that the association between smoking and longevity might be stronger in 
men, compared to women (25, 29). However, this observation is based on a limited 
number of studies. Therefore, this possible interaction should be further assessed 
in future studies. One study investigated the effect of quitting smoking after 50 
years of age on longevity, and did not find a significant increase in the chance 
for reaching longevity (27). The potential beneficial effect of quitting smoking on 
longevity in older individuals should therefore be further evaluated.
Studies that investigated the relationship between alcohol consumption and longevity 
showed contradictory results (16, 19). Only the HHP cohort found a significantly 
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inverse association between alcohol consumption and reaching longevity (24, 26), 
while the other cohorts did not find any association. However, the HHP cohort is 
characterized by a specific study population, of Japanese-American men, who might 
be genetically more vulnerable to the effects of alcohol consumption compared to 
other populations caused by an unfavourable distribution of the ALDH2 allele in 
Asian populations (32). Furthermore, different standards were used for defining 
(high) alcohol consumption which also limits the comparability across these studies. 
Physical activity seems to be strongly associated with reaching longevity even at 
a minimal level of intensity (17, 19, 20, 24, 25, 28). Furthermore, no linear dose-
response relationship was found between increasing levels of physical activity and 
reaching longevity. This suggests that being physically active is more important 
than the actual quantity of physical activity (19).  However, it should be noted that 
a lack of physical activity can also be a symptom of underlying health problems 
which by itself might lead to premature mortality. One study stratified for smoking 
status and found no significant association between physical activity and longevity 
in smokers, while it was found in non-smokers (28). This could be explained by a 
possible interaction between smoking and physical activity on reaching longevity, or 
by a lack of power in the smoking group. 
BMI showed significant inverse associations with longevity in both extremes of the 
spectrum (<20 kg/m2 and >30 kg/m2) (19, 24, 28, 29). Furthermore, the association 
seemed to increase in the non-smoking population compared to the smoking 
population. Therefore, not stratifying for smoking could lead to an underestimation 
of the effect of BMI on reaching longevity. No differences were found across sexes. 
Unintentional weight loss, in addition to underweight (BMI<20 kg/m2), showed 
a significant negative association with reaching longevity (18, 30). This could be 
explained by disease-associated weight loss or the correlation between smoking 
and being underweight (33). Because of this, it would be particularly interesting to 
investigate whether weight loss in the elderly as an intervention would be helpful 
or harmful and in what way weight changes can affect longevity in healthy and/or 
non-smoking populations.
Education has often been associated with health benefits and was found to be 
predictive for unhealthy behaviours that are associated with an increased risk for 
mortality (34, 35). However, we found no clear evidence that educational level is 
independently associated with reaching longevity. Out of four studies, only one study 
found a significant association between a higher education level and a higher chance 
of reaching longevity (31). Being married is usually associated with health benefits, 
also in the elderly, even if only moderately (36). The reviewed studies also showed 
significant associations between marital status and reaching longevity (24, 26). 
Parental longevity was significantly associated with the offspring’s longevity. 
Furthermore, it was found that this association was primarily present for maternal 
longevity, and not for paternal longevity (20, 25), and more pronounced in female 
offspring (16, 25, 29). There is a lot of potential for further research to see whether 
these maternal or paternal differences are upheld across different studies, and which 
factors might contribute to these differences. The potential different outcomes in men 
and women with regard to parental longevity, is another interesting question and 
should be analysed more closely in future studies. 
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The lack of data on dietary and reproductive factors, and longevity was another 
remarkable result of this review. Dietary factors other than alcohol intake and coffee 
consumption were not found. This is surprising, because dietary restriction in animal 
subjects is often associated with longevity (37), and several studies have shown 
significant relationships between specific dietary patterns and mortality in humans 
(i.e. (38, 39)). 
The lack of cohort studies on the association between reproductive factors and 
longevity, given the higher average life-expectancy of females, is also surprising. 
Only one study investigated parental age at birth on longevity, which yielded no 
significant association (25). Furthermore, there was one excluded case-control study 
identified during the review, which assessed the age of mothers and fathers at birth 
and the birth order on longevity (40). They found that, following adjustments, the 
only remaining predictor of the offspring’s longevity, was if the mother was below 
the age of 25 when giving birth to the offspring. These parameters need to be 
further assessed, as the PAQUID cohort did not find any associations (25).
Studying longevity is challenging and faces limitations. A possible source of bias 
includes depletion of susceptibles. Depletion of susceptibles helps us understand 
why some factors could have an attenuated relationship to longevity the older the 
subject gets. Examples of this are smokers who have already reached an advanced 
age. Their susceptibility to adverse health outcomes might differ from smokers 
who have died at an earlier age. This is important to consider, as the association 
with longevity will probably vary using different longevity cut-off ages, as well 
as different baseline ages at which the exposure was measured. The problem of 
reverse causation arises as well. Some baseline characteristics might be explained 
by the participants’ preclinical disease status. For example, a person who contracts 
a potentially lethal or chronic disease on a younger age, and who is therefore less 
likely to reach longevity, will simultaneously be less likely to be physically active. 
Therefore, causal conclusions cannot be drawn based on the presented results. 
In addition to the limitations of longevity research, one can argue that our in- and 
exclusion criteria were restrictive. However, the presented studies already vary 
widely between themselves, so relaxing our in- and exclusion criteria would have 
made interpreting the results on longevity even more challenging. To tackle the 
complexity of longevity research, the effect of different longevity cut-off ages, as 
well as the effect of different (baseline) ages, would be very interesting to assess 
within one study, as this was very informative in the study of Rantanen et al. (20). 
Such approaches could allow us more to understand longevity within a life course 
setting. Even though studies with a long observation time are scarce for this specific 
topic, many longitudinal cohort studies, that were previously set up for other 
purposes, could be used to assess longevity, as mortality is usually integrated in the 
outcomes.
Many gaps of knowledge have been identified in this review. In general it is 
evident that more research is needed to address the gaps of interest, test consistency 
and deepen our understanding of this research area.
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Sex-specific associations between smoking habits and reaching 
longevity: Netherlands Cohort Study
Lloyd Brandts, Piet A. van den Brandt
Abstract
Aim
Tobacco smoking has been found to be significantly associated with a decreased 
chance of reaching longevity in men, but not in women. Furthermore, it is still 
unclear how the association of smoking status with longevity varies under the 
influence of underlying smoking characteristics. Therefore, we aimed to quantify the 
association between several smoking characteristics and the chance of reaching the 
age of 90 years in men and women separately. 
Methods
We conducted a prospective cohort study among the oldest birth cohorts (1916-1917) 
of the Netherlands Cohort Study, who completed a baseline questionnaire in 1986 
(at ages 68-70), and had complete vital status information until 90 years of age 
(2006-2007, n=7,807). Multivariable-adjusted analyses were based on 6,642 men and 
women, of which 16.0 and 34.3 percent reached longevity, respectively.
Results
The relationship of smoking status with longevity was stronger in men than in 
women (current vs. never smokers; Risk Ratio (RR), 0.44; 95%CI, 0.34-0.56 in 
men, and RR, 0.67; 95%CI, 0.57-0.79 in women). Furthermore, significantly inverse 
associations were found between longevity and increasing cigarette smoking quantity, 
duration, and tar and nicotine exposure, which partially explain the observed 
difference between both sexes. Quitting smoking significantly increased the chance of 
reaching longevity compared to current smokers.
Conclusions
The effect of smoking status on reaching longevity seemed stronger in men 
compared to women, which can be partially explained by differences in smoking 
habits. Never smokers had the highest chance of reaching 90 years of age in both 
sexes. 
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Introduction         
Surviving to the age of 90 years is a phenomenon that only a small part of 
the population has been able to reach. To date, tobacco smoking is one of few 
established lifestyle factors associated with a decreased chance of reaching an old 
age, commonly referred to as longevity (1-11). Although most studies found a 
significant negative association between tobacco smoking and reaching longevity in 
men, inconclusive results were found in women (1, 9, 11). Additionally, besides 
smoking status little is known on how specific smoking characteristics relate to the 
chance of reaching longevity. 
Using a large prospective cohort, we examined whether overall- and tobacco 
specific smoking status) at the age 68-70 years was associated with an increased or 
decreased chance of reaching longevity, defined as reaching 90 years of age in both 
sexes separately. In addition, we assessed which, if any, (early) cigarette smoking 
features, such as smoking quantity, duration, age at smoking initiation and cessation, 
inhalation, filter-tip usage, and the amount of tar and nicotine exposure were 
associated with reaching longevity. 
Methods
Study design and population 
For this study data from the Netherlands Cohort Study (NLCS) was used. The 
NLCS was set up in 1986 as a large prospective cohort study, which aimed to 
investigate the relationship between diet and cancer in the Netherlands (12). Baseline 
data were collected from 120,852 men and women on lifestyle, dietary habits and 
other cancer risk factors using a self-administered questionnaire. Generally, the 
NLCS uses a case-cohort design with a random subcohort of 5,000 participants to 
increase efficiency in the data processing and follow-up (13). In addition, the full 
NLCS cohort has been followed-up for mortality. This was done by record linkage 
to the Central Bureau for Genealogy (CBG) from September 1986 until 1995, and 
to the municipal population registries (GBA) from 1995 until 2007. Because only 
a part of the subcohort was “at risk” to reach the age of 90 years at the onset 
of this longevity project, we were forced to look beyond the subcohort and select 
those participants in the full cohort who were able to reach the age of 90 years 
in 2007. Therefore, the data entry was restricted to the oldest birth cohorts (1916, 
and 1917) of the NLCS cohort. The participants from these two birth years form 
the longevity cohort for the current analyses in the NLCS (i.e. aged 68-70 years at 
baseline). 
Follow-up for vital status of the longevity cohort until the age of 90 (2006-2007) 
was 99.9% complete. Seven participants were lost to follow-up due to migration. As 
a result, this study population consisted of 3,646 men and 4,161 women (Figure 1). 
The NLCS study has been approved by the institutional review boards of Maastricht 
University (Maastricht, Netherlands) and the Netherlands Organisation for Applied 
Scientific Research TNO (Zeist, Netherlands).
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Exposure assessment
At baseline, all participants completed an 11-page self-administered questionnaire, 
including detailed information on tobacco consumption. Besides smoking status 
(never, former, and current smoker), participants were asked about their starting 
age, quitting age, smoking quantity, -duration and smoke inhalation for each 
tobacco product separately. Additional information was asked about specific 
cigarette characteristics like brand, filter usage, and type of cigarette (mild, regular, 
and strong)(14). Cigarette brand-specific information on nicotine (in mg) and tar 
content (in mg) was obtained from the Dutch Inspectorate for Health Protection, 
the Dutch Foundation on Smoking and Health, and the Dutch Foundation of the 
Tobacco Industry(14). The product of cigarette smoking quantity and cigarette 
brand-specific content was used to calculate the exposure to tar and nicotine per 
day. Questionnaire data used of the birth cohorts 1916-1917 were key-entered and 
processed in a standardized manner, and blinded with respect to the outcome. 
Participants with missing information on overall tobacco smoking status (n=37), and 
potential confounders were excluded from the analyses (n=1,275). As a result, 3,283 
(49.4%) men and 3,359 (50.6%) women were included in the analyses (Figure 1).
Figure 1: Flow diagram of the number of cohort members included for the analyses 
on smoking and longevity.
Statistical Analyses
Baseline characteristics were presented by gender, and overall tobacco smoking 
status with frequencies (percentages) for categorical variables, and with mean 
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including SD for continuous variables. Investigated smoking habits included, overall 
and tobacco specific (cigarette, cigar, and pipe) smoking status, cigarette smoking 
quantity, cigarette smoking duration, age at cigarette smoking initiation, age at 
cigarette smoking cessation, time since cigarette smoking cessation, cigarette smoke 
inhalation, filter-tip usage, and exposure to tar and nicotine. 
Age- and multivariable-adjusted Risk Ratios(RR) of reaching longevity with 
corresponding 95% confidence intervals (95%CI) were estimated using Cox 
regression models with a fixed follow-up time(15, 16). Standard errors were 
calculated using the robust Huber-White sandwich estimator to account for 
underdispersion(17). All analyses were performed separately for men and women.
In multivariable analyses, RRs were adjusted for potential confounders. Diseases for 
which we adjusted had the potential to influence smoking habits, and the chance of 
reaching longevity. These included any type of cancer, asthma, chronic bronchitis, 
angina pectoris, heart attack, stroke and diabetes. For trend-analyses, ordinal 
exposure variables were fitted as continuous terms, and never cigarette smokers were 
excluded. To evaluate potential effect-modification, multivariable-adjusted analyses of 
cigarette smoking status with longevity were performed within strata of important 
risk factors. Wald-tests and cross-product terms were used to test for interaction 
with these factors. All analyses were performed using Stata 14.0 (StataCorp. 2015. 
College Station). P-values were based on two-sided tests and considered statistically 
significant if P <0.05.
Results
Compared to women, men were more likely to be an ever smoker of any tobacco 
product at baseline (Table 1).  Most smokers exclusively smoked cigarettes, 
especially in women. In general, the average number of cigarettes smoked per day, 
and years of smoking duration was higher in men compared to women (Table 1). 
Among ever cigarette smokers, men were more likely to inhale smoke, and less 
likely to smoke filter-tipped cigarettes than women (Table 1). 
In men, smokers were less often highly-educated compared to never smokers (Table 
1). In women, smokers had a somewhat lower average BMI, and were more often 
highly-educated compared to never smokers.  In both sexes, the mean alcohol 
consumption per day was highest in smokers, and the proportion of people with a 
history of (selected) diseases at baseline was highest in former smokers (Table 1).
Overall, men were less likely to reach the age of 90 years compared to women 
(16.0% vs 34.3%). The proportion of people who have reached the age of 90 years 
was higher in never smokers, compared to former and current smokers for both 
men (25.6% vs. 18.2% and 11.4%, respectively) and women (36.5% vs. 32.4% and 
26.1%, respectively) (Table 1).
C
hapter 4
 
68
Table 1: Baseline characteristics of the cohort members by gender and overall tobacco smoking status in birth cohorts of 
1916-17; Netherlands Cohort Study on diet and cancer (1986-2007).
Baseline characteristics Men Women
Never smoker Former smoker Current smoker Never smoker Former smoker Current smoker 
n (%) 305 (9.3) 1,605 (48.9) 1,373 (41.8) 2,314 (68.9) 550 (16.4) 495 (14.7)
Use of tobacco products, %
Ever cigarette smokersa NA 59.5 49.5 NA 99.6 98.0
Ever cigar smokersa NA 2.6 5.5 NA 0.2 0.6
Ever pipe smokersa NA 0.4 2.0 NA 0 0
Ever cigar and pipe smokera NA 1.2 2.8 NA 0 0
Ever cigarette & other type of tobacco smoker NA 36.3 40.2 NA 0.2 1.4
Smoking characteristicsb,  mean ± SD
Exclusively cigarette smokersa
Number of cigarettes smoked per day NA 17.8 ± 11.8 15.4 ± 8.6 NA 8.8 ± 9.0 12.1 ± 8.2
Cigarette smoking duration (y) NA 35.0 ± 11.1 50.4 ± 5.9 NA 22.9 ± 12.9 37.2 ± 12.9
Age at cigarette smoking initiation (y) NA 17.6 ± 4.2 17.1 ± 4.4 NA 27.3 ± 10.2 28.6 ± 11.9
Age at cigarette smoking cessation (y) NA 54.2 ± 10.2 NA NA 53.1 ± 12.6 NA
Cigarette smoke inhalation, % yes NA 76.5 74.4 NA 32.9 41.8
Filter-tipped cigarettes, % yes NA 20.0 36.4 NA 70.5 79.9
Type of cigarette, n (%)
Mild NA 32.8 22.9 NA 56.4 55.4
Regular NA 54.8 59.5 NA 30.7 32.9
Strong NA 11.4 16.2 NA 0.7 1.5
Tar (mg/d) NA 368.1± 263.8 318.8± 206.0 NA 123.7± 135.3 154.5± 140.8
Nicotine (mg/d) NA 31.2 ± 29.2 28.1 ± 24.0 NA 9.4 ± 10.3 12.1 ± 11.1
Exclusively cigar smokersa
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Number of cigars smoked per day NA 4.0 ± 2.6 4.2 ± 3.3 NA NA NA
Cigar smoking duration (in years) NA 30.8 ± 12.6 44.5 ± 10.3 NA NA NA
Exclusively pipe smokersa
Number of pipes smoked per day NA 5.3 ± 3.4 8.8 ± 8.7 NA NA NA
Pipe smoking duration (in years) NA 35 ± 11.9 45.4 ± 10.5 NA NA NA
Non-smoking characteristics 
Year of birth, %
1916 20.0 23.6 23.8 24.3 22.4 19.4
1917 80.0 76.5 76.2 75.7 77.6 80.6
Body Mass Index (kg/m2), mean ± SD 24.8 ± 2.8 25.1 ± 2.6 24.6 ± 2.8 25.3 ± 3.6  25.0 ± 3.4    24.2 ± 3.4
Non-occupational physical activity (min/day), 
mean ± SD
72.0 ± 62.4 72.6 ± 59.9 72.3 ± 65.2 55.2 ± 50.0 54.0 ± 42.3 54.0 ± 45.4
Educational level, %
Higher vocational education/ university 21.6 15.6 16.0 6.9 11.5 8.9
Alcohol consumption, mean ± SD 6.0 ± 9.7 13.3 ± 14.6 15.3 ± 16.8 3.1 ± 6.0 7.8 ± 9.8 10.2 ± 14.3
History of (selected) diseasesc, % 29.8  43.0 32.8  27.4 32.2 24.8
Survival status
Survived to the age of 90 years, % 25.6 18.2 11.4 36.5 32.4 26.1
a Smokers of other tobacco products not included. b Number of participants used may vary from the study population due to 
missing values on specific exposure variables. c Diseases included; diseases that had the potential to influence smoking habits, 
and the chance of reaching longevity including any type of cancer, diabetes, asthma, bronchitis, heart attack, angina pectoris, 
and cerebral hemorrhage.
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As shown in Table 2,  male tobacco smokers had a significantly decreased chance 
of reaching longevity, compared to never smokers (RR, 0.44; 95%CI, 0.34-0.56 
and RR 0.76; 95%CI, 0.61-0.95 for current and former smokers, respectively) 
after adjustment for selected confounders. In tobacco-specific multivariable-adjusted 
analyses, male current cigarette smokers had a significantly decreased chance of 
reaching longevity compared to never smokers (RR, 0.37; 95%CI, 0.27-0.50). After 
additional adjustments for cigarette smoking quantity and –duration, the effect 
estimate between cigarette smoking status and longevity was somewhat weaker (RR, 
0.47; 95%CI, 0.33-0.66). Current cigar smokers had a significantly decreased chance 
of reaching longevity, compared to never smokers (RR, 0.48; 95%CI, 0.25-0.90. 
Because the number of exclusively pipe smokers was small, we combined cigar and 
pipe smokers. In these analyses current cigar and/or pipe smokers had a significantly 
decreased chance of reaching longevity compared to never smokers (RR, 0.48; 
95%CI, 0.29-0.77). Men who were current cigarette smoker and current cigar and/
or pipe smoker also showed a significantly decreased chance of reaching longevity, 
compared to never smokers (RR, 0.41; 95%CI, 0.28-0.60; Table 2).
In women, current and former cigarette smokers had a decreased chance of reaching 
longevity compared to never smokers (RR, 0.67; 95%CI, 0.57-0.78, and RR 0.85; 
95%CI, 0.75-0.98, respectively), After additional adjustment for cigarette smoking 
quantity and duration, the association with longevity became somewhat stronger for 
currently cigarette smoking women (RR, 0.61; 95%CI, 0.52-0.73;Table 2). After 
adjustment for cigarette smoking quantity and –duration, gender still acted as a 
significant effect-modifier (P-interaction=0.040). 
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Table 2: Age- and multivariable-adjusted RRs for reaching longevity according to overall and tobacco specific smoking status 
in birth cohorts of 1916-17; Netherlands Cohort Study (1986-2007).
Men Women
Model 1a Model 2b Model 1a Model 2b
n 90+ RR§ (95% CI) RR§ (95% CI) n 90+ RR§ (95% CI) RR§ (95% CI)
Tobacco smoking status
Overall tobacco
Never tobacco 305 78 1 (reference) 1 (reference) 2,314 844 1 (reference) 1 (reference)
Former 1,605 292 0.71 (0.57-0.88) 0.76 (0.61-0.95) 550 178 0.89 (0.78-1.01) 0.85 (0.74-0.97)
Current 1,373 156 0.44 (0.35-0.57) 0.44 (0.34-0.56) 495 129 0.71 (0.61-0.84) 0.67 (0.57-0.79)
P for trend <0.001 <0.001 <0.001 <0.001
P-interaction(sex)
 b 0.015
Exclusively cigarettesc
Former 955 161 0.66 (0.52-0.84) 0.73 (0.57-0.94) 548 178 0.89 (0.78-1.02) 0.85 (0.75-0.98)
Current 679 63 0.36 (0.27-0.49) 0.37 (0.27-0.50) 485 125 0.71 (0.60-0.83) 0.67 (0.57-0.78)
P for trend <0.001 <0.001 <0.001 <0.001
P-interaction(sex)
 b 0.002
Exclusively cigarettesc (additionally 
adjusted for smoking quantity and 
duration)
Former 900 156 0.64 (0.50-0.82) 0.68 (0.53-0.88) 497 161 0.72 (0.59-0.88) 0.70 (0.57-0.86)
Current 616 58 0.51 (0.36-0.71) 0.47 (0.33-0.66) 442 114 0.66 (0.55-0.78) 0.61 (0.52-0.73)
P for trend <0.001 <0.001 <0.001 <0.001
P-interaction(sex)
 b 0.040
Exclusively cigarsc
Former 42 10 0.92 (0.52-1.64) 1.07 (0.62-1.85) 1 0 NA NA
Current 76 10 0.51 (0.28-0.94) 0.48 (0.25-0.90) 3 2 NA NA
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P for trend 0.031 0.026
Exclusively cigar and/or pipec
Former 72 14 0.80 (0.48-1.32) 0.91 (0.55-1.49) 1 0 NA NA
Current 137 18 0.50 (0.31-0.79) 0.48 (0.29-0.77) 3 2 NA NA
P for trend 0.003 0.003
Exclusively cigarettes with cigar 
and/or pipec
Former cigarette, former cigar and/
or pipe
582 117 0.78 (0.61-1.01) 0.78 (0.60-1.00) 1 0 NA NA
Former cigarette, current cigar and/
or pipe
160 29 0.71 (0.48-1.04) 0.68 (0.46-1.01) 1 0 NA NA
Current cigarette, former cigar and/
or pipe
35 5 0.56 (0.24-1.28) 0.62 (0.28-1.41) 0 0 NA NA
Current cigarette, current cigar 
and/or pipe
357 41 0.45 (0.32-0.64) 0.41 (0.28-0.60) 6 2 NA NA
a Age adjusted model. b Model adjusted for age (years), body mass index (<18.5, 28.5-25, 25-<30, 30+ kg/m2), non-occupational physical activity (≤30/ >30-60/ >60-90/ 
>90 min/day), alcohol consumption (0, 0.1-15, >15 g/day), educational level (low, medium, high), and number of diseases at baseline (0,1,2,3 or more). c Using never 
tobacco smokers as a reference.
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In multivariable-adjusted analyses among current smokers, increasing cigarette 
smoking quantity was significantly associated with a decreasing chance of reaching 
longevity, with Ptrend=0.006, and Ptrend=0.007 in men and women respectively 
(Table 3). Men and women who smoked more than 20 cigarettes per day, had a 
substantially lower chance of reaching longevity compared to never tobacco smokers 
(RR 0.29; 95%CI 0.14-0.58, and RR 0.49; 95%CI, 0.33-0.72, respectively). A 
non-significantly inverse dose-response relationship between smoking quantity and 
longevity was observed in former cigarette smokers of both sexes (Table 3). 
 
Across increasing categories of smoking duration, a decreased chance of reaching 
longevity was observed among current smokers of both sexes (Table 3). In 
multivariable-adjusted analyses, currently smoking men and women who smoked 
over 50 years at baseline were substantially less likely to reach longevity compared 
to never smokers (RR, 0.33; 95%CI, 0.23-0.48, and RR, 0.62; 95%CI, 0.44-0.88, 
respectively). In former smokers an inverse trend across categories of smoking 
duration with reaching longevity was only observed in men (Ptrend<0.001). No 
significant associations were observed between age at smoking initiation and 
longevity in both sexes (Table 3).  
In men, multivariable-adjusted analyses showed an increasing chance of reaching 
longevity with earlier ages at smoking cessation compared to current smokers (Table 
4). Men who had quit smoking less than 5 years before baseline already had a 
significantly increased chance to reach longevity (RR, 1.60; 95%CI, 1.02-2.52) 
compared to current smokers at baseline. Although less strong than in men, an 
increasing chance of reaching longevity with earlier ages at smoking cessation was 
also observed in women (Ptrend=0.011). 
In multivariable-adjusted analyses, whether or not subjects did inhale cigarette smoke 
(yes vs. no), or smoked filter-tipped cigarettes (yes vs. no) made little difference 
for reaching longevity in both sexes (Table 5). We found a significantly inverse 
association of tar and nicotine exposure with longevity in women, and to lesser 
extent in men (Table 5). 
 In Table 6, no risk factors were identified that significantly modified the effect 
between cigarette smoking status and longevity. In analyses with a longevity cut-off 
age of 80 years instead of 90 years, the associations between smoking status and 
longevity became weaker, but remained statistically significant (Table 7). 
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Table 3: Age- and multivariable-adjusted RRs for reaching longevity according to cigarette smoking frequency, duration, and 
initiation in birth cohorts of 1916-17; Netherlands Cohort Study (1986-2007).  
 
Men Women
Model 1a Model 2 b Model 1a Model 2b
median n 90+ RR (95% CI) RR (95% CI) median n 90+ RR (95% CI) RR (95% CI)
Number of cigarettes smoked (N/
day) c
Never tobacco 0 305 78 1 (reference) 1 (reference) 0 2,314 844 1 (reference) 1 (reference)
Current smokers
>0 – 9 6 126 17 0.53 (0.33-0.85) 0.67 (0.36-1.24) 4 86 42 1.03 (0.84-1.25) 0.86 (0.70-1.05)
10- 19 13 274 28 0.40 (0.27-0.60) 0.51 (0.28-0.92) 12 85 22 0.51 (0.36-0.71) 0.48 (0.35-0.68)
20+ 20 206 13 0.23 (0.13-0.41) 0.29 (0.14-0.58) 20 100 19 0.47 (0.32-0.69) 0.49 (0.33-0.72)
P for trendd 0.014 0.006 <0.001 0.007
Continuous (increment 5 cigt/
day)
0.72 (0.64-0.81) 0.77 (0.66-0.90) 0.82 (0.76-0.88) 0.81 (0.75-0.88)
Former smokers
>0 – 9 5 117 40 0.89 (0.64-1.24) 0.72 (0.50-1.06) 3 337 118 0.96 (0.82-1.12) 0.85 (0.66-1.08)
10- 19 12 316 58 0.72 (0.53-0.98) 0.71 (0.52-0.96) 10 110 36 0.90 (0.68-1.18) 0.86 (0.64-1.14)
20+ 20 425 59 0.54 (0.40-0.74) 0.56 (0.40-0.77) 20 83 19 0.63 (0.42-0.93) 0.69 (0.46-1.03)
P for trendd 0.007 0.090 0.054 0.325
Continuous (increment 5 cigt/
day)
0.92 (0.87-0.98) 0.94 (0.88-1.00) 0.93 (0.88-0.99) 0.94 (0.88-1.00)
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Cigarette smoking duration (y) e
Never tobacco 0 305 78 1 (reference) 1 (reference) 0 2,314 844 1 (reference) 1 (reference)
Current smokers
>0 - <20 yr 12 50 20 1.10 (0.78-1.55) 0.81 (0.55-1.20)
20 - <30 35 29 4 0.53 (0.21-1.34) 0.46 (0.18-1.14) 25 74 19 0.70 (0.48-1.04) 0.52 (0.36-0.76)
30 - <40 35 87 23 0.72 (0.51-1.03) 0.61 (0.43-0.87)
40-  <50 46 136 17 0.49 (0.30-0.80) 0.45 (0.26-0.78) 43 143 28 0.54 (0.38-0.75) 0.42 (0.29-0.61)
50+ 53 502 41 0.32 (0.22-0.45) 0.33 (0.23-0.48) 51 108 28 0.71 (0.51-0.98) 0.62 (0.44-0.88)
P for trendd 0.070 0.454 0.074 0.245
Continuous (5 year incre-
ment)
0.90 (0.88-0.93) 0.90 (0.87-0.93) 0.95 (0.93-0.97) 0.93 (0.91-0.95)
Former smokers
>0 - <20 yr 15 82 23 1.09 (0.74-1.62) 1.13 (0.76-1.68) 10 205 72 0.96 (0.79-1.17) 0.91 (0.72-1.14)
20 - <30 25 181 42 0.91 (0.65-1.26) 0.92 (0.66-1.29) 23 129 36 0.76 (0.58-1.01) 0.71 (0.53-0.96)
30 - <40 34 287 48 0.66 (0.48-0.91) 0.67 (0.48-0.93) 34 105 31 0.81 (0.60-1.09) 0.76 (0.56-1.02)
40- <50 44 282 37 0.51 (0.36-0.74) 0.59 (0.41-0.86) 44 67 25 1.02 (0.75-1.40) 0.94 (0.69-1.28)
50+ 51 94 8 0.34 (0.17-0.67) 0.40 (0.20-0.80)
P for trendd <0.001 <0.001 0.862 0.876
Continuous (5 year incre-
ment)
0.93 (0.90-0.95) 0.94 (0.91-0.97) 0.98 (0.95-1.00) 0.97 (0.94-1.00)
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Age at cigarette smoking initia-
tion (y) f
Never tobacco NA 305 78 1 (reference) 1 (reference) NA 2,314 844 1 (reference) 1 (reference)
Current smokers
26 or later 36 223 52 0.64 (0.50-0.82) 0.48 (0.36-0.63)
22-25 25 72 8 0.44 (0.22-0.86) 0.40 (0.19-0.83) 25 55 12 0.60 (0.36-0.99) 0.49 (0.30-0.80)
17-21 18 222 23 0.41 (0.26-0.63) 0.40 (0.25-0.65) 18 136 41 0.83 (0.64-1.07) 0.72 (0.55-0.95)
15-16 16 217 20 0.36 (0.23-0.57) 0.45 (0.28-0.73) 15 44 11 0.68 (0.41-1.14) 0.64 (0.38-1.08)
<15 14 153 11 0.28 (0.15-0.51) 0.41 (0.22-0.79)
P for trendd 0.208 0.583 0.274 0.051
Continuous (1 year decre-
ment)
0.99 (0.94-1.04) 1.04 (0.98-1.12) 1.00 (0.98-1.01) 1.01 (0.99-1.02)
Former smokers
26 or later 34 250 78 0.86 (0.71-1.04) 0.75 (0.58-0.98)
22-25 25 115 24 0.82 (0.55-1.28) 0.77 (0.50-1.18) 24 67 20 0.82 (0.56-1.19) 0.70 (0.46-1.05)
17-21 18 369 66 0.70 (0.52-0.94) 0.71 (0.53-0.97) 18 173 61 0.97 (0.78-1.19) 0.88 (0.67-1.16)
15-16 16 272 47 0.68 (0.49-0.94) 0.77 (0.56-1.06) 16 37 12 0.89 (0.55-1.42) 0.64 (0.36-1.14)
<15 14 188 24 0.50 (0.33-0.76) 0.62 (0.40-0.95)
P for trendd 0.068 0.608 0.461 0.398
Continuous (1 year decre-
ment)
0.97 (0.94-1.00) 0.99 (0.95-1.02) 1.00 (0.99-1.02) 1.01 (0.99-1.02)
a  Age adjusted model. b Model adjusted for age (years), body mass index (<18.5, 28.5-25, 25-<30, 30+ kg/m2), non-occupational physical activity (≤30/ 
>30-60/ >60-90/ >90 min/day), alcohol consumption (0, 0.1-15, >15 g/day), educational level (low, medium, high), and number of diseases at baseline (0,1,2,3 
or more). c Model 2 additionally adjusted for smoking duration (continuous; centered). d Never smokers excluded. e Model 2 additionally adjusted for 
smoking quantity (continuous; centered). f Model 2 additionally adjusted for cigarette-years (continuous; centered).
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Table 4: Age- and multivariable-adjusted RRs for reaching longevity according to timing of cigarette smoking cessation in 
birth cohorts of 1916-17; Netherlands Cohort Study (1986-2007).  
Men Women
Model 1a Model 2 b Model 1a Model 2b
median n 90+ RR (95% CI) RR (95% CI) median n 90+ RR (95% CI) RR (95% CI)
Age at cigarette smoking cessation (y) 
Current smokers NA 679 63 1 (Reference) 1 (Reference) NA 485 125 1 (Reference) 1 (Reference)
60 or later 65 349 41 1.27 (0.87-1.84) 1.57 (1.09-2.28) 65 225 60 1.03 (0.79-1.35) 1.00 (0.76-1.31)
50-59 55 331 56 1.83 (1.30-2.55) 1.89 (1.33-2.70) 54.5 146 47 1.25 (0.94-1.65) 1.17 (0.88-1.56)
40-49 44 199 43 2.33 (1.63-3.31) 2.05 (1.38-3.04) 44 82 35 1.66 (1.24-2.22) 1.42 (1.02-1.97)
<40 35 74 21 3.05 (1.98-4.69) 2.17 (1.31-3.61) 31 84 32 1.48 (1.08-2.02) 1.27 (0.89-1.81)
Never tobacco NA 305 78 2.75 (2.03-3.73) 2.55 (1.84-3.54) NA 2,314 844 1.42 (1.21-1.66) 1.65 (1.38-1.98)
P for trend c <0.001 0.128 0.007 0.011
Time since cigarette smoking cessation 
(y) 
Current smokers 0 679 63 1 (Reference) 1 (Reference) 0 485 125 1 (Reference) 1 (Reference)
Less than 5 yr 2 179 22 1.33 (0.84-2.09) 1.60 (1.02-2.52) 2 110 33 1.16 (0.84-1.60) 1.15 (0.83-1.60)
5-10 7 163 19 1.25 (0.77-2.04) 1.61 (1.00-2.60) 7 109 27 0.96 (0.67-1.38) 0.89 (0.61-1.31)
10-19 14 336 56 1.80 (1.29-2.52) 1.88 (1.32-2.67) 14 148 46 1.21 (0.91-1.60) 1.14 (0.85-1.52)
20-29 24 201 42 2.25 (1.57-3.21) 1.96 (1.32-2.92) 24 85 36 1.65 (1.23-2.20) 1.40 (1.01-1.93)
30+ 34 74 22 3.20 (2.10-4.87) 2.33 (1.42-3.82) 38 85 32 1.46 (1.07-2.00) 1.24 (0.87-1.77)
Never tobacco NA 305 78 2.75 (2.03-3.73) 2.55 (1.84-3.54) NA 2,314 844 1.42 (1.21-1.66) 1.66 (1.39-1.99)
P for trendc <0.001 0.101 0.034 0.050
Continuous (5 year increment) d 1.16 (1.11-1.22) 1.11 (1.05-1.17) 1.06 (1.03-1.10) 1.04 (1.00-1.08)
a  Age adjusted model. b Model adjusted for age (years), body mass index (<18.5, 28.5-25, 25-<30, 30+ kg/m2), non-occupational physical activity (≤30/ 
>30-60/ >60-90/ >90 min/day), alcohol consumption (0, 0.1-15, >15 g/day), educational level (low, medium, high), number of diseases at baseline (0,1,2,3 or 
more), and cigarette-years (continuous; centered). c Never- and current smokers excluded.d Never smokers excluded. 
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Table 5: Age- and multivariable-adjusted RRs for reaching longevity according to inhalation, filter usage, and tar and nicotine 
exposure to cigarettes in birth cohorts of 1916-17; Netherlands Cohort Study (1986-2007). 
Men Women
Model 1a Model 2b Model 1a Model 2b
median n 90+ RR (95% CI) RR (95% CI) median n 90+ RR (95% CI) RR (95% CI)
Cigarette smoke inhalationc
Never tobacco 305 78 1 (reference) 1 (reference) 2,314 844 1 (reference) 1 (reference)
No 389 65 0.65 (0.49-0.88) 0.75 (0.54-1.03) 628 192 0.84 (0.74-0.95) 0.72 (0.57-0.91)
Yes 1,207 156 0.51 (0.40-0.64) 0.67 (0.51-0.88) 369 96 0.71 (0.60-0.85) 0.70 (0.56-0.88)
P-value(yes vs. no) 0.058 0.447 0.131 0.792
Filter-tipped cigarettes usagec
Never tobacco 305 78 1 (reference) 1 (reference) 2,314 844 1 (reference) 1 (reference)
Yes 334 43 0.50 (0.36-0.71) 0.69 (0.48-1.00) 707 219 0.84 (0.75-0.96) 0.74 (0.60-0.92) 
No 939 138 0.58 (0.45-0.74) 0.68 (0.52-0.90) 238 59 0.68 (0.54-0.85) 0.61 (0.47-0.80)
P-value(yes vs. no) 0.408 0.915 0.076 0.127
Tar (mg/d)d
Never tobacco 0 305 78 1 (reference) 1 (reference) 0 2,314 844 1 (reference) 1 (reference)
>0 to <200 123 236 38 0.63 (0.45-0.90) 0.75 (0.51-1.10) 54 387 118 0.84 (0.71-0.98) 0.83 (0.64-1.07)
200 to <400 285 337 51 0.59 (0.43-0.81) 0.78 (0.54-1.13) 270 107 19 0.49 (0.32-0.73) 0.58 (0.36-0.92)
≥400 540 272 31 0.45 (0.30-0.65) 0.63 (0.42-0.95) 468 32 4 0.34 (0.13-0.85) 0.43 (0.17-1.04)
P for trend†† <0.001 0.039 <0.001 0.004
Continuous (increment of 
100 mg/d)
0.87 (0.81-0.94) 0.92 (0.85-1.00) 0.77 (0.69-0.85) 0.82 (0.73-0.93)
Nicotine (mg/d) d
Never tobacco 0 305 78 1 (reference) 1 (reference) 0 2,314 844 1 (reference) 1 (reference)
>0 to <10 6.2 126 29 0.90 (0.62-1.31) 0.98 (0.65-1.48) 3.5 317 103 0.89 (0.75-1.05) 0.87 (0.66-1.14)
10 to <20 14.9 200 28 0.55 (0.37-0.82) 0.70 (0.46-1.07) 14.0 103 23 0.61 (0.43-0.88) 0.70 (0.48-1.03)
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20 to <30 24.0 191 22 0.45 (0.29-0.70) 0.61 (0.38-0.99) 22.5 75 13 0.47 (0.29-0.78) 0.58 (0.35-0.99)
≥30 42.0 335 42 0.49 (0.35-0.69) 0.67 (0.46-0.99) 35.0 34 3 0.24 (0.8-0.71) 0.29 (0.10-0.85)
P for trende <0.001 0.013 <0.001 0.001
Continuous (increment of 
10 mg/d)
0.88 (0.79-0.99) 0.94 (0.85-1.04) 0.71 (0.62-0.82) 0.78 (0.67-0.91)
a  Age-adjusted model. b Model adjusted for age (years), body mass index (<18.5, 28.5-25, 25-<30, 30+ kg/m2), non-occupational physical activity (≤30/ >30-60/ >60-90/ 
>90 min/day), alcohol consumption (0, 0.1-15, >15 g/day), educational level (low, medium, high), and number of diseases at baseline (0,1,2,3 or more). c Model addition-
ally adjusted for cigarette smoking quantity (continuous; centered) ,cigarette smoking duration (continuous; centered) and current smoker (yes/no). d Model additionally 
adjusted for cigarette smoking duration (continuous; centered) and current smoker (yes/no). e Never smokers excluded.
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Table 6: Multivariable-adjusteda Risk Ratios for reaching longevity according to exclusively cigarette smoking status, by strata 
of potentially important lifestyle factors in birth cohorts of 1916-17; Netherlands Cohort Study (1986-2007).
Men Women
Never smokers Former smokers Current smokers P-trend Never smokers Former smokers Current smokers P-trend
Overall
Survivors (90+)/ n 78/305 156/900 58/616 844/2,314 161/497 114/442
RR (95%CI) 1 (reference) 0.68 (0.53-0.94) 0.47 (0.33-0.66) <0.001 1 (reference) 0.70 (0.57-0.86) 0.61 (0.52-0.78) <0.001
P-interaction (gender) 0.040
Body Mass Index (BMI)
18.5- <25 kg/m2
Survivors (90+)/ n 47/162 86/455 31/356 459/1,172 92/262 77/265
RR (95%CI) 1 (reference) 0.72 (0.52-1.01) 0.35 (0.22-0.56) <0.001 1 (reference) 0.70 (0.52-0.93) 0.62 (0.50-0.77) <0.001
≥25 kg/m2
Survivors (90+)/ n 31/139 70/442 25/249 378/1,115 69/232 37/169
RR (95%CI) 1 (reference) 0.67 (0.45-1.00) 0.62 (0.37-1.02) 0.048 1 (reference) 0.67 (0.50-0.90) 0.60 (0.44-0.82) <0.001
P-interaction 0.663 0.883
Non-occupational physical 
activity
≤30 min/day 
Survivors (90+)/ n 10/72 35/218 9/153 273/810 43/162 40/164
RR (95%CI) 1 (reference) 1.15 (0.58-2.30) 0.67 (0.28-1.61) 0.401 1 (reference) 0.58 (0.40-0.85) 0.63 (0.47-0.85) 0.001
>30-60 min/day
Survivors (90+)/ n 26/88 47/257 16/201 276/708 58/153 37/117
RR (95%CI) 1 (reference) 0.54 (0.34-0.86) 0.43 (0.22-0.82) 0.004 1 (reference) 0.84 (0.61-1.17) 0.71 (0.54-0.95) 0.017
>60-90 min/day
Survivors (90+)/ n 19/58 28/177 12/106 167/433 29/98 23/79
RR (95%CI) 1 (reference) 0.56 (0.32-0.97) 0.34 (0.16-0.74) 0.003 1 (reference) 0.64 (0.40-1.03) 0.63 (0.43-0.95) 0.016
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>90 min/day
Survivors (90+)/ n 23/87 46/248 21/156 128/363 31/84 14/82
RR (95%CI) 1 (reference) 0.72 (0.45-1.15) 0.49 (0.27-0.87) 0.013 1 (reference) 0.69 (0.39-1.21) 0.45 (0.26-0.77) 0.003
P-interaction 0.178 0.506
Alcohol consumption
0 g/day 
Survivors (90+)/ n 23/108 18/138 11/107 307/966 27/112 17/114
RR (95% CI) 1 (reference) 0.56 (0.30-1.03) 0.71 (0.34-1.47) 0.134 1 (reference) 0.56 (0.32-0.98) 0.49 (0.29-0.69) <0.001
0.1-15 g/day
Survivors (90+)/ n 44/160 85/458 26/298 487/1,224 106/290 60/213
RR (95% CI) 1 (reference) 0.79 (0.57-1.10) 0.39 (0.24-0.65) <0.001 1 (reference) 0.74 (0.56-0.98) 0.62 (0.49-0.79) <0.001
>15 g/day
Survivors (90+)/ n 11/37 53/304 21/211 50/124 28/95 37/115
RR (95% CI) 1 (reference) 0.56 (0.31-1.03) 0.46 (0.23-0.89) 0.038 1 (reference) 0.70 (0.46-1.05) 0.76 (0.53-1.09) 0.118
P-interaction 0.241 0.426
Educational level
Primary/ Lower vocational 
education
Survivors (90+)/ n 36/148 74/439 32/350 506/1,486 66/211 44/220
RR (95% CI) 1 (reference) 0.64 (0.44-0.95) 0.40 (0.25-0.64) <0.001 1 (reference) 0.82 (0.61-1.12) 0.56 (0.43-0.73) <0.001
Junior/senior high school
Survivors (90+)/ n 21/91 53/350 16/192 273/668 80/232 54/182
RR (95% CI) 1 (reference) 0.66 (0.42-1.04) 0.43 (0.22-0.85) 0.009 1 (reference) 0.65 (0.49-0.86) 0.61 (0.48-0.79) <0.001
Higher vocational/ University 
education
Survivors (90+)/ n 21/66 29/111 10/74 65/160 15/54 16/40
RR (95% CI) 1 (reference) 0.82 (0.47-1.44) 0.56 (0.28-1.15) 0.107 1 (reference) 0.42 (0.21-0.85) 0.71 (0.40-1.25) 0.253
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P-interaction 0.909 0.348
History of (selected) diseasesb
No history of disease
Survivors (90+)/ n 65/214 118/516 48/423 701/1,680 125/334 99/336
RR (95% CI) 1 (reference) 0.73 (0.55-0.97) 0.42 (0.29-0.61) <0.001 1 (reference) 0.73 (0.58-0.91) 0.63 (0.53-0.76) <0.001
History of disease
Survivors (90+)/ n 69/240 126/632 49/468 724/1,819 135/375 101/354
RR (95% CI) 1 (reference) 0.65 (0.49-0.85) 0.43 (0.30-0.63) <0.001 1 (reference) 0.71 (0.57-0.88) 0.63 (0.53-0.76) <0.001
P-interaction 0.989 0.840
a Model adjusted for age (years), smoking quantity (continuous, centered), smoking duration (continuous, centered), body mass index (<18.5, 28.5-25, 25-<30, 30+ kg/m2), 
non-occupational physical activity (≤30/ >30-60/ >60-90/ >90 min/day), alcohol consumption (0, 0.1-15, >15 g/day), educational level (low, medium, high), and number of 
diseases at baseline (0,1,2,3 or more). b Diseases included, any type of cancer, asthma, chronic bronchitis, angina pectoris, heart attack, stroke and diabetes.
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Table 7: Age- and multivariable-adjusted RRs for reaching 80 years of age according to overall and tobacco specific smoking 
status in birth cohorts of 1916-17; Netherlands Cohort Study (1986-2007). 
Men Women
Model 1a Model 2b Model 1a Model 2b
n 80+ RR (95% CI) RR (95% CI) n 80+ RR (95% CI) RR (95% CI)
Tobacco smoking status
Overall tobacco
Never 305 226 1 (reference) 1 (reference) 2,314 1,909 1 (reference) 1 (reference)
Former 1,605 1,014 0.85 (0.79-0.92) 0.88 (0.81-0.95) 550 442 0.97 (0.93-1.02) 0.96 (0.92-1.01)
Current 1,373 757 0.74 (0.69-0.81) 0.75 (0.69-0.81) 495 373 0.91 (0.87-0.96) 0.90 (0.85-0.95)
P for trend <0.001 <0.001 0.001 <0.001
P-interaction(sex)
 b <0.001
Exclusively cigarettesc
Former 955 601 0.85 (0.78-0.92) 0.87 (0.80-0.94) 548 440 0.97 (0.93-1.02) 0.96 (0.92-1.01)
Current 679 344 0.68 (0.62-0.76) 0.68 (0.62-0.75) 485 366 0.91 (0.87-0.97) 0.90 (0.85-0.95)
P for trend <0.001 <0.001 0.001 <0.001
P-interaction(sex)
 b <0.001
Exclusively cigarettes (adjusted for smoking 
quantity and duration)c
Former 900 570 0.86 (0.79-0.94) 0.86 (0.79-0.94) 497 398 0.94 (0.88-1.00) 0.93 (0.87-0.99)
Current 616 312 0.77 (0.68-0.86) 0.73 (0.65-0.82) 442 338 0.92 (0.87-0.97) 0.90 (0.85-0.95)
P for trend <0.001 <0.001 0.001 <0.001
P-interaction(sex)
 b <0.001
Exclusively cigarsc
Former 42 28 0.89 (0.71-1.11) 0.95 (0.77-1.18) 1 1 NA NA
Current 76 63 1.11 (0.98-1.25) 1.09 (0.97-1.23) 3 3 NA NA
P for trend 0.208 0.224
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Exclusively pipec
Former 7 5 0.98 (0.60-1.60) 1.06 (0.68-1.66) 0 0 NA NA
Current 27 12 0.60 (0.39-0.92) 0.58 (0.39-0.88) 0 0 NA NA
P for trend 0.019 0.011
Exclusively cigar and/or pipec 
Former 68 44 0.86 (0.71-1.04) 0.91 (0.76-1.08) 1 1 NA NA
Current 141 98 0.93 (0.82-1.06) 0.92 (0.81-1.05) 3 3 NA NA
P for trend 0.194 0.189
Exclusively cigarettes with cigar and/or pipe§
Former¶ 582 369 0.85 (0.78-0.93) 0.89 (0.81-0.97) 1 1 NA NA
Former cigarette, current cigar and/or pipe 160 89 0.75 (0.64-0.87) 0.78 (0.67-0.91) 1 1 NA NA
Current cigarette, former cigar and/or pipe 35 18 0.69 (0.50-0.96) 0.75 (0.55-1.03) 0 0 NA NA
Current†† 357 208 0.78 (0.70-0.87) 0.80 (0.71-0.89) 6 3 NA NA
a Age adjusted model.b Model adjusted for age (years), body mass index (<18.5, 28.5-25, 25-<30, 30+ kg/m2), non-occupational physical activity (≤30/ >30-60/ >60-90/ 
>90 min/day), alcohol consumption (0, 0.1-15, >15 g/day), educational level (low, medium, high), and number of diseases at baseline (0,1,2,3 or more).c Using never 
tobacco smokers as a reference.
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Discussion
In this large prospective cohort study of those born in 1916 and 1917, tobacco 
smoking was significantly inversely associated with the chance of reaching longevity, 
defined as 90 years of age, in both sexes. The use of specific tobacco products 
(cigarette, cigars, and pipe) showed comparable results. The association between 
smoking status and longevity was stronger in men than in women. Several cigarette 
smoking habits were independently associated with reaching longevity, including 
cigarette smoking quantity, duration, cessation and exposure to tar and nicotine. 
Among former smokers, age at smoking cessation was inversely associated with 
reaching longevity. In men, quitting smoking after the age of 60 years was still 
found to increase the chance of reaching longevity compared to current smokers at 
the age of 68-70 years. No significant associations were found with age at smoking 
initiation. 
Unlike previous studies (9, 11, 18), the NLCS is the first cohort study in which 
a significant association between smoking status and longevity has been found 
in women. Even though smoking affected reaching longevity in both sexes, the 
association was somewhat stronger in men than in women. There are several 
mortality studies in which the association between smoking habits, and short- 
and long term mortality has been assessed.  In a meta-analysis on smoking and 
mortality in older adults it was also concluded that the effect estimate of smoking 
status on mortality was somewhat stronger in men than in women (19). 
A possible explanation for the differences between men and women regarding 
smoking status and longevity may be the result of underlying differences in 
smoking habits.  In our study, women had smoked on average smaller amounts of 
cigarettes, and a shorter period of time. After additional adjustment for smoking 
quantity and duration, the effect estimates on smoking status and longevity became 
more comparable between men and women. However, gender still acted as a 
significant effect-modifier between smoking status and longevity after this adjustment. 
Another possible explanation could be that never smoking women are more often 
exposed to passive smoking than never smoking men, which might have led to an 
underestimation of the association between active smoking and longevity in women. 
Given the small number of women who have never been exposed to active or 
passive smoking in the NLCS, we were unable to check whether this was the case. 
Few studies have examined other aspects of smoking besides smoking status on 
reaching longevity, and those who did only focused on smoking quantity (1, 2). 
In these studies, increasing cigarette smoking quantity was significantly inversely 
associated with reaching the age of 75 years in both sexes (1), and reaching 85 
years in men (2). Similarly, several mortality studies in older adults observed dose 
response relationships of increasing mortality with increasing number of cigarettes 
(20-22), and smoking duration (21, 23). 
Similarly to smoking status, the association of smoking quantity and duration with 
longevity seemed stronger in men than in women. In contrast, we observed that the 
inverse association of exposure to tar and nicotine with longevity seemed stronger 
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in women than in men. In another study, the association of increasing exposure 
to cigarette components, including tar and nicotine, with mortality from respiratory 
and cardiovascular disease was found to be stronger in women than in men (24). 
Furthermore, there is some evidence that women who smoke are relatively deficient 
in estrogen (25). This indicates that women might be more susceptible to tar and 
nicotine than men. In our study, we observed that female smokers smoked on 
average more often a light type of tobacco, and filter-tipped cigarettes than men. 
As a result, the average cumulative exposure to tar and nicotine per cigarette might 
be lower in female smokers than in male smokers. This might explain why we did 
observe a somewhat stronger effect of cigarette smoking quantity in men compared 
to women, despite a potentially higher susceptibility to tar and nicotine in women. 
However, this explanation is speculative, and should be further explored in future 
studies.
Quitting smoking after the age of 60 was significantly associated with an increased 
chance of reaching longevity compared to current smokers. One other study has 
assessed the relation of quitting smoking after the age of 50 with reaching the age 
of 90 years and reported no significant association, but data were not shown (8).  
Similar to our study, mortality studies in older adults found a decreasing risk on 
mortality with earlier ages at smoking cessation, and increasing time since smoking 
cessation in both sexes (20, 22). 
To our knowledge, this is the first study that has assessed the relationship of cigar 
and pipe usage, with reaching longevity. Our findings suggest that, in addition to 
cigarette smoking, pipe and cigar smoking are both associated with a decreased 
chance of reaching longevity.  
Results of our additional sensitivity analyses using a longevity cut-off age of 80 
instead of 90 years were in line with the results of a previous study, which also 
studied the relationship between smoking status and longevity using different cut-
off ages (5). These findings, together, illustrate that the strength of the association 
between smoking status and reaching longevity may vary using different cut-off 
ages. 
An important strength of this study is the prospective character and completeness of 
follow-up. Furthermore, we had extensive data on various smoking habits, making 
it possible to investigate as well as adjust for several smoking characteristics. 
Nonetheless, some caution is needed when interpreting these results. When 
investigating smoking habits that are highly correlated with each other, the problem 
of multi-collinearity may arise (26). We tried to reduce collinearity between smoking 
factors by centering and combining smoking variables, but there might still be some 
risk that multi-collinearity has influenced our results (26). 
One limitation of this study is that no information was collected on changing 
smoking habits after baseline measurement. Although few people will start smoking 
at an older age, some cohort members might have quit smoking during follow-up, 
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and would still be classified as a current smoker in our analyses (27). This might 
have led to an underestimation of the association between smoking and longevity. 
Furthermore, the participants were aged 68-70 years at baseline. This means that 
these participants already survived to an advanced age. Therefore, the effect of 
smoking on reaching longevity might be stronger in younger cohorts. 
In conclusion, the inverse association between smoking and longevity was stronger 
in men, than in women. The deleterious effect of cigarette smoking on longevity 
seemed to strengthen with increasing smoking quantity and duration, which may 
partially explain the observed difference between sexes.  Overall, never smokers 
of both sexes had the highest chance of reaching longevity. Quitting smoking 
significantly increased the chance of reaching longevity compared to current smokers 
at the age of 68-70 years, in men even quitting beyond the age of 60 years.
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Body size, non-occupational physical activity and the chance of 
reaching longevity in men and women: Findings from the 
Netherlands Cohort Study 
Lloyd Brandts, Piet A. van den Brandt
Abstract
Introduction
The rising number of obese- and/or physically inactive individuals might negatively 
impact human lifespan. This study assessed the association between height, Body 
Mass Index (BMI) and non-occupational physical activity, and the likelihood of 
reaching 90 years of age, in both sexes separately. 
Methods
Analyses were conducted using data from the Netherlands Cohort Study (NLCS). 
Participants born in 1916-17 (n=7,807) completed a questionnaire in 1986 (at age 
68-70), and were followed up for vital status information until the age of 90 years 
(2006-07). Cox regression analyses were based on 5,479 participants with complete 
data, to calculate Risk Ratios (RR) of reaching longevity (age 90 years). 
Results
In women, we observed significant associations between reaching longevity and 
height (RR, 1.05; 95% confidence interval (CI), 1.00-1.09 per 5 cm increment), 
BMI at baseline (≥30 vs. 18.5-<25 kg/m2; RR, 0.68; 95% CI, 0.54-0.86), and BMI 
change since age 20 years (≥8 vs. 0-<4 kg/m2; RR, 0.81; 95% CI, 0.66-0.98). In 
men, height and BMI were not associated with reaching longevity. In women, non-
occupational physical activity showed an inverse U-shaped association with reaching 
longevity, with the highest RR around 60 minutes of physical activity per day. 
In men, a positive linear association was observed between physical activity and 
reaching longevity.
Conclusion
This study indicates that body size and physical activity are related to the likelihood 
of reaching 90 years of age, and that these associations differ by sex.
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Introduction     
With an increasing life expectancy in recent decades, the absolute number of 
elderly reaching longevity (>90 years of age) is expected to quadruple by 2060(1). 
However, recent data from the United States and United Kingdom suggest that the 
increase in life-expectancy is leveling-off (2, 3). One commonly used argument 
for the potential stagnating life expectancy is the growing number of obese and/or 
physically inactive individuals worldwide (4, 5). However, studies that prospectively 
studied the association between these factors and reaching old age, or longevity, are 
limited. 
Regarding body mass, six studies have been performed assessing the relationship 
between BMI and longevity (6-11). Across these studies, a decreased chance of 
reaching longevity could be observed in both extremes (i.e. high and low) of 
the BMI spectrum. Regarding physical activity, seven studies have assessed the 
association with reaching longevity (6, 8, 9, 12-15). In these studies, physical 
activity was positively associated with the chance of reaching longevity.
Most of the current longevity studies investigated men only (6-9, 13), or combined 
both sexes(10, 14, 16). However, men and women follow different survival patterns, 
which may be determined by differences in hormones, genetics, and/or lifestyle (17, 
18). Therefore, it would be interesting to investigate the relation between BMI and 
physical activity, and longevity separately for men and women.
Using the prospective Netherlands Cohort Study (NLCS), the aim here was to 
quantify the association between height, several dimensions of BMI and non-
occupational physical activity, and the chance of reaching longevity, defined as 
reaching the age of 90 years in men and women separately.
 
Methods
Study design and population
The NLCS was initiated in 1986 as a large prospective cohort study, and included 
120,852 men and women aged 55 to 69 years from 204 Dutch municipalities 
(19). Baseline information was collected in 1986 on cancer risk factors using a 
self-administrated questionnaire. The full NLCS cohort has been followed-up for 
mortality. This was done by record linkage to the Central Bureau for Genealogy 
(CBG) from September 1986 until 1995, and to the municipal population registries 
(GBA) from 1995 until 2007. Because only a small part of the cohort was “at 
risk” of reaching the age of 90 years in 2007, the data entry was restricted to the 
oldest birth cohort (1916, and 1917) of the NLCS cohort (i.e. aged 68-70 years at 
baseline). 
Vital status information of the longevity cohort until the age of 90 years was 
>99.9% complete. The study population consisted of 3,646 men and 4,161 women 
(Figure 1). The NLCS study has been approved by the institutional review boards 
of Maastricht University and the Netherlands Organisation for Applied Scientific 
Research TNO (Zeist).
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Figure 1: Flow diagram on analyses of height, BMI, and non-occupational physical 
activity with longevity.
Exposure assessment
At baseline, participants completed a self-administered questionnaire, including 
detailed information on weight, height, weight at age 20 years and non-occupational 
physical activity. BMI categories at baseline were based on the WHO International 
Classification (<18.5 kg/m2/18.5-<25 kg/m2/≥25-<30 kg/m2/ ≥30 kg/m2)(20). For the 
analyses on BMI at age 20,other categories were used, namely <20, 20-<21.5, 21.5-
<23, 23 to <25, and ≥25kg/m2. BMI at baseline minus BMI at age 20 years was 
used to calculate change in BMI since the age of 20 years, and was categorized as 
<0, 0 to <4, 4 to <8, and ≥8 kg/m2. These categorizations have been used before 
in other NLCS analyses (21, 22). For these analyses, we assumed that height at age 
20 years was similar to the height of the participant at baseline.
At baseline, participants were asked “How many minutes do you spend on average 
per day walking/cycling to your work, to go shopping, or to walk the dog?” 
and “How many hours of leisure time do you spend on average per week on 1)
recreational walking/cycling, 2)gardening/doing odd jobs, and 3)sports/gymnastics?”. 
The reported times from both questions were summed to calculate an overall 
measure of total non-occupational physical activity with categories of ≤30,>30-
60,>60-90, and >90min/day.  
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Statistical analyses 
Baseline characteristics were presented by sex and survival status at age 90 years. 
The characteristics were presented in percentages and with mean values including 
SD for categorical and continuous variables, respectively.
The associations of body size, and non-occupational physical activity with the 
chance of reaching longevity were evaluated using Cox regression models with 
a fixed follow-up time(23, 24). Standard errors were calculated using the Huber-
White sandwich estimator to account for underdispersion(25). A priori factors were 
selected as potential confounders based on the literature, and  included age at 
baseline, smoking status, cigarettes smoked per day, cigarette smoking duration in 
years, alcohol consumption, educational level, energy intake, and depending on the 
analyses additionally adjusted for sex, baseline weight, BMI at age 20 years, BMI 
at baseline, and non-occupational physical activity. Other co-variables considered 
included marital status, vegetables intake, fruit intake, fish intake, red meat intake, 
and total meat intake. None of these changed the effect estimates more than 10%, 
and were therefore not included in the analyses.
In trend analyses, ordinal variables were fitted as continuous variables. Restricted 
cubic spline regression analyses using three knots at the 10th, 50th, and 90th 
percentile, and Wald test were performed to test for non-linearity. 
Wald tests for interaction and cross-product terms were used to evaluate potential 
effect-modification by sex, smoking- and disease status. Selected diseases at baseline 
included heart attack, angina pectoris, stroke, any type of cancer, asthma, bronchitis 
and diabetes.  Regarding BMI and longevity, additional analyses have been 
performed to test for linearity in never smokers, non-diseased individuals and non-
diseased never smokers. All analyses were performed using Stata 15.0 (StataCorp. 
2017. College Station, TX).
Results
Among men included in our analyses, 433 (16.7%) survived to the age of 90 years 
(Table 1). Male survivors and non-survivors were comparable regarding average 
height, BMI at baseline, BMI at age 20 years and change in BMI since the age of 
20 years, but survivors spent more time on non-occupational physical activity per 
day. Among women included in our analyses, 994 (34.4%) survived to 90 years of 
age (Table 1). Compared to female non-survivors, female survivors were on average 
taller, had a somewhat lower average BMI at baseline, and had a lower average 
increase in BMI since the age of 20 years. Furthermore, female survivors had more 
often a higher level of physical activity than female non-survivors (Table 1). 
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Table 1: Baseline characteristics of the cohort members overall and by survival 
status in birth cohorts of 1916-17; Netherlands Cohort Study on diet and cancer 
(1986-2007). 
Men Women
Survivors Non-survivors Survivors Non-survivors
Na 433 2,158 994 1,894
Height (cm), mean  (SD) 175.1 (6.7) 175.0 (6.7) 164.4 (6.2) 163.9 (6.5)
Height (cm), %
<160 2.1 1.0 21.6 25.4
160-<165 3.5 5.0 29.9 28.3
165-<170 16.8 16.7 34.4 33.3
170-<175 23.7 21.5 8.4 8.6
175-<180 32.0 34.1 5.1 4.1
180-<185 13.6 12.6 0.5 0.2
185+ 8.3 9.1 0.1 0.1
BMI (kg/m2) at baseline, mean (SD) 24.7 (2.5) 24.9 (2.7) 24.8 (3.1) 25.2 (3.7)
BMI (kg/m2) at baseline, %
<18.5  0.7 1.1 0.9 1.7
18.5 to <25 58.7 53.3 56.4 50.6
25 to <30 37.2 42.0 36.6 37.3
30+ 3.4 3.6 6.1 10.4
BMI (kg/m2) at age 20 years, mean (SD)b 21.8 (2.6) 21.9 (2.4) 21.4 (2.7) 21.4 (2.8)
BMI (kg/m2) at age 20 years, %b
<20 20.6 19.0 29.5 31.8
20 to <21.5  24.5 26.1 25.9 25.2
21.5 to <23  26.5 25.0 21.8 19.9
23 to <25 20.1 21.3 15.8 15.3
25+  8.3 8.6 7.0 7.8
Change in BMI (kg/m2) since age 20 
years, mean (SD)b
2.9 (3.2) 2.9 (3.1) 3.5  (3.7) 3.9 (4.0)
Change in BMI (kg/m2) since age 20 
years, %b
<0 13.3 15.1 14.6 13.2
0 to <4 57.8 50.6 42.8 40.0
4 to <8 22.7 29.2 33.0 33.5
8+ 6.2 5.1 9.6 13.3
Non-occupational physical activity (min/
day), mean (SD)
81.8 (71.5) 72.6 (61.3) 55.8 (47.5) 55.5 (49.6)
Non-occupational physical activity, %
≤30 min/day 17.1 23.2 31.7 35.5
>30-60 min/day 31.5 30.4 33.3 28.8
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>60-90 min/day 20.1 18.6 19.5 18.7
>90 min/day 31.3 27.8 15.5 17.0
Year of birth, %
1916 22.9 22.9 23.3 23.1
1917 77.1 77.1 76.7 76.9
a Number of participants with complete information on height, BMI at baseline, non-occupational 
physical activity, and confounders including: year of birth, tobacco smoking status, cigarette smoking 
quantity, cigarette smoking duration, educational level, alcohol consumption and energy intake. b Number 
of participants used may vary from the study population due to missing values on specific exposure 
variables.
In multivariable-adjusted analyses, no significant associations were found between 
reaching longevity and height, BMI at baseline, BMI at age 20 years and change 
in BMI since age 20 in men (Table 2). In women, a significant association was 
observed between reaching longevity and height, BMI at baseline and increase in 
BMI since the age of 20 years. Women taller than 175 cm had an  increased 
chance (RR, 1.31; 95%CI, 1.01-1.68) of reaching longevity compared to women 
shorter than 160 cm. Obese women (≥30 kg/m2) had a RR of 0.68; 95%CI, 0.54-
0.86 of reaching longevity compared to normal weight women. In underweight 
women, a non-statistically significantly inverse association (RR, 0.61; 95%CI, 0.35-
1.09) was observed with reaching longevity compared to normal weight women. 
Women who gained 8kg/m2 or more since the age of 20 years had a significantly 
reduced chance (RR, 0.81; 95%CI, 0.66-0.98) of reaching longevity compared to 
women who gained 0-<4 kg/m2. As in men, no significant associations were found 
between BMI at age 20 years and reaching longevity in women (Table 2).  
In table 2, men who reported >90 min of non-occupational physical activity per day 
were more likely to reach longevity compared to those who reported ≤30 min/day 
(RR, 1.39; 95%CI, 1.07-1.82). The association between non-occupational physical 
activity seemed to strengthen with increasing categories of physical activity (RR, 
1.05 per increment of 30 min/day; 95%CI, 1.02-1.09).  In women, a significantly 
increased chance of reaching longevity was found for those who reported >30-60 
min/day of non-occupational physical activity (RR, 1.21;95%CI, 1.07-1.37) compared 
to those with 30min/day of non-occupational physical activity or less. The effect 
estimate became weaker and non-significant in higher categories of non-occupational 
physical activity. 
Restricted cubic spline analyses (Figure 2) showed a non-linear association between 
BMI at baseline (P<0.001) with reaching longevity in women, but not in men. 
In women, a non-linear association was also observed between non-occupational 
physical activity and reaching longevity (P=0.003), with the highest RR around 60 
minutes of non-occupational physical activity per day. 
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Table 2: Age- and multivariable-adjusted RRs for reaching longevity according to height, BMI at baseline, BMI at age 20, 
Change in BMI since age 20 years, and non-occupational physical activity in birth cohorts of 1916-17; Netherlands Cohort 
Study (1986-2007).  
Men Women
Model 1a Model 2b Model 1a Model 2b
median n 90+ RR 95% CI RR 95% CI median n 90+ RR 95% CI RR (95% CI)
Height (cm)c
<160 156 646 199 reference reference
160-<165 167 507 84 reference reference 162 774 276 1.16 1.00-1.34 1.15 0.99-1.33
165-<170 167 905 317 1.14 0.98-1.32 1.15 1.00-1.34
170-<175 172 675 112 1.00 0.78-1.30 0.99 0.76-1.28 171 422 148 1.14 0.96-1.36 1.12 0.93-1.34
175-<180 176 755 120 0.96 0.75-1.24 0.93 0.71-1.21
180-<185 182 453 86 1.15 0.87-1.51 1.03 0.77-1.39 176 141 54 1.24 0.98-1.58 1.31 1.01-1.68
185+ 187 201 31 0.94 0.64-1.37 0.87 0.56-1.34
P for trend 0.732 0.726 0.074 0.070
Continuous (increment 5cm) 1.02 0.95-1.08 0.99 0.92-1.07 1.04 1.00-1.08 1.05 1.00-1.09
P-interactiond 0.026
BMI at baseline (kg/m2)e 
<18.5 17.5 26 3 0.63 0.22-1.85 0.77 0.26-2.24 17.7 40 9 0.61 0.34-1.09 0.61 0.35-1.09
18.5-<25 23.5 1,404 254 reference reference 23.0 1,519 560 reference reference
25-<30 26.4 1,068 161 0.83 0.69-1.00 0.88 0.73-1.06 26.6 1,071 364 0.92 0.83-1.03 0.93 0.84-1.04
30+ 31.1 93 15 0.89 0.55-1.44 1.00 0.63-1.60 31.6 258 61 0.64 0.51-0.81 0.68 0.54-0.86
P for trendf 0.077 0.287 <0.001 0.002
Continuousf (increment 1 kg/
m2)
0.97 0.94-1.01 0.98 0.95-1.02 0.98 0.96-0.99 0.98 0.97-1.00
P-interactiond 0.418
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BMI at age 20 (kg/m2)e 
<20 19.1 389 70 1.13 0.85-1.51 1.08 0.81-1.44 18.8 792 264 0.93 0.81-1.08 0.94 0.82-1.08
20-<21.5 20.8 521 83 reference reference 20.8 651 232 reference reference
21.5-<23 22.2 511 90 1.11 0.85-1.46 1.10 0.84-1.43 22.1 526 195 1.04 0.90-1.21 1.04 0.89-1.21
23-<25   23.7 426 68 1.00 0.75-1.35 1.00 0.75-1.33 23.9 396 141 1.00 0.84-1.18 1.00 0.85-1.19
25+   26.0 173 28 1.01 0.69-1.50 1.03 0.70-1.53 26.3 192 63 0.92 0.73-1.15 0.97 0.77-1.21
P for trend 0.614 0.811 0.591 0.412
Continuous (increment 1 kg/m2) 0.98 0.94-1.03 0.99 0.95-1.03 1.00 0.98-1.02 1.01 0.99-1.02
P-interactiond 0.871
Change in BMI since age 20 (kg/
m2)g 
<0 -1.4 299 45 0.80 0.60-1.08 0.90 0.67-1.21 -1.6 351 131 1.02 0.87-1.19 1.07 0.91-1.27
0-<4 2.3 1,046 196 reference reference 2.3 1,048 383 reference reference
4-<8 5.2 568 77 0.72 0.57-0.92 0.74 0.57-0.94 5.5 852 295 0.95 0.84-1.07 0.97 0.86-1.09
8+ 9.3 107 21 1.05 0.70-1.58 1.01 0.67-1.52 9.5 306 86 0.77 0.63-0.94 0.81 0.66-0.98
P for trend 0.576 0.291 0.011 0.024
Continuous (increment 1kg/m2) 0.99 0.96-1.03 0.99 0.95-1.02 0.98 0.97-1.00 0.98 0.96-1.00
P-interactiond 0.055
Non-occupational physical 
activity (min/day)h
≤30 21.4 569 69 reference reference 17.1 972 299 reference reference
>30-60 42.9 794 137 1.42 1.09-1.86 1.34 1.02-1.75 42.9 898 353 1.27 1.13-1.45 1.21 1.07-1.37
>60-90 72.9 489 88 1.49 1.11-1.99 1.28 0.96-1.71 72.9 542 187 1.12 0.97-1.30 1.05 0.90-1.22
>90 132.9 739 139 1.55 1.19-2.03 1.39 1.07-1.82 115.7 476 155 1.06 0.90-1.24 1.00 0.85-1.17
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P for trend 0.002 0.036 0.494 0.814
Continuous (increment 30 min/
day)
1.06 1.03-1.09 1.05 1.02-1.09 1.00 0.97-1.03 0.99 0.96-1.02
P-interactiond 0.100
a Age adjusted model. b Model adjusted for age (years), smoking status (never, former, current), number of cigarettes smoked per day (continuous, centered), 
smoking duration in years (continuous, centered), alcohol consumption (0, 0.1-15, >15 g/day), educational level (low, medium, high), and energy intake (kcal, 
continuous). c Additionally adjusted for weight in kg (continuous). d Wald test for interaction between main exposure and sex.e Additionally adjusted for non-
occupational activity (≤30/ >30-60/ >60-90/ >90 min/day). f Participants with BMI <18.5 kg/m2 excluded.  g Additionally adjusted for non-occupational activity 
(≤30/ >30-60/ >60-90/ >90 min/day) and BMI at age 20 years (in kg/m2, continuous).  h Additionally adjusted for BMI at baseline (<18.5, 28.5-25, 25-<30, 
30+ kg/m2).
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Figure 2. Nonparametric regression curve for the association of height (cm), BMI at baseline (kg/
m2), change in BMI since age 20 years (kg/m2), and non-occupational physical activity (min/day) with 
the chance of reaching longevity in men and women separately. Solid line represents point estimate and 
dashed lines represent 95% confidence intervals. All models were adjusted for  age (years), smoking 
status (never, former, current), number of cigarettes smoked per day (continuous, centered), smoking 
duration in years (continuous, centered), alcohol consumption (0, 0.1-15, >15 g/day), educational level 
(low, medium, high), energy intake (kcal, continuous), (A) Additionally adjusted for non-occupational 
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physical activity (≤30/ >30-60/ >60-90/ >90 min/day). P-value for non-linearity was 0.671 for men, and 
0.211 for women. (B) Adjusted as in A. P-value for non-linearity was 0.572 in men, and <0.001 in 
women. (C) As in A, and additionally adjusted for BMI at age 20 years (in kg/m2, continuous). P-value 
for non-linearity was 0.567 in men, and 0.115 in women. (D) Additionally adjusted for BMI at baseline 
(<18.5, 28.5-25, 25-<30, 30+ kg/m2). P-value for non-linearity was 0.363 in men, and 0.003 in women.
In table 3, in men, a significant interaction was observed between smoking status 
and categorical BMI on reaching longevity (P-interaction=0.041). A BMI of ≥25 kg/
m2 seemed to be inversely associated with reaching longevity in never- and former 
smokers, while a BMI ≥25kg/m2 was positively associated with reaching longevity 
in current smokers. However, a statistically significant effect estimate was only 
observed in former smokers. In analyses with BMI as a continuous variable no 
significant interaction was observed by smoking status (Table 3; P-interaction=0.128). 
In women, a significant interaction was observed between history of disease at 
baseline and categorical BMI (P-interaction=0.039). In women with a history of 
disease, the RR of reaching longevity with a BMI ≥25 kg/m2 was 0.67 (95%CI, 
0.51-0.88), compared to women with a BMI <25 kg/m2. In women without a 
history of disease this association was weaker (RR, 0.95; 95%CI, 0.86-1.06) (Table 
3). Regarding physical activity, in men we observed that the association between 
non-occupational physical activity with reaching longevity was significantly modified 
by BMI in continuous levels of non-occupational physical activity (p=0.023), but not 
in categorical physical activity. An inverse association between BMI at baseline and 
longevity was observed in men without a history of disease, but this relationship 
was non-significant (Figure 3). 
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Table 3: Multivariable-adjusteda RRs for reaching longevity according to BMI at baseline and non-occupational physical 
activity by strata of smoking status and disease history in birth cohorts of 1916-17; Netherlands Cohort Study (1986-2011).   
Body Mass index (kg/m2) Non-occupational physical activity
18.5-<25 ≥25 Continuous  ≤30 >30-60 >60-90 >90 P-trend Continuous 
Men
Overall
Survivors (90+)/n 254/1,404 176/1,161 69/569 137/794 88/489 139/739
RR (95% CI) 1 (ref.) 0.88 (0.74-1.05) 0.98 (0.95-1.02) 1 (ref.) 1.34 (1.02-1.75) 1.28 (0.96-1.71) 1.39 (1.07-1.82) 0.036 1.02 (1.00-1.03)
Smoking status
Never smokers
Survivors (90+)/n 39/136 28/116 8/53 22/75 17/49 21/79
RR (95% CI) 1 (ref.) 0.81 (0.54-1.21) 1.01 (0.93-1.10) 1 (ref.) 2.11 (1.01-4.41) 2.45 (1.16-5.18) 2.02 (0.97-4.22) 0.089 1.03 (1.01-1.06)
Former smokers
Survivors (90+)/n 149/689 92/626 48/294 74/379 48/273 71/374
RR (95% CI) 1 (ref.) 0.70 (0.55-0.89) 0.95 (0.90-0.99) 1 (ref.) 1.13 (0.81-1.58) 0.98 (0.68-1.41) 1.09 (0.79-1.52) 0.847 1.01 (0.99-1.03)
Current smokers
Survivors (90+)/n 66/579 56/419 13/222 41/340 23/167 47/286
RR (95% CI) 1 (ref.) 1.25 (0.90-1.74) 1.03 (0.97-1.09) 1 (ref.) 1.91 (1.04-3.49) 2.01 (1.05-3.85) 2.66 (1.46-4.85) 0.001 1.03 (1.01-1.05)
P-interaction 0.041 0.128 0.124 0.245
History of disease at 
baselinec
No history of disease
Survivors (90+)/n 201/890 130/720 47/318 111/524 63/300 112/482
RR (95% CI) 1 (ref.) 0.85 (0.70-1.04) 0.97 (0.93-1.01) 1 (ref.) 1.37 (1.01-1.87) 1.28 (0.91-1.79) 1.45 (1.06-1.97) 0.048 1.02 (1.01-1.03)
History of disease
Survivors (90+)/n 53/514 46/441 22/251 26/270 25/189 27/257
RR (95% CI) 1 (ref.) 1.05 (0.71-1.56) 1.03 (0.96-1.11) 1 (ref.) 1.09 (0.64-1.86) 1.28 (0.75-2.20) 1.10 (0.65-1.85) 0.626 1.01 (0.98-1.04)
P-interaction 0.300 0.122 0.722 0.680
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Body Mass Index (kg/m2)
18.5-<25
Survivors (90+)/n NA NA NA 36/283 83/443 60/283 75/395
RR (95% CI) NA NA NA 1 (ref.) 1.37 (0.96-1.95) 1.46 (1.00-2.14) 1.38 (0.96-1.99) 0.121 1.01 (0.99-1.02)
≥25
Survivors (90+)/n NA NA NA 33/282 52/338 27/202 64/339
RR (95% CI) NA NA NA 1 (ref.) 1.29 (0.86-1.93) 0.97 (0.60-1.55) 1.39 (0.94-2.06) 0.195 1.03 (1.01-1.04)
P-interaction NA 0.296 0.023
Women
Overall
Survivors (90+)/n 560/1,519 425/1,329 299/972 353/898 187/542 155/476
RR (95% CI) 1 (ref.) 0.89 (0.80-0.99) NAd 1 (ref.) 1.21 (1.07-1.37) 1.05 (0.90-1.22) 1.00 (0.85-1.17) 0.814 NAe
Smoking status
Never smokers
Survivors (90+)/n 407/1,043 324/968 229/690 258/641 141/381 112/328
RR (95% CI) 1 (ref.) 0.88 (0.78-0.99) NAd 1 (ref.) 1.16 (1.01-1.34) 1.06 (0.89-1.25) 0.96 (0.80-1.15) 0.677 NAe
Former smokers
Survivors (90+)/n 86/240 66/213 40/143 57/147 26/91 29/76
RR (95% CI) 1 (ref.) 0.92 (0.70-1.20) 1 (ref.) 1.33 (0.95-1.85) 0.95 (0.62-1.45) 1.31 (0.89-1.94) 0.457 NAe
Current smokers
Survivors (90+)/n 67/236 35/148 30/139 38/110 20/70 14/72
RR (95% CI) 1 (ref.) 0.92 (0.65-1.29) NAd 1 (ref.) 1.60 (1.07-2.39) 1.37 (0.85-2.21) 0.89 (0.50-1.59) 0.835 NAe
P-interaction 0.823 0.491
History of disease at 
baselinec
No history of disease
Survivors (90+)/n 454/1,120 359/937 248/675 288/662 158/398 127/356
RR (95% CI) 1 (ref.) 0.95 (0.86-1.06) NAd 1 (ref.) 1.14 (1.00-1.30) 1.04 (0.89-1.22) 0.94 (0.79-1.12) 0.458 NAe
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History of disease
Survivors (90+)/n 106/399 66/392 51/297 65/236 29/144 28/120
RR (95% CI) 1 (ref.) 0.67 (0.51-0.88) NAd 1 (ref.) 1.41 (1.02-1.94) 1.01 (0.67-1.52) 1.18 (0.79-1.77) 0.685 NAe
P-interaction 0.010 0.090
Body Mass Index (kg/m2)
18.5-<25
Survivors (90+)/n NA NA NA 155/468 206/483 98/286 101/282
RR (95% CI) NA NA NA 1 (ref.) 1.24 (1.05-1.46) 0.99 (0.81-1.22) 1.04 (0.85-1.26) 0.775 NAe
≥25
Survivors (90+)/n NA NA NA 141/489 143/402 87/249 54/189
RR (95% CI) NA NA NA 1 (ref.) 1.20 (0.99-1.45) 1.14 (0.92-1.42) 0.97 (0.75-1.26) 0.831 NAe 
P-interaction NA 0.604
a Model adjusted for age (years), smoking status (never, former, current), number of cigarettes smoked per day (continuous, centered), smoking duration in 
years (continuous, centered), alcohol consumption (0, 0.1-15, >15 g/day), educational level (low, medium, high), energy intake (kcal, continuous), and non-
occupational physical activity (≤30/ >30-60/ >60-90/ >90 min/day). b Excluding <18 kg/m2. c Diseases included; any type of cancer, heart attack, angina 
pectoris, cerebral hemorrhage, asthma,  bronchitis, and diabetes. d Not applicable due to non-linearity between BMI at baseline and longevity. e Not applicable 
due to non-linearity between non-occupational physical activity and longevity.   
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Figure 3: Nonparametric regression curve for the association between BMI at baseline (kg/m2), and the chance of reaching longevity 
in men and women separately. Restricted cubic spline regression analyses were performed using three knots at the 10th, 50th, and 90th 
percentile. Solid line represents point estimate and dashed lines represent 95% confidence intervals. All models were adjusted for age (years), 
alcohol consumption (0, 0.1-15, >15 g/day), educational level (low, medium, high), non-occupational physical activity energy intake (kcal, 
continuous), (A) P-value for non-linearity was 0.902 for men, and 0.002 for women. (B) Additionally adjusted for smoking status (never, 
former, current), number of cigarettes smoked per day (continuous, centered), smoking duration in years (continuous, centered). P-value for 
non-linearity was 0.413 in men, and <0.001 in women. (C) P-value for non-linearity was 0.775 in men, and 0.003 in women.
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Discussion
In this large prospective cohort study, significant associations between reaching the 
age of 90 years and height, BMI at baseline (age 68-70 years), and an increase 
in BMI since the age of 20 years were observed in women, but not in men. 
In women, height was positively associated with reaching longevity. Significantly 
inverse associations were observed between reaching longevity and BMI at baseline, 
and BMI change since the age of 20 years. No significant associations between 
BMI at age 20 years and reaching longevity were found in both sexes. In men, a 
significantly linear positive dose-response relationship was found between increasing 
non-occupational physical activity and the chance of reaching longevity. In women, 
a significantly inverse U-shaped relationship was found between non-occupational 
physical activity and longevity, with the highest chance of reaching longevity around 
60 minutes of non-occupational physical activity per day. 
In our study, height was positively associated with the chance of reaching longevity 
in women, but not in men. In epidemiological studies, height is often positively 
associated with several types of cancer (26), and inversely associated with 
cardiovascular disease, diabetes, pulmonary disease, and mortality risk (27, 28), in 
both men and women. However, these findings have not always been consistent 
(29). Attained adult height is genetically determined as well an indicator for early-
life circumstances, like energy intake, childhood infections, and socioeconomic status 
(30). Some studies suggest that childhood infections and nutritional deprivation 
in early-life may have long-lasting effects that express themselves in a shorter 
adult height and a higher risk for late-life diseases (31-35). In contrast, other 
researchers suggest that a shorter body stature actually increases lifespan, and that 
the observed inverse relationship between height and mortality is mainly caused by 
residual confounding of income, stress, and self-esteem (29, 36). Although it is still 
unclear whether height and longevity are associated, our results indicate that the 
underlying mechanisms may differ by sex. We can only speculate as to why height 
is differentially associated with reaching longevity between men and women in 
our study. Maybe, the observed relationship is related to shrinkage, which is more 
common in women during aging (37). However, no data was available to further 
investigate this relationship. 
In men, we observed no significant associations between BMI and the chance of 
reaching longevity. In the Physicians’ Health Study (PHS), it found that men aged 
66 years and older with a BMI higher than 30kg/m2 had a significantly decreased 
chance of reaching 90 years (HR,0.69) compared to those with a BMI lower than 
25kg/m2(9). No significant associations with longevity were observed for overweight 
men (HR,1.03) (9). Two other studies from the Honolulu Heath Program (HHP) 
and Iowa-ESEPE cohort, observed inverse but non-significant odds ratios (OR’s) 
between reaching longevity, and overweight (≥25-<30 kg/m2) and obesity (≥30 kg/
m2) compared to normal weight men (<25 kg/m2) (7, 10). However, these studies 
used other longevity cut-off ages (LCA) in men, 85 and 94 years respectively. In 
addition to studies on longevity, three literature reviews on BMI and mortality risk 
showed that a BMI ≥25kg/m2 in men was associated with an increased mortality 
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risk (38-40). 
Although our results seem to differ from those of earlier studies, some study-
specific characteristics may explain the observed differences. Firstly, 38% of the 
men included in our analyses had a history of (selected) disease at baseline, 
whereas diseased individuals were excluded from the longevity analyses in the 
PHS-, HHP- and Iowa-ESEPE cohorts. As shown in Figure 3, an inverse, but 
non-significant association was found between BMI and reaching longevity in non-
diseased individuals. Although no significant modifying effect of disease status on 
the relationship between BMI and longevity was observed, diseased men might 
benefit from a higher BMI in terms of survival, in contrast to non-diseased men. 
Secondly, the men in our study had a relatively high baseline age (68-70 years). 
Two literature reviews of BMI and mortality have shown that the effect estimate 
between BMI and mortality became weaker at higher baseline ages (70-89 years) 
(38, 40). Future studies should investigate whether age and/or disease status in men 
might alter the association between BMI and reaching longevity. 
In women, two cohort studies (Iowa-ESEPE: LCA, 97 and Gothenburg: LCA, 85) 
reported the association between BMI and reaching longevity (10, 11). Compared 
to normal weight women, in Iowa-ESEPE, a non-significantly decreased chance 
of reaching longevity was observed in overweight (25-<30 kg/m2) or obese (≥30 
kg/m2) women, with corresponding ORs of 0.87, and 0.44, respectively. In the 
Gothenburg cohort, women in the two highest BMI quintiles (26.6-29.2 kg/m2 and 
29.3-39.8 kg/m2) also showed non-significantly inverse associations with reaching 
longevity compared to the middle BMI quintile (24.6-26.5 kg/m2) (RR, 0.86 and 
RR, 0.80, respectively). Although the results of these studies were not statistically 
significant, the effect estimates are in line with results of our study, suggesting an 
adverse effect of overweight and obesity on the chance of reaching longevity in 
women. In addition to overweight and obesity, we observed an inverse but non-
significant association between being underweight (<18.5 kg/m2) and reaching 
longevity in both sexes, but the sample size was small.
Not stratifying for smoking and disease status has often led to biased results on 
the relationship between BMI and mortality (38, 39). Current smokers and diseased 
individuals more often have a lower BMI, and a higher risk for mortality compared 
to never smokers and non-diseased individuals, respectively. As a result, the risk for 
mortality tends to be underestimated in overweight individuals, while overestimated 
in underweight individuals when not stratifying for these factors. Only one longevity 
study, that of the Oslo Ischemia Study (OIS) (LCA, 85), has stratified for smoking 
status, but only in men (6). It found that men with overweight or obesity at ages 
51-59 years had a significantly lower chance of reaching the age of 85 compared to 
men with lower weight (BMI <25kg/m2), but only in non-smokers (6).
In our study, smoking status in men acted as a significant effect-modifier between 
categories of BMI at baseline and longevity (P=0.041). However, additional 
continuous analyses, showed no significant interaction between smoking status and 
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BMI per 1 kg/m2 increase in men. As a result, the potential modifying effect of 
smoking on the relationship between BMI and longevity in men remains unclear. In 
women, no significant interaction by smoking status was observed. 
In men, we observed no significantly modifying effect of disease history on the 
relationship between BMI and longevity. In women, a history of (selected) disease 
at baseline seems to act as a potential effect-modifier. The association between being 
overweight and reaching longevity seems to be stronger in women with a history 
of (selected) disease compared to women without a history of disease.  These 
results indicate that not stratifying by smoking- and disease status when studying 
the association between BMI and longevity might also lead to biased results. 
Furthermore, the potential modifying effect by smoking and disease history seems to 
differ by sex. 
In our study, we observed a positive linear dose-response relationship between 
non-occupational physical activity and reaching longevity in men (Figure 2). In 
women, we observed an inverse U-shaped relationship between physical activity and 
longevity with the highest likelihood of reaching longevity around 60min/day (Figure 
2). One analysis from the PHS cohort investigated a dose-response relationship 
between different levels of physical activity and the chance of reaching longevity 
(90 years) in men (9). As in our study, it found a significant positive association 
with longevity at a low level of physical activity (1-4 times/month) (HR,1.28), but 
the effect estimate did not increase further in higher levels of physical activity. In 
a European study (PAQUID), the association between regular exercise (yes/no) and 
reaching 90 years was somewhat stronger in men compared to women (HR,1.35 vs. 
HR,1.12), which is in line with the results of our study(15). 
Although the dose-response relation between physical activity and longevity in 
our study seems to differ between both sexes, no significant effect-modification 
by sex was observed (Table 2). This leaves open the possibility that the observed 
differences are due to chance. Furthermore, no information was available on the 
intensity level of physical activity (e.g. moderate, vigorous) for these analyses. 
However, in studies on mortality, it has been suggested that the beneficial effect of 
a higher intensity level is counterbalanced by an increased risk on mortality due to 
cardiovascular side-effects (41). This decreases the probability that the intensity level 
has influenced our results. 
Strengths of this study are the prospective design, large sample size, and detailed 
information on the main exposures, as well on potential confounders. Furthermore, 
our study population was very homogeneous with respect to age, making 
confounding by age unlikely. 
There were some limitations to our study. Firstly, information on weight has only 
been collected at baseline measurement, and retrospectively for the age of 20 
years. Secondly, our exposure variables were self-reported. This might have led 
to some under- or overestimation, depending on the exposure of interest. Thirdly, 
the potential problem of reverse causation arises as well. Although we collected 
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information on disease status at baseline, some baseline characteristics might be 
explained by the participants’ preclinical disease status (i.e. weight and physical 
activity). Lastly, the diseases selected for our additional analyses were restricted to 
the most important non-communicable diseases that are associated with premature 
mortality, and BMI and/or physical activity (42-49). Therefore, “history of selected 
diseases” is no direct indication for a participants’ health status. 
Our findings showed that height, BMI at age 68-70 years, and BMI change since 
the age of 20 years were significantly associated with reaching longevity in women, 
but not in men. Non-occupational physical activity was positively significantly 
associated with an increased chance of reaching longevity in both sexes, but 
evidence for a non-linear relationship was observed in women.
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Alcohol consumption in later life and reaching longevity: the 
Netherlands Cohort Study
Piet A. van den Brandt, Lloyd Brandts
Abstract
Background: 
Whether light to moderate alcohol intake is related to reduced mortality remains a 
subject of intense research and controversy. There are very few studies available on 
alcohol and reaching longevity.
Methods
We investigated the relationship of alcohol drinking characteristics with the 
probability to reach 90 years of age. Analyses were conducted using data from the 
Netherlands Cohort Study. Participants born in 1916–1917 (n=7807) completed a 
questionnaire in 1986 (age 68–70 years) and were followed up for vital status until 
the age of 90 years (2006–2007). Multivariable Cox regression analyses with fixed 
follow-up time were based on 5479 participants with complete data to calculate risk 
ratios (RRs) of reaching longevity (age 90 years). 
Results
We found statistically significant positive associations between baseline alcohol intake 
and the probability of reaching 90 years in both men and women. Overall, the 
highest probability of reaching 90 was found in those consuming 5-<15 g/d alcohol, 
with RR=1.36 (95% CI, 1.20-1.55) when compared with abstainers. The exposure-
response relationship was significantly nonlinear in women, but not in men. Wine 
intake was positively associated with longevity (notably in women), whereas liquor 
was positively associated with longevity in men and inversely in women. Binge 
drinking pointed towards an inverse relationship with longevity. Alcohol intake was 
associated with longevity in those without and with a history of selected diseases.
Conclusions
The highest probability of reaching 90 years was found for those drinking 5-<15 g 
alcohol/day. Although not significant, the risk estimates also indicate to avoid binge 
drinking.
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Introduction
Whether light to moderate alcohol intake is related to reduced mortality remains a 
subject of intense research and controversy, e.g. (1, 2). Whereas alcohol consumption 
has been studied frequently in relation to mortality (especially CVD), the findings 
were inconsistent. Many studies have reported J-shaped curves relating alcohol to 
mortality suggesting the lowest risk for light-moderate drinkers (2-5), while others 
found nonsignificant associations or linear associations (1, 6, 7). Many early cohort 
studies may have suffered from “abstainer bias” where ex-drinkers are misclassified 
as abstainers and related inclusion of subjects with chronic diseases (sick quitters), 
and limited confounder adjustment (5, 6, 8). A recent meta-analysis addressing 
these issues (6) found no protective effect of low-moderate drinking in the subset 
of studies that controlled for these biases, but this selection was criticized (9). 
While mortality studies investigate risk factors for premature death (i.e. earlier than 
average), longevity studies investigate determinants of attaining exceptionally high 
ages (exceeding life expectancy). The relationship between alcohol and longevity has 
been investigated rarely, with survival cut-off ages of 85 (10, 11) or younger (12) 
in early cohort studies, and 90 in recent studies (13, 14). Furthermore, most studies 
involved men only (10, 11, 13), did not exclude ex-drinkers and results were 
inconsistent.
We investigated the relationship between habitual alcohol intake in later life and 
the probability of reaching 90 years in men and women (because alcohol affects 
women differently from men (15)), within the Netherlands Cohort Study (NLCS). 
Given the controversies surrounding light-to-moderate alcohol intake and mortality, 
we concentrated on this category in dose-response modelling. We also aimed to 
investigate beverage types, stability of drinking over time and effect of excluding 
ex-drinkers, and binge drinking, because these factors were important in mortality 
studies.
Methods
Study design and population 
For this study, data from the ongoing NLCS was used. The NLCS started in 
September 1986 as a large population-based prospective study, with detailed 
information on baseline alcohol use and many confounders available from men 
and women (16, 17). Eligible subjects were men and women living in 204 Dutch 
municipalities, aged 55-70 years at cohort baseline (1986). NLCS-participants born 
in 1916-1917 were selected to form the longevity cohort for the current analyses 
(i.e. aged 68-70 at baseline), because younger birth cohorts could not have reached 
age 90 at the end of follow-up (14, 18). Vital status follow-up consisted of record 
linkage to the Central Bureau for Genealogy and to municipal population registries 
from 1986-2007, yielding exact dates of death. Vital status follow-up of the 
longevity cohort until age 90 (2006-2007) was 99.9% complete; seven participants 
were lost to follow-up due to migration. The resulting study population consisted of 
3,646 men and 4,161 women (Figure 1). 
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Figure 1: Flow diagram on analyses of alcohol intake and longevity in birth 
cohorts 1916-17, Netherlands Cohort Study (1986-2007).
Exposure assessment
The 11-page baseline questionnaire measured dietary intake, detailed information on 
lifestyle factors, and medical conditions (16). Habitual consumption of food and 
(alcoholic) beverages during the year preceding baseline was assessed using a semi-
quantitative food-frequency questionnaire (FFQ), which was validated against a 9-day 
diet record (19). 
Consumption of alcoholic beverages was addressed by questions on beer, red wine, 
white wine, sherry and other fortified wines, liqueur types containing on average 
16% ethanol, and (Dutch) gin, brandy, and whiskey. Respondents who consumed 
alcoholic beverages less than once a month were considered non-users. Four 
items from the questionnaire (i.e. red wine, white wine, sherry, and liqueur) were 
combined into one wine variable, since these items were substantially correlated 
(20). Mean daily alcohol consumption was calculated using the Dutch food 
composition table (21). The FFQ has been validated and tested for reproducibility 
(19, 22). For mean daily ethanol intake, Spearman correlation coefficients between 
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the 9-day diet record and the questionnaire were 0.89 for all subjects and 0.85 for 
alcohol users (19). The absolute amount of ethanol reported in the questionnaire by 
alcohol users was, on average, 86% of that reported in the 9-day diet record (19).
The baseline questionnaire also asked about the usual pattern of drinking alcoholic 
beverages (parties only/ weekend & parties/ throughout week). To measure binge 
drinking, subjects were asked how often they drank more than 6 alcoholic drinks 
per occasion during the half year preceding baseline. Finally, a question provided 
information on the subjects’ drinking habits five years before baseline. Ex-drinkers 
were defined as participants who were not drinking alcohol at baseline, but who 
drank alcoholic beverages 5 years before baseline.
Statistical analyses 
Subjects with missing data on alcohol and confounding variables were excluded. The 
associations of alcohol consumption, alcoholic beverages and drinking characteristics 
with the probability of reaching 90 years (longevity) were estimated in age(-sex) 
and multivariable-adjusted analyses using Cox regression models with a fixed follow-
up time (18, 23), in categorical and continuous exposure analyses, correcting for 
potential confounders (related to longevity and alcohol (see footnotes in Tables)). 
Standard errors were calculated using the Huber-White sandwich estimator (24). 
Ex-drinkers were excluded from the main analyses to avoid misclassification of 
ex-drinkers as abstainers. Beverage-specific analyses for beer, wine and liquor were 
additionally mutually adjusted to evaluate the association of each beverage with 
longevity independently of other alcoholic beverages. Analyses of the effect of 
pattern of drinking, and binge drinking were additionally adjusted for total intake of 
alcoholic beverages.
Tests for trends were assessed using Wald tests, by fitting median values of intake 
per intake category as continuous terms. Restricted cubic spline regression analyses 
using four knots (at the midpoints of the categories used in categorical analyses), 
and Wald test were performed to test for non-linearity. We conducted sensitivity 
analyses, by restricting analyses to participants who reported to have had the same 
alcohol intake five years before baseline, including abstainers on both occasions 
(i.e., the stable subgroup). To evaluate potential residual confounding by other 
risk factors, and effect modification, analyses of alcohol and longevity were also 
conducted within strata of covariables. Interactions were tested using Wald tests and 
cross-product terms. Analyses were performed using Stata 14; presented P-values are 
two-sided.
Results
Among the 2591 men, 433 (16.7%) survived until 90 years, and there were 994 
survivors (34.4%) among the 2888 women. In the total group, 40 men and 32 
women were ex-drinkers. When excluding ex-drinkers, the proportion of alcohol 
abstainers was higher among non-survivors than survivors in both men (15.6% 
versus 10.6%) and women (37.4% and 30.1%). Among male alcohol consumers, 
mean intake (SD) was 16.5 (15.8) g/day in non-survivors and 15.9 (14.9) g/
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day in survivors. For women these numbers were 8.0 (10.5) and 7.2 (9.0) g/day, 
respectively. Table 1 also shows these comparisons for beverage types (glasses/
week), pattern of drinking, stable drinking, and binge drinking. The proportion of 
binge drinkers was higher among non-survivors than survivors, and higher in men: 
18.5% versus 14.2% in men, and 6.1% versus 4.0% in women, respectively. Alcohol 
consumption was positively associated with smoking, educational level and energy 
intake in both sexes, with physical activity in women, and with BMI and height in 
men (Table 2). There was no clear association with history of selected diseases. Ex-
drinkers more often had a history of selected diseases than those in other drinking 
categories. Excluded subjects with missings had a lower likelihood of reaching 90, 
were less often smokers and less highly educated (Table 3).
Alcohol intake was positively associated with the probability of reaching 90 years 
in men and women in multivariable-adjusted analyses (Table 4). In analyses of 
men and women combined, those drinking 5-<10 g alcohol/day had a RR of 
1.41 (95%CI, 1.21-1.63) of reaching 90, compared to abstainers. This probability 
remained elevated at higher alcohol intake levels (P-trend= 0.014). Ex-drinkers had 
a decreased probability of reaching 90, when compared to abstainers. Ex-drinkers 
were excluded from subsequent analyses. When alcohol was analyzed as continuous 
variable, the RR per increment of 10 g/d was 1.05 (95%CI 1.01-1.09). In analyses 
limited to the stable subgroup, similar associations were seen as in the overall 
group. There was no statistically significant interaction between men and women 
(p=0.168). However, the estimated associations showed differences: whereas in men 
the probability of reaching 90 remained elevated at higher alcohol consumption 
levels (e.g., RR=1.64 (1.15-2.34) for men drinking 30+g/day compared to abstainers), 
this was not seen in women with: RR=0.99 (0.69-1.44). This difference in dose-
response was also noticed in restricted cubic splines analyses, where a significantly 
nonlinear relationship was observed in women (p for nonlinearity= 0.004), but not 
in men (Figure 2). We therefore continued with sex-specific analyses.
In beverage-specific analyses, we found no association with beer intake (Table 5). 
Wine intake was associated with higher chances of reaching 90 among women, with 
RRs of 1.43 (95%CI 1.21-1.68) and 1.35 (1.14-1.59) for women drinking 3.5-<7 
and 7+ glasses/week, respectively, when compared to nondrinkers of wine (p-trend 
<0.001, and p-trend= 0.049 among wine drinkers). For men, the weakly positive 
associations with wine were nonsignificant. Liquor intake was significantly positively 
associated with longevity among men in several drinking categories compared 
to nondrinkers of liquor, but the trend test and continuous analyses were not 
significant. In women, however, higher liquor intake was inversely associated with 
longevity (p-trend= 0.044, and p-trend= 0.018 among liquor drinkers).   
A
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Table 1. Baseline characteristics of the cohort members by survival (90+ years) status in birth cohorts 1916-17; Netherlands 
Cohort Study (1986-2007).
Men     Women   
Died before 90 Survived to age 90 Died before 90 Survived to age 90
 N %  N %  N %  N %
N 2158 433 1894 994
ALL (including non-drinkers)
Alcohol intake categories 
 Ex, 0 g/d 34 1.6 6 1.4 27 1.4 5 0.5
 0 g/day (abstainer) 337 15.6 46 10.6 709 37.4 299 30.1
 0.1-<5 512 23.7 106 24.5 691 36.5 401 40.3
 5-<10 260 12.0 75 17.3 156 8.2 106 10.7
 10-<15 280 13.0 52 12.0 109 5.8 79 7.9
 15-<30 443 20.5 84 19.4 133 7.0 82 8.2
 30+ 292 13.5 64 14.8 69 3.6 22 2.2
Alcohol consumers Mean (SD)   Mean (SD)   Mean (SD)   Mean (SD)  
Alcohol (g/day); mean (SD) 16.5 (15.8) 15.9 (14.9) 8.0 (10.5) 7.2 (9.0)
Beer (glasses/week); mean (SD) 2.2 (4.6) 2.0 (4.3) 0.1 (0.8) 0.1 (0.8)
Wine incl sherry, liqueur (glasses/week); mean (SD) 2.9 (5.6) 3.3 (5.4) 4.0 (5.6) 4.2 (5.1)
Liquor (glasses/week); mean (SD) 5.2 (6.7) 4.7 (6.2) 1.0 (3.0) 0.5 (2.0)
N %  N %  N %  N %
Change in alcohol consumption in last 5 years
 Stable 1060 68.4 260 76.9 636 77.1 393 76.2
C
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 Moderated 302 19.5 48 14.2 115 13.9 66 12.8
 Increased 187 12.1 30 8.9 74 9.0 57 11.0
Type of alcoholic beverage
 Only beer 90 5.1 14 3.7 13 1.1 5 0.7
 Only wine 269 15.1 58 15.3 851 73.9 536 78.1
 Only liquor 288 16.2 54 14.2 47 4.1 15 2.2
 Beer and wine 156 8.8 37 9.8 63 5.5 45 6.6
 Wine and liquor 272 15.3 63 16.6 134 11.6 66 9.6
 Beer and liquor 274 15.4 44 11.6 9 0.8 2 0.3
 Beer, wine and liquor 433 24.3 109 28.8 34 3.0 17 2.5
Pattern of alcohol drinking
 Only at parties 301 18.4 64 18.2 320 32.8 179 30.3
 Weekend and parties 501 30.6 124 35.2 334 34.2 224 37.9
 Throughout the week 836 51.0 164 46.6 322 33.0 188 31.8
Frequency of 7+ drinks/occasion in last 6 months
 0 times/ last 6 months 1127 81.5 260 85.8 749 93.9 437 96.0
 1-<2 times 52 3.8 13 4.3 19 2.4 7 1.5
 2-<3 times 45 3.3 8 2.6 10 1.3 2 0.4
 3-<5 times 59 4.3 6 2.0 8 1.0 4 0.9
 5 times or more 100 7.2 16 5.3 12 1.5 5 1.1
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Binge drinking (7+ drinks/occasion) in last 6 months
 No 1127 81.5 260 85.8 749 93.9 437 96.0
 Yes 256 18.5 43 14.2 49 6.1 18 4.0
            
Table 2. Baseline characteristics (means or percent) according to alcohol consumption level in men and women with complete dietary 
and covariable data, NLCS 1916-1917 birth cohorts.
Characteristic Alcohol consumption (g/day)      
 0  0.1-<5  5-<10  10-<15  15-<30  30+  Ex, 0 g/d
Men
N 383 618 335 332 527 356 40
Median alcohol intake(g/day) 0 2.1 7.4 12.1 22.4 40.6 0
BMI (kg/m2); mean 24.4 24.8 24.7 25.1 25.0 25.2 24.4
Height (cm), mean 174.7 174.9 175.0 174.9 175.0 175.6 175.1
Physical activity, nonocc. (min/day); mean 73.0 77.5 71.2 74.9 75.6 71.5 74.0
Energy intake (kcal/day); mean 1969 1968 2013 2095 2083 2180 1985
Never smoker (%) 20.9 13.1 11.0 6.9 4.7 2.0 7.5
University or higher vocational education 
(%) 13.1 14.6 17.3 17.5 18.2 29.8 7.5
History of (selected) diseasesa (% yes) 47.8 41.6 42.1 49.4 45.0 38.5 57.5
Women
N 1008 1092 262 188 215 91 32
Median alcohol intake(g/day) 0 1.4 7.2 12.1 20.7 35.6 0
BMI (kg/m2); mean 25.2 25.2 25.0 24.4 24.6 24.1 25.5
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Height (cm), mean 164.0 164.1 164.4 164.3 164.4 163.1 165.1
Physical activity, nonocc. (min/day); mean 52.1 57.4 57.0 58.6 57.8 59.8 56.3
Energy intake (kcal/day); mean 1615 1643 1700 1723 1693 1722 1672
Never smoker (%) 82.1 74.9 64.1 51.1 41.9 23.1 59.4
University or higher vocational education 
(%) 5.6 7.2 13.4 12.2 13.5 12.1 15.6
History of (selected) diseasesa (% yes) 52.7 47.1 45.4 39.9 40.5 44.0 56.3
a Physician-diagnosed myocardial infarction, angina pectoris, stroke, cancer (excluding skin cancer), diabetes or hypertension.
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Table 3. Baseline characteristics (means or percent) and survival for excluded 
subjects due to missings on alcohol or covariables in men and women, NLCS 1916-
1917 birth cohort.
Characteristic
Excluded: 
Missing alcohol 
intake
Excluded:  
Missing 
covariables
Included: 
No missings
Men
N 163 892 2591
Median alcohol intake(g/day) - 12.2 13.7
BMI (kg/m2); mean 24.9 - 24.8
Height (cm), mean 172.9 - 175.0
Physical activity, nonocc. (min/
day); mean 69.3 - 74.4
Energy intake (kcal/day); mean 1828 - 2042
Never smoker (%) 15.3 - 9.9
University or higher vocational 
education (%) 6.1 - 17.8
History of (selected) diseasesa 
(% yes) 40.5 - 44.1
Survived to age 90 (%) 11.0 12.8 16.7
Women
N 501 772 2888
Median alcohol intake(g/day) - 4.5 4.9
BMI (kg/m2); mean 25.3 - 25.1
Height (cm), mean 163.9 - 164.1
Physical activity, nonocc. (min/
day); mean 44.0 - 55.7
Energy intake (kcal/day); mean 1549 - 1650
Never smoker (%) 83.7 - 70.6
University or higher vocational 
education (%) 0.2 - 8.2
History of (selected) diseasesa 
(% yes) 52.7 - 47.9
Survived to age 90 (%) 28.1 33.6 34.4
a Physician-diagnosed myocardial infarction, angina pectoris, stroke, cancer (excluding skin cancer), diabetes or 
hypertension.
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Table 4. Age- and multivariable-adjusteda RRs for reaching longevity according to alcohol intake in birth cohort 1916-17; 
Netherlands Cohort Study (1986-2007).
 Alcohol (g/day)      
 Ex, 0 g/d Abstainers  >0-<5 g/d  5-<10 g/d  10-<15 g/d  15-<30 g/d  30+ g/d P for Continuousb, P for
          trendb per 10 g/d
inter-
actionb
Men and women
   Overall
      Median intake (g/day) 0.0 0.0 1.6 7.2 12.1 21.4 39.5
      N 72 1391 1710 597 520 742 447
      Survivors(90+) 11 345 507 181 131 166 86
      Age-sex-adjusted RR 0.74 1 1.26 1.49 1.32 1.24 1.15 0.391 1.01
       (95 %CI) (0.43 - 1.30) (Ref.) (1.13 - 1.42) (1.28 - 1.73) (1.11 - 1.56) (1.06 - 1.46) (0.93 - 1.43) (0.97 - 1.05)
      Multivariable-adjusted RRa 0.84 1 1.19 1.41 1.30 1.29 1.31 0.014 1.05 0.168
       (95 %CI) (0.48 - 1.47) (Ref.) (1.07 - 1.33) (1.21 - 1.63) (1.10 - 1.55) (1.10 - 1.52) (1.06 - 1.63) (1.01 - 1.09)
   Stable subgroup
      Median intake (g/day) 0.0 1.8 7.2 12.1 22.0 40.0
      N 1180 907 364 319 467 292
      Survivors(90+) 288 287 114 83 109 60
      Age-sex-adjusted RR 1 1.37 1.52 1.34 1.28 1.18 0.364 1.01
       (95 %CI) (Ref.) (1.20 - 1.57) (1.27 - 1.82) (1.09 - 1.64) (1.05 - 1.55) (0.92 - 1.52) (0.97 - 1.06)
      Multivariable-adjusted RRa 1 1.25 1.42 1.30 1.31 1.36 0.024 1.05 0.468
       (95 %CI) (Ref.) (1.09 - 1.43) (1.18 - 1.70) (1.05 - 1.60) (1.08 - 1.59) (1.05 - 1.76) (1.00 - 1.11)
Men
      Median intake (g/day) 0.0 0.0 2.1 7.4 12.1 22.4 40.6
      N 40 383 618 335 332 527 356
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      Survivors(90+) 6 46 106 75 52 84 64
      Age-adjusted RR 1.24 1 1.43 1.86 1.31 1.33 1.50 0.453 1.01
       (95 %CI) (0.56 - 2.72) (Ref.) (1.04 - 1.97) (1.33 - 2.61) (0.90 - 1.89) (0.95 - 1.86) (1.06 - 2.13) (0.96 - 1.07)
      Multivariable-adjusted RRa 1.49 1 1.39 1.81 1.37 1.43 1.64 0.100 1.04
       (95 %CI) (0.69 - 3.23) (Ref.) (1.01 - 1.90) (1.30 - 2.53) (0.95 - 1.97) (1.02 - 1.99) (1.15 - 2.34) (0.98 - 1.10)
Women
      Median intake (g/day) 0.0 0.0 1.4 7.2 12.1 20.7 35.6
      N 32 1008 1092 262 188 215 91
      Survivors(90+) 5 299 401 106 79 82 22
      Age-adjusted RR 0.53 1 1.24 1.36 1.42 1.29 0.81 0.526 1.01
       (95 %CI) (0.23 - 1.18) (Ref.) (1.09 - 1.40) (1.14 - 1.62) (1.17 - 1.72) (1.06 - 1.56) (0.56 - 1.19) (0.96 - 1.07)
      Multivariable-adjusted RRa 0.62 1 1.17 1.28 1.38 1.31 0.99 0.078 1.05
       (95 %CI) (0.27 - 1.38) (Ref.) (1.03 - 1.32) (1.08 - 1.52) (1.13 - 1.68) (1.08 - 1.60) (0.69 - 1.44) (0.99 - 1.11)
a Multivariable analyses were adjusted for: age at baseline (continuous, in years), tobacco smoking status (coded as never, former, current smoker), number 
of cigarettes smoked per day, and years of smoking (both continuous, centered)), body height (continuous, m), BMI (<18.5, 18.5-<25, 25-<30, ≥30 kg/m2), 
non-occupational physical activity (<30, 30-60, 61-90, ≥90 min/day), history of selected diseases at baseline (physician-diagnosed myocardial infarction, angi-
na pectoris, stroke, cancer (excluding skin cancer), diabetes and hypertension; categorized as 0,1,2,3+ diseases), highest level of education (primary school or 
lower vocational, secondary or medium vocational, and higher vocational or university), energy intake (continuous, kcal/day). b Excluding ex-drinkers.
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Figure 2. Spline regression curves for the association of alcohol consumption with 
the probability of reaching longevity in men and women separately. Red lines: men. 
Blue lines: women. Solid lines represents point estimates and dashed lines represent 
95% confidence intervals. Multivariate HRs are calculated by restricted cubic spline 
regression adjusting for: age at baseline (continuous, in years), tobacco smoking 
status (coded as never, former, current smoker), number of cigarettes smoked per 
day, and years of smoking (both continuous, centered)), body height (continuous, 
m), BMI (<18.5, 18.5-<25, 25-<30, ≥30 kg/m2), non-occupational physical activity 
(<30, 30-60, 61-90, ≥90 min/day), history of selected diseases at baseline (physi-
cian-diagnosed myocardial infarction, angina pectoris, stroke, cancer (excluding skin 
cancer), diabetes and hypertension; categorized as 0,1,2,3+ diseases), highest level of 
education (primary school or lower vocational, secondary or medium vocational, and 
higher vocational or university), energy intake (continuous, kcal/day).
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Table 5. Age- and multivariable-adjusted RRs for reaching longevity according to intake of specific alcoholic beverages in 
birth cohort 1916-17; Netherlands Cohort Study (1986-2007)
Men        Women       
Alcoholic beverage Median N 90+ RRa (95% CI) RRb (95% CI) Median N 90+ RRa (95% CI) RRb (95% CI)
 (gl/wk)         (gl/wk)        
                  
Beer (glasses/week)
 No 0.0 1388 221 1 (reference) 1 (reference) 0.0 2665 919 1 (reference) 1 (reference)
 >0-<3.5 1.0 764 144 1.18 (0.98 - 1.43) 1.03 (0.85 - 1.25) 0.5 173 63 1.06 (0.86 - 1.30) 1.00 (0.82 - 1.22)
 3.5-<7 5.0 198 33 1.05 (0.75 - 1.46) 1.00 (0.71 - 1.39) 5.0 13 6 1.33 (0.74 - 2.41) 1.22 (0.70 - 2.12)
 7+ gl/wk 13.0 201 29 0.91 (0.63 - 1.29) 0.92 (0.64 - 1.31) 13.0 5 1 0.58 (0.10 - 3.32) 0.61 (0.09 - 4.09)
P for trend 0.493 0.611 0.970 0.857
P trend, beer drink-
ers 0.140 0.545 0.768 0.913
Continuous, per 7 
gl/wk 2551 427 0.98 (0.85 - 1.13) 1.01 (0.86 - 1.18) 2856 989 1.00 (0.59 - 1.70) 0.97 (0.55 - 1.73)
P for interaction 
by sex 0.739
Wine (glasses/
week)
 No 0.0 1149 159 1 (reference) 1 (reference) 0.0 1099 321 1 (reference) 1 (reference)
 >0-<3.5 1.0 881 167 1.37 (1.12 - 1.67) 1.17 (0.95 - 1.44) 1.0 1135 413 1.25 (1.10 - 1.40) 1.16 (1.03 - 1.30)
 3.5-<7 5.0 236 49 1.50 (1.12 - 2.00) 1.15 (0.85 - 1.55) 5.1 265 116 1.50 (1.27 - 1.77) 1.43 (1.21 - 1.68)
 7+ gl/wk 13.0 285 52 1.32 (0.99 - 1.76) 1.08 (0.81 - 1.46) 13.0 357 139 1.33 (1.14 - 1.56) 1.35 (1.14 - 1.59)
P for trend 0.087 0.880 0.001 <0.001
P trend, wine 
drinkers 0.825 0.400 0.287 0.049
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Continuous, per 7 
gl/wk 2551 427 1.08 (0.99 - 1.19) 1.04 (0.94 - 1.16) 2856 989 1.09 (1.02 - 1.16) 1.11 (1.04 - 1.19)
P for interaction 
by sex 0.555
Liquor (glasses/
week)
 No 0.0 1011 156 1 (reference) 1 (reference) 0.0 2531 889 1 (reference) 1 (reference)
 >0-<3.5 1.2 603 120 1.29 (1.04 - 1.60) 1.34 (1.08 - 1.67) 1.0 185 70 1.08 (0.89 - 1.31) 1.02 (0.85 - 1.24)
 3.5-<7 5.0 365 55 0.98 (0.74 - 1.30) 1.12 (0.83 - 1.49) 6.5 81 19 0.67 (0.45 - 0.99) 0.72 (0.49 - 1.07)
 7+ gl/wk 13.0 572 96 1.09 (0.86 - 1.37) 1.30 (1.02 - 1.66) 13.0 59 11 0.53 (0.31 - 0.91) 0.67 (0.40 - 1.15)
P for trend 0.956 0.172 0.003 0.044
P trend, liquor 
drinkers 0.257 0.919 0.003 0.018
Continuous, per 7 
gl/wk 2551 427 0.97 (0.89 - 1.07) 1.05 (0.95 - 1.16) 2856 989 0.69 (0.54 - 0.89) 0.78 (0.60 - 1.01)
P for interaction 
by sex 0.062
a Age-adjusted analyses. b Multivariable analyses were adjusted for: age at baseline (continuous, in years), tobacco smoking status (coded as never, former, 
current smoker), number of cigarettes smoked per day, and years of smoking (both continuous, centered)), body height (continuous, m), BMI (<18.5, 18.5-<25, 
25-<30, ≥30 kg/m2), non-occupational physical activity (<30, 30-60, 61-90, ≥90 min/day),  history of selected diseases at baseline (physician-diagnosed myo-
cardial infarction, angina pectoris, stroke, cancer (excluding skin cancer), diabetes and hypertension; categorized as 0,1,2,3+ diseases), highest level of educa-
tion (primary school or lower vocational, secondary or medium vocational, and higher vocational or university), energy intake (continuous, kcal/day), intake of 
the other 2 types of alcoholic beverages (each categorical).
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Table 6. Age- and multivariable-adjusted RRs for reaching longevity according to alcohol drinking characteristics in drinkers, 
birth cohorts 1916-17; Netherlands Cohort Study (1986-2007).
Drinking 
characteristic Men       Women       
Median N 90+ RRa (95% CI) RRb (95% CI) Median N 90+ RRa (95% CI) RRb (95% CI)
 (gl/wk)        (gl/wk)       
Pattern of alcohol drinking
 Only at parties 1.4 365 64 1 (reference) 1 (reference) 0.9 499 179 1 (reference) 1 (reference)
 Weekend and 
parties 4.5 625 124 1.14 (0.87 - 1.50) 1.18 (0.90 - 1.55) 2.2 558 224 1.12 (0.96 - 1.30) 1.10 (0.95 - 1.28)
 Throughout the 
week 14.0 1000 164 0.94 (0.73 - 1.23) 0.97 (0.71 - 1.32) 10.7 510 188 1.03 (0.87 - 1.21) 1.10 (0.89 - 1.36)
P for trend 0.360 0.736 0.759 0.277
P for interaction 
with alcohol 0.979 0.105
Binge drinking in last 6 months
 No 6.5 1387 260 1 (reference) 1 (reference) 2.4 1186 437 1 (reference) 1 (reference)
 Yes 14.2 299 43 0.76 (0.57 - 1.03) 0.91 (0.66 - 1.26) 7.5 67 18 0.74 (0.49 - 1.10) 0.80 (0.53 - 1.20)
P for interaction 
with alcohol 0.080 0.404
How often 7+ drinks/occasion in last 6 months
 0 times/ last 6 
months 6.5 1387 260 1 (reference) 1 (reference) 2.4 1186 437 1 (reference) 1 (reference)
 1-<2 times 11.9 65 13 1.06 (0.65 - 1.75) 1.22 (0.76 - 1.96) 2.2 26 7 0.73 (0.39 - 1.39) 0.69 (0.37 - 1.31)
 2-<3 times 13.0 53 8 0.80 (0.42 - 1.53) 0.97 (0.51 - 1.84) 8.2 12 2 0.46 (0.13 - 1.64) 0.61 (0.19 - 1.96)
 3-<5 times 13.5 65 6 0.49 (0.23 - 1.06) 0.58 (0.27 - 1.24) 8.8 12 4 0.92 (0.41 - 2.06) 1.04 (0.45 - 2.38)
 5 times or more 21.0 116 16 0.73 (0.46 - 1.17) 0.88 (0.51 - 1.49) 26.7 17 5 0.81 (0.39 - 1.68) 0.98 (0.45 - 2.12)
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P for trend 0.044 0.345 0.266 0.605
P for interaction 
with alcohol 0.510 0.147
a Age-adjusted analyses b Multivariable analyses were adjusted for: age at baseline (continuous, in years), tobacco smoking status (coded as never, former, 
current smoker), number of cigarettes smoked per day, and years of smoking (both continuous, centered)), body height (continuous, m), BMI (<18.5, 18.5-
<25, 25-<30, ≥30 kg/m2), non-occupational physical activity (<30, 30-60, 61-90, ≥90 min/day),  history of selected diseases at baseline (physician-diagnosed 
myocardial infarction, angina pectoris, stroke, cancer (excluding skin cancer), diabetes and hypertension; categorized as 0,1,2,3+ diseases), highest level of 
education (primary school or lower vocational, secondary or medium vocational, and higher vocational or university), alcohol intake (continuous, glasses/week), 
energy intake (continuous, kcal/day).
Table 7. Multivariable-adjusteda RRs for reaching longevity according to alcohol intake in men and women, by strata of 
smoking and other factors, NLCS.
Alcohol intake (g/day)     
 Abstainers  >0-<5  5-<15  15-<30  30+ P for Continuous, P for
      trend per 10 g/d interaction
Overall
   90+  /  N 345/1391 507/1710 312/1117 166/742 86/447 1416/5407
   RR 1 (Ref.) 1.19 1.36 1.30 1.32 0.009 1.05
   (95 %CI) (1.07 - 1.34) (1.20 - 1.55) (1.10 - 1.53) (1.06 - 1.64) (1.01 - 1.09)
Smoking status
  Never smokers
      90+  /  N 276/908 336/899 134/324 48/115 8/28 802/2274
      RR 1 (Ref.) 1.19 1.31 1.31 0.98 0.053 1.06 0.662
      (95 %CI) (1.05 - 1.35) (1.11 - 1.55) (1.03 - 1.66) (0.56 - 1.71) (0.99 - 1.15)
  Former smokers
      90+  /  N 48/260 112/467 119/476 66/338 45/207 390/1748
      RR 1 (Ref.) 1.21 1.43 1.18 1.31 0.450 1.02
      (95 %CI) (0.90 - 1.63) (1.06 - 1.91) (0.85 - 1.64) (0.91 - 1.87) (0.95 - 1.08)
  Current smokers
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      90+  /  N 21/223 59/344 59/317 52/289 33/212 224/1385
      RR 1 (Ref.) 1.56 1.88 2.04 1.87 0.040 1.08
      (95 %CI) (0.99 - 2.47) (1.19 - 2.98) (1.28 - 3.25) (1.10 - 3.18) (1.01 - 1.16)
BMI (kg/m2)
  18.5-<25
      90+  /  N 199/734 269/912 184/613 99/394 57/240 808/2893
      RR 1 (Ref.) 1.11 1.36 1.33 1.50 <0.001 1.08 0.110
      (95 %CI) (0.95 - 1.29) (1.15 - 1.61) (1.08 - 1.63) (1.15 - 1.96) (1.03 - 1.14)
  25+
      90+  /  N 142/634 233/779 126/495 66/341 29/202 596/2451
      RR 1 (Ref.) 1.35 1.42 1.32 1.10 0.793 1.00
      (95 %CI) (1.14 - 1.61) (1.15 - 1.76) (1.01 - 1.72) (0.75 - 1.59) (0.94 - 1.07)
Physical activity (min/day)
  =<30
      90+  /  N 122/476 129/481 65/263 33/184 16/116 365/1520
      RR 1 (Ref.) 1.06 1.19 1.05 1.02 0.847 1.00 0.256
      (95 %CI) (0.87 - 1.31) (0.92 - 1.55) (0.73 - 1.50) (0.61 - 1.70) (0.92 - 1.10)
  >30
      90+  /  N 223/915 378/1229 247/854 133/558 70/331 1051/3887
      RR 1 (Ref.) 1.29 1.47 1.44 1.48 0.002 1.06
      (95 %CI) (1.13 - 1.48) (1.26 - 1.72) (1.20 - 1.74) (1.16 - 1.88) (1.02 - 1.11)
Level of education
  Primary school, lower vocational
      90+  /  N 216/890 277/960 143/506 52/324 24/143 712/2823
      RR 1 (Ref.) 1.20 1.52 1.08 1.18 0.357 1.02 0.172
      (95 %CI) (1.04 - 1.40) (1.27 - 1.82) (0.82 - 1.43) (0.79 - 1.76) (0.95 - 1.10)
  Secondary, medium vocational
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      90+  /  N 103/395 174/581 121/437 77/293 34/187 509/1893
      RR 1 (Ref.) 1.14 1.29 1.45 1.27 0.025 1.08
      (95 %CI) (0.93 - 1.38) (1.04 - 1.60) (1.13 - 1.85) (0.91 - 1.78) (1.02 - 1.14)
  Higher vocational, university
      90+  /  N 26/106 56/169 48/174 37/125 28/117 195/691
      RR 1 (Ref.) 1.48 1.33 1.68 1.68 0.110 1.04
      (95 %CI) (1.00 - 2.20) (0.88 - 2.01) (1.08 - 2.63) (1.01 - 2.78) (0.96 - 1.13)
History of selected disease at baseline
  No
      90+  /  N 205/677 334/939 206/618 106/418 63/270 914/2922
      RR 1 (Ref.) 1.24 1.38 1.23 1.38 0.056 1.03 0.534
      (95 %CI) (1.08 - 1.42) (1.18 - 1.61) (1.01 - 1.50) (1.07 - 1.78) (0.99 - 1.09)
  Yes
      90+  /  N 140/714 173/771 106/499 60/324 23/177 502/2485
      RR 1 (Ref.) 1.15 1.41 1.55 1.23 0.032 1.09
      (95 %CI) (0.95 - 1.40) (1.12 - 1.77) (1.17 - 2.06) (0.81 - 1.87) (1.01 - 1.17)
a Multivariable analyses were adjusted for: age at baseline (continuous, in years), sex, tobacco smoking status (coded as never, former, current smoker), number of cigarettes 
smoked per day, and years of smoking (both continuous, centered)), body height (continuous, m), BMI (<18.5, 18.5-<25, 25-<30, ≥30 kg/m2), non-occupational physical 
activity (<30, 30-60, 61-90, ≥90 min/day), history of selected diseases at baseline (physician-diagnosed myocardial infarction, angina pectoris, stroke, cancer (excluding 
skin cancer), diabetes and hypertension; categorized as 0,1,2,3+ diseases), highest level of education (primary school or lower vocational, secondary or medium vocational, 
and higher vocational or university), energy intake (continuous, kcal/day).
Alcohol consumption and reaching longevity
 
135
6
There was no significant association with pattern of drinking (Table 6). Although 
binge drinkers seemed to have a lower probability of reaching 90 than non-binge 
drinkers, especially in women, the multivariable-adjusted associations were non-
significant. This may be due to the small proportion of binge drinking women. 
When binge drinking was further categorized according to frequency, lower chances 
of longevity were found in more frequently binge drinking men, but the trend test 
was not significant. 
In subgroup analyses of alcohol and longevity, categorical (or continuous) alcohol 
intake showed no significant interactions with smoking status, BMI, physical 
activity, level of education, or history of diseases at baseline (Table 7). Significant 
associations between alcohol and probability of reaching 90 were seen in many 
subgroups, including never and current smokers, and those with or without a history 
of selected diseases. The highest RRs were generally observed in those drinking 
5-<15 g/day. 
Discussion
In this large prospective study, we found statistically significant positive associations 
between alcohol intake and the probability of reaching 90 years in both men and 
women. Overall, the highest probability was found in those consuming 5-<15 g/d 
alcohol, which corresponds to 0.5-1.5 glass of alcoholic beverage per day. The 
exposure-response relationship was significantly nonlinear in women, but not in men. 
Whereas the probability of longevity was decreasing in women with alcohol intakes 
above 15 g/d, it remained elevated at higher alcohol consumption levels in men. 
In beverage-specific analyses, wine intake was positively associated with longevity 
(notably in women), whereas liquor was positively associated with longevity in 
men and inversely in women. Binge drinking was not significantly associated with 
longevity, but the risk estimates indicate to avoid binge drinking. In subgroup 
analyses, alcohol intake was associated with longevity in those with or without a 
history of selected diseases.
Previous prospective studies on longevity from the US and France that reported on 
alcohol were rather limited (no alcohol focus) and found no significant associations 
using longevity cut-offs of 75 (12) and 90 years (13, 25). However, higher alcohol 
intakes were seen in survivors compared to non-survivors (25), and in subsequent 
analyses (85+ years) of the Framingham Heart Study(26). The Physicians Health 
Study among US male physicians (survival cut-off 90) reported small, and non-
significantly increased chances of longevity for various drinking categories 
compared to rarely/never alcohol drinkers, with no dose-response relationship (13). 
The association between alcohol drinking and longevity was studied twice in the 
Honolulu Heart Program (HHP) among Japanese-American men using 85 years as 
longevity cut-off (10, 11). Heavy alcohol intake, measured at baseline age 45-68 
years, was significantly inversely related to longevity (OR=0.63, for 3+ drinks/day 
versus drinking less) (10). In the second analysis, moderate-heavy alcohol intake 
around 75 years was also significantly inversely related to longevity (OR=0.66, for 
drinking >14.5 g/day versus less) (11). The fact that the HHP-study was conducted 
Chapter 6
 
136
among men of Japanese ancestry may (partly) explain the more negative association 
of alcohol with longevity, and suggests a potential mechanism. It is known that 
east Asians are less efficient alcohol metabolizers due to a common loss-of-function 
variant of the ALDH2-gene which decreases breakdown of acetaldehyde, the 
first, toxic alcohol metabolite (27). It could be that those who nevertheless drink 
experience a higher mortality risk. 
Overall, the results of previous longevity studies seem quite limited. Our detailed 
analyses show significantly positive associations between alcohol and longevity 
in both men and women, which is in agreement with the PHS (13). Overall in 
men and women combined in the NLCS, the highest probability of reaching 90 
was found in those consuming 5-<15 g/d alcohol, with a HR of 1.36 compared 
to abstainers. Women experience higher blood alcohol concentrations than men of 
similar weight due to lower total body water (15). Thus, adverse effects of higher 
alcohol intakes may appear earlier in women. This might explain the nonlinear 
exposure-response relationship in women and not in men. We also found that 
wine intake was positively associated with longevity, whereas liquor was positively 
associated with longevity in men, and inversely in women. Before speculating 
on reasons for these beverage differences, future longevity studies are needed to 
replicate these sex-specific findings, with those on pattern and binge drinking. In 
mortality studies, there was no clear indication for sex differences (2, 5), and 
although beneficial associations with wine have been described for mortality, e.g. 
(2), this topic remains controversial. 
As in observational studies on alcohol and mortality (1, 2, 8), studies on alcohol 
and longevity may be hampered by possible biases (selection and residual 
confounding biases). Here, selection bias can refer to abstainer bias (when the 
reference category of non-drinkers also includes sick quitters), the healthy drinker/
survivor bias (when cohorts of elderly participants may be overrepresented by 
healthier drinkers who may have survived adverse effects of alcohol). Reverse 
causation may occur because health status may influence alcohol drinking (8), 
which could be addressed by restricting analyses to healthy people at baseline. 
Incomplete adjustment for confounding factors may lead to residual confounding. In 
our longevity analysis, we tried to address these possible biases by: 1) excluding 
ex-drinkers from the reference category; 2) limiting analyses to stable drinkers and 
abstainers by taking alcohol consumption five years before baseline into account; 
3) restricting analyses to participants without prevalent diseases; and 4) adjusting 
for a large range of possible confounders with detailed information. These analysis 
strategies do not necessarily provide a full remedy against all possible biases 
(8), but these were the possibilities with the available data from our cohort. For 
example, we had no information on lifetime alcohol consumption or consumption 
on various ages during lifetime, so our analysis of past consumption was limited. 
After excluding ex-drinkers from the reference category, the analyses in the stable 
subgroup were essentially similar to what was seen overall. We also found that 
alcohol intake was associated with longevity in the subgroup without a history of 
selected diseases. Still, other diseases might have affected alcohol use or longevity. 
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Residual confounding by socioeconomic status is also possible, because we only 
controlled for educational level. 
It should be noted that the percentages of never drinkers were relatively high in 
the NLCS: 15% in men and 35% in women, making this common behavior a 
logical reference category. These percentages were substantially higher than in other 
cohorts, e.g. 8% in male and 16% in female PLCO-participants (2), and 6% in 
male and 16% in female EPIC-participants (28). Strengths of the NLCS are the 
prospective design and high completeness of follow-up, making information bias 
and selection bias due to differential follow-up unlikely. The validation study of 
the food frequency questionnaire has shown that it performs relatively well with 
respect to alcohol (19), but measurement error may still have attenuated associations. 
The lack of possibilities to update alcohol intake or other lifestyle data during 
follow-up may have resulted in some attenuated associations too. Our study was 
aimed at measuring alcohol intake at 68-70 years. Therefore, our study results 
are limited to alcohol drinking in later life; future longevity studies preferably 
include lifetime consumption. The alcohol measures in our study were not aimed 
to get an all-encompassing indication of risky drinking, like in the Alcohol Use 
Disorders Identification Test/AUDIT (29). Our cutoff for binge drinking (>6 drinks 
per occasion) as used in the 1980s/1990s (29, 30) is somewhat higher than current 
cutoffs (29). Because we were interested in the association of late life drinking with 
longevity, our study likely examined a resilient population that survived already until 
68 years despite possible earlier risky drinking.
While older people perceive themselves as controlled responsible drinkers, according 
to a recent thematic synthesis of qualitative studies, they consider alcohol use often 
as important part of social occasions, and report that alcohol helps creating feelings 
of relaxation (31). A possible beneficial effect of light-moderate alcohol intake on 
longevity (with inverted J-shaped dose-response on longevity) may also be related to 
hormesis (32, 33). With higher consumption in elderly people, medication may be 
negatively affected by alcohol, and there is decreased physiological tolerance (34). 
In conclusion, in this prospective study of men and women aged 68-70 years at 
baseline, we found the highest probability of reaching 90 years of age for those 
drinking 5-<15 g alcohol/day. This does not necessarily mean that light-to-moderate 
drinking improves health. The estimated RR of 1.36 implies a modest absolute 
increase in this probability and should not be used as motivation to start drinking 
if one does not drink alcoholic beverages. Although no significant association was 
found, the risk estimates also indicate to avoid binge drinking.
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Female reproductive factors and the likelihood of reaching the age 
of 90 years. The Netherlands Cohort Study
Lloyd Brandts, Frans W.A. van Poppel, Piet A. van den Brandt
Abstract
Objectives
The aim of this study was to prospectively assess the relationship between several 
reproductive factors in women and the likelihood of reaching the age of 90 years 
(longevity). 
Study design
For this study, data from the oldest birth cohort (1916-17) of the prospective 
Netherlands Cohort Study (NLCS) was used. These participants filled in a baseline 
questionnaire in 1986 (at age 68-70 years). Follow-up for vital status information 
until the age of 90 years (2006-07) was >99.9% complete.
Main outcome measures
Multivariable-adjusted Cox regression analyses with a fixed follow-up time were 
based on 2,697 women with complete exposure and co-variable data to calculate 
risk ratios (RR) of reaching age 90. 
Results
No associations were observed between the likelihood of reaching the age of 90 
years, and age at menarche, age at menopause, parity, menstrual lifespan, and oral 
contraceptive use after adjustment for potential confounders. A later age at first 
childbirth pointed towards a higher chance of reaching longevity (age ≥30 vs. 20-
24; RR,1.17; 95%CI,0.98-1.39). Ever use of hormone replacement therapy (HRT) 
was significantly associated with a higher chance of reaching longevity compared 
to never HRT-users, but only in women who had an early menopause (<50 years)
(RR,1.32; 95% CI, 1.07-1.61). 
Conclusion
Age at first childbirth, and ever HRT use in women with an early menopause (<50 
years) were associated with the likelihood of reaching the age of 90 years.   
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Introduction
In recent history, women have had a survival advantage over men. Women are 
almost twice as likely to become a nonagenarian, as compared to men (1). Estrogen 
exposure and reproductive processes in women have been considered as a potential 
explanation for the higher survival rates (2, 3). Based on findings from observational 
studies, exposure to endogenous steroid hormones has been hypothesized to reduce 
the risk for cardiovascular disease and -mortality, and to increase the risk for 
developing several types of cancer (incl. breast, endometrial, and ovarian cancer) (4-
7). The use of exogenous steroid hormones showed no associations with all-cause, 
cancer, or cardiovascular mortality risk (8-10).
To date, the number of studies that have prospectively assessed the relationship 
between reproductive factors and longevity is limited (11, 12). Using a prospective 
cohort, here we aim to assess the relationship between several female reproductive 
factors and the likelihood of reaching longevity, defined as reaching the age of 90 
years. 
Methods
Population and study design
For this study data from the Netherlands Cohort Study (NLCS) was used. The 
NLCS was set up in 1986 as a large prospective cohort study (13). Baseline data 
were collected from 62,573 women on lifestyle, dietary habits, reproductive history, 
and other cancer risk factors using a self-administered questionnaire. In addition, 
the cohort has been followed-up for mortality. This was done by record linkage to 
the Central Bureau for Genealogy (CBG) from September 1986 until 1995, and to 
the municipal population registries (GBA) from 1995 until 2007. Given the case-
cohort design usually used in the NLCS (13), the data entry for these analyses was 
restricted to the oldest birth cohorts (1916, and 1917) of the NLCS cohort, similar 
to a NLCS study published earlier (14). The women from these two birth years 
form the longevity cohort for the current analyses. 
Follow-up for vital status of the longevity cohort until the age of 90 (2006-2007) 
was 99.9% complete, which resulted in a study population of 4,161 women (Figure 
1). The NLCS has been approved by the institutional review boards of Maastricht 
University (Maastricht) and the Netherlands Organisation for Applied Scientific 
Research TNO (Zeist).
Exposure assessment
At baseline, participants filled in an 11-page self-administered questionnaire, 
including detailed information on number of childbirths (incl. stillbirths), age at first 
birth, age at menarche, age at menopause, induction of menopause (natural/surgical/
or by medication), oral contraceptive (OC) usage (incl. age at initiation and quitting 
age), and use of Hormone Replacement Therapy (HRT) (incl. age at initiation and 
quitting age). In an open question, participants could indicate whether they had 
undergone a surgery, by which the researchers could identify whether women had 
undergone oophorectomy, hysterectomy, or both. Menstrual lifespan was defined by 
the number of years between menarche and menopause, minus the number of full-
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term pregnancies x0.75 years and the duration of OC use (in years), as was done 
before in other analyses(6, 15). Additional baseline information was collected on 
lifestyle, diet, other cancer risk factors and history of diseases at baseline. 
Statistical analyses 
Baseline characteristic were presented by survival status at the age of 90 years. 
Mean values with corresponding SD were presented for continuous variables, and 
percentages for categorical variables. Participants (n=1,482) with missing information 
on age at menarche, age at menopause, and a priori confounders were excluded 
from the analyses(Figure 1). 
The association between several reproductive factors and the likelihood of reaching 
90 years was assessed by multivariable-adjusted Cox regression models with 
a fixed follow-up time(16, 17). Huber-White sandwich estimator was used to 
calculate standard errors to account for underdispersion(18). A priori confounders 
were selected based on the literature and directed acyclic graphs (DAGs). All 
multivariable-adjusted models were corrected for age (years), smoking status (never, 
former, current), number of cigarettes smoked per day (continuous, centered), 
smoking duration in years (continuous, centered), alcohol consumption (0,0.1-15,>15 
g/day), educational level (primary/ lower vocational education,junior/senior high 
school, and higher vocational/university), and energy intake (kcal, continuous), non-
occupational activity (≤30,>30-60,>60-90,>90 min/day), and body mass index (BMI) 
at baseline (<18.5,18.5-25,25-<30,30+ kg/m2). Other potential confounders, including 
marital status (never married, divorced, married, widowed), history of selected 
diseases at baseline (0,1,2, and ≥3 diseases), number of childbirths (continuous), age 
at first birth (continuous, centered), hysterectomy/oophorectomy (yes,no), and OC use 
(yes, no), age at menarche (9-12,13-14,15-16, and 17-22 year), age at menopause 
(24-44,45-49,50-54, and 55-65 year), and hypertension (yes/no) were added to the 
model depending on the association under study, based on literature/DAGs and/or 
a 10% change-in-estimate. History of selected diseases includes heart attack, angina 
pectoris, stroke, any type of cancer, excluding skin cancer, and diabetes. Categorical 
exposures were fitted as continuous variables in trend analyses. 
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7Figure 1: Flow diagram on the analyses between reproductive factors and longevity in a female birth cohort of 1916-17; Netherlands Cohort Study of diet and cancer (1986-2007).
In earlier studies, a non-linear relationship between age at menarche, age at first 
birth and number of full-term pregnancies, and all-cause mortality was observed 
(15, 19). Therefore, we performed some additional analyses, to test for non-linear 
relationships. To test for non-linearity, restricted cubic spline analyses were fitted 
using three knots at the 10th, 50th and 90th percentile. The model including the 
linear and cubic spline term was compared with the linear model using a Wald test.
Adult BMI smoking status, and hysterectomy and/or oophorectomy are thought to 
potentially modify the association of age at menarche and/or menopause, on the 
risk for all-cause mortality (7, 15, 20). Therefore, we aimed to investigate whether 
these factors act as a potential effect-modifier in the relationship between age at 
menopause and/ or menarche and reaching longevity. After performing our main 
analyses, we observed an unexpected association between the timing of HRT use 
and reaching longevity. Therefore, we also investigated whether there might be 
effect modification by onset of menopause. Wald test and cross-product terms were 
used to test for effect-modification. Additional sensitivity analyses included, firstly, 
investigating survival to the age of 80 years instead of 90 years. Secondly, using a 
dichotomous age at menarche variable (<12 vs. ≥12 years) as performed in Shadyab 
et.al (11). Thirdly, not adjusting for disease history at baseline for the analyses 
between age at menopause and reaching longevity. All analyses were performed 
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using Stata 15.0 (StataCorp. 2017. College Station, TX).
Results
Of the 2,697 women included in our analyses 34.4% survived to the age of 90 
years. The mean ages at menarche and menopause were 13.4 year (range 9-22), and 
48.4 year (range 24-65), respectively (Table 1). The percentage of women who gave 
birth to at least one child was 81.8%. The average number of childbirths among 
parous women was 3.6 (SD, 2.1), and the mean age at first birth was 27.8 years 
(SD, 4.5). Only 3.7% of the women had ever used OC, and among these the mean 
age at initiation was 46.7 years (SD, 4.1). The proportion of women who have ever 
used HRT was 11.4%, with an average HRT use of 4.1 years (SD,5.0). The average 
menstrual lifespan was 32.6 years (SD,5.1) (Table 1).
Table 1: Baseline characteristics of the cohort members overall and by survival 
status in a female birth cohort of 1916-17; Netherlands Cohort Study on diet and 
cancer (1986-2007).
Total Survived to age 90 Died before age 90
na 2,697 928 1,769
Age at menarche, mean  ± SD 13.4 ± 1.6 13.4 ± 1.6 13.4 ± 1.6
Age at menarche, %
9-12 29.5 29.1 29.7
13-14 49.1 48.7 49.4
15-16 17.0 17.9 16.6
17-22 4.4 4.3 4.4
Age at menopause, mean ± SD 48.4 ± 4.5 48.5 ± 4.4 48.3 ± 4.5
Age at menopause, %
24-44  17.8 17.1 18.1
45-49 33.8 32.7 34.4
50-54 41.0 42.7 40.2
55-65 7.4 7.5 7.3
Parous, % b
Yes 81.8 82.7 81.4
No 18.2 17.3 18.6
Number of children, mean ± 
SD b,c
3.6 ± 2.1 3.6 ± 2.1 3.7 ± 2.2
Number of children, % b
Nulliparous  18.2 17.3 18.6
1  9.4 10.1 9.0
2 18.9 19.1 18.9
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3 18.4 18.3 18.5
4 12.9 14.4 12.1
5-10 21.4 19.9 22.2
11+ 0.8 0.9 0.7
Age at first child birth, mean ± 
SD  b,c
27.8 ± 4.5 28.2 ± 4.4 27.6 ± 4.6
Age at first child birth, %b
Nulliparous 18.0 17.2 18.4
15-19 1.2 0.8 1.4
20-24 18.0 15.1 19.6
25-29 36.5 37.7 35.9
≥30 26.3 29.2 24.8
Hysterectomy or oophorectomy, 
% b
Yes 11.3 11.0 11.5
No 88.7 89.0 88.5
Oral contraceptive use, % b
Yes 3.7 4.2 3.4
No 96.3 95.8 96.6
Duration oral contraceptive use, 
mean ± SD  b,d
3.9 ± 3.9 2.9 ± 2.4 4.5 ± 4.6
Age at first oral contraceptive 
use, mean ± SD  b,d
46.7 ± 4.1 46.9 ± 3.6 46.6 ± 4.5
Hormone Replacement Therapy 
(HRT), % b
Yes 11.4 13.3 10.5
No 88.6 86.7 89.5
Duration HRT use, mean ± SD  b,e 4.1 ± 5.0 3.9 ± 4.7 4.3 ± 5.2
Age at first HRT use, mean ± 
SD  b,e
50.2 ± 5.1 49.5 ± 4.7 50.6 ± 5.4
Menstrual lifespan (years), mean 
± SD  b
32.6 ± 5.1 32.8 ± 4.9 32.5 ± 5.1
Menstrual lifespan (years), %  b
<25 8.0 7.0 8.6
25-<30 19.5 19.2 19.7
30-<35 37.4 37.3 37.4
35-<40 29.2 30.5 28.5
≥40 5.9 6.0 5.8
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Cigarette smoking status, %
Never 70.9 74.9 68.7
Former 15.9 15.1 16.3
Current 13.3 10.0 15.0
BMI at baseline (kg/m2),  mean 
± SD  
25.1 ± 3.5 24.9 ± 3.1 25.2 ± 3.7
Non-occupational physical activ-
ity (min/day), mean ± SD  
55.8 ± 48.3 56.1 ± 47.8 55.7 ± 48.5
Alcohol consumption (g/day), 
mean ± SD  
4.9 ± 8.8 5.0 ± 8.2 4.8 ± 9.0
Energy intake (kcal/day), mean 
± SD  
1652 ± 371 1677 ± 374 1639 ± 368
Educational level, %
Primary school/ lower voca-
tional
58.2 54.9 59.9
Junior/ senior high school 33.6 35.9 32.5
University or higher vocational 8.2 9.3 7.6
Number of (selected) diseases at 
baseline, %
0 72.4 82.4 67.1
1 21.5 14.6 25.2
2 4.7 2.3 5.9
3 or more 1.4 0.8 1.8
a Number of participants with complete information on age at menarche, age at menopause, and confounders in-
cluding: year of birth, tobacco smoking status, cigarette smoking quantity, cigarette smoking duration, educational 
level, alcohol consumption, BMI at baseline, non-occupational physical activity and energy intake. b Number of 
participants used may vary from the study population due to missing values on specific exposure variables. c Nul-
liparous women excluded. d Never oral contraceptive users excluded. e Never HRT users excluded.
In both age-adjusted and multivariable-adjusted analyses, no significant associations were 
observed between age at menarche, age at menopause, and the likelihood of reaching the 
age of 90 years (Table 2). Nulliparous and parous women did not differ regarding likeli-
hood of reaching longevity (RR, 0.99; 95% CI, 0.82-1.19). The number of childbirths was 
also not significantly associated with the likelihood of reaching longevity in the multivari-
able-adjusted model. In multivariable-adjusted analyses, Women who had their first child-
birth at age ≥30 years were more likely (RR, 1.17; 95%CI, 0.98-1.39) to reach longevity, 
compared to women who had their first childbirth at age 20-24 years. No evidence for a 
non-linear relationship between reaching longevity and age at menarche, age at menopause, 
age at first childbirth, and number of childbirths with P-nonlinearity values of 0.794, 0.726, 
0.308, and 0.614, respectively (Figure 2). Menstrual lifespan was not associated with the 
likelihood of reaching longevity (Table 2).   
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Table 2: Age- and multivariable-adjusted RRs for reaching longevity according to 
reproductive factors in a female birth cohort of 1916-17; Netherlands Cohort Study 
(1986-2007). 
Model 1a Model 2b
median n 90+ RR (95% CI) RR (95% CI)
Age at menarche (years)
9-12 12 796 270 0.99 (0.88-1.12) 0.99 (0.88-1.12)
13-14 13 1,325 452 Reference Reference                        
15-16 15 459 166 1.06 (0.92-1.22) 1.06 (0.92-1.22)
17-22 17 117 40 1.00 (0.77-1.30) 1.04 (0.81-1.35)
P for trend 0.561 0.417
Continuous (per increment of 1 
year)
1.00 (0.97-1.03) 1.00 (0.97-1.04)
Age at menopause (years) c,d
24-44 42 467 154 0.91 (0.78-1.06) 0.99 (0.85-1.15)
45-49 47 889 297 0.92 (0.81-1.04) 0.95 (0.85-1.07)
50-54 51 1,067 388 Reference Reference
55-65 55 196 68 0.95 (0.77-1.17) 0.98 (0.80-1.21)
P for trend 0.206 0.772
Continuous (per increment of 1 
year)
1.01 (1.00-1.02) 1.00 (0.99-1.01)
Age at natural  menopause (years) c
24-44 42 399 136 0.94 (0.80-1.10) 1.01 (0.86-1.18)
45-49 47 773 257 0.91 (0.80-1.04) 0.94 (0.83-1.07)
50-54 51 973 354 Reference Reference
55-65 55 174 62 0.98 (0.79-1.22) 1.00 (0.81-1.24)
P for trend 0.301 0.801
Continuous (per increment of 1 
year)
1.01 (0.99-1.02) 1.00 (0.99-1.01)
Age at surgically induced menopause 
(years) c
24-44 42 68 18 0.73 (0.45-1.18) 0.71 (0.44-1.16)
45-49 47 116 40 0.95 (0.66-1.38) 0.89 (0.62-1.26)
50-54 51 94 34 Reference Reference
55-65 56 22 6 0.75 (0.36-1.57) 0.90 (0.42-1.92)
P for trend 0.459 0.250
Continuous (per increment of 1 
year)
1.01 (0.98-1.05) 1.02 (0.98-1.06)
P-interaction(natural vs. surgical menopause) 0.630 0.635
Paritye
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Nulliparous 477 158 Reference Reference
  Parous 2,142 749 1.06 (0.92-1.21) 0.99 (0.82-1.19)
Number of childrene,f,g
1 1 245 92 Reference Reference
2 2 496 173 0.93 (0.76-1.14) 0.96 (0.78-1.18)
3 3 484 168 0.92 (0.75-1.13) 0.95 (0.77-1.18)
4 4 337 129 1.02 (0.83-1.26) 1.04 (0.83-1.30)
5-10 6 559 179 0.85 (0.70-1.04) 0.88 (0.71-1.09)
11+ 12 21 8 1.01 (0.57-1.79) 1.07 (0.64-1.79)
P for trend 0.294 0.396
Continuous (per increment of 
1 child)
0.98 (0.95-1.01) 0.98 (0.96-1.01)
Age at first birth (years)e,g,h
15-19 19 31 7 0.78 (0.40-1.53) 0.94 (0.50-1.76)
20-24 23 468 135 Reference Reference
25-29 27 955 343 1.25 (1.06-1.47) 1.10 (0.93-1.29)
≥30 32 688 264 1.33 (1.12-1.58) 1.17 (0.98-1.39)
P for trend <0.001 0.073
Continuous (per increment of 
1 year)
1.00 (1.00-1.01) 1.00 (0.99-1.01)
Hysterectomy/Oophorectomyi
No 2,323 811 Reference Reference
Yes 300 98 0.94 (0.79-1.11) 0.94 (0.80-1.12)
Oral contraceptive usej 
Never-users 2,521 868 Reference Reference
Ever-users 98 39 1.16 (0.90-1.48) 1.12 (0.88-1.42)
Duration oral contraceptive usek 
Continuous (per increment of 
1 year)
3 77 32 0.91 (0.84-1.00) 0.92 (0.84-1.00)
Hormone Replacement Therapy 
(HRT) j, l
Never-users 2,260 793 Reference
Ever-users 295 119 1.19 (1.02-1.39) 1.20 (1.03-1.39)
Duration HRT usek
<5 years 1.5 184 73 Reference Reference
5-<10 years 6 32 13 1.03 (0.65-1.62) 1.24 (0.77-1.99)
10-<15 years 12.5 16 7 1.10 (0.62-1.98) 1.13 (0.55-2.32)
>15 years 21 10 3 0.75 (0.29-1.97) 0.67 (0.22-2.02)
P for trend 0.829 0.899
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Continuous (per increment of 
1 year)
3 242 96 0.99 (0.96-1.02) 0.99 (0.96-1.02)
Age at HRT initiationk
<50 years 46 95 39 Reference Reference
≥50 years 53 152 60 0.96 (0.70-1.31) 0.95 (0.63-1.44)
Continuous (per increment of 
1 year)
50 247 99 0.97 (0.95-1.00) 0.97 (0.94-1.01)
Menstrual lifespan (years)m 
<25 23 209 63 0.87 (0.70-1.09) 0.96 (0.76-1.20)
25-<30 28 510 174 0.99 (0.85-1.14) 1.02 (0.89-1.18)
30-<35 33 974 337 Reference Reference
35-<40 37 760 275 1.05 (0.92-1.19) 1.05 (0.92-1.19)
≥40 41 153 54 1.02 (0.81-1.29) 1.06 (0.84-1.34)
P for trend 0.154 0.438
Continuous (per increment of 1 
year)
1.01 (0.98-1.02) 1.00 (0.99-1.02)
a Age-adjusted model.  
b Multivariable-adjusted model. 
c Additionally adjusted for marital status, number of selected diseases at baseline, number of children, age at first 
birth (centered), and oral contraceptive use.  
d Additionally adjusted for hysterectomy/oophorectomy 
e Additionally adjusted for age at menarche, age at menopause, marital status, number of selected diseases, 
hysterectomy/oophorectomy, and oral contraceptive use.   
f Additionally adjusted for age at first child (centered).  
g Nulliparous women excluded. 
h Additionally adjusted for number of children.  
i Additionally adjusted for  age at menarche, number of selected diseases, number of children, age at first birth 
(centered), and oral contraceptive use.  
j Additionally adjusted for marital status, number of selected diseases, age at menarche, age at menopause, number 
of children, age at first birth (centered), hysterectomy/oophorectomy.  
k Never users excluded.  
l Additionally adjusted for hypertension. 
m Additionally adjusted for  marital status, number of selected diseases, and hysterectomy/oophorectomy.
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Figure 2: Nonparametric regression curve for the association between age at menarche, age 
at menopause, and number of childbirths with the likelihood of reaching longevity. Solid line 
represents point estimate and dashed lines represent 95% confidence intervals. All models 
were adjusted for age, smoking status, number of cigarettes smoked per day (centered), smok-
ing duration in years (centered), alcohol consumption, educational level, and energy intake, 
non-occupational activity, and BMI at baseline. (A) P-value for nonlinearity was 0.794. (B) 
Additionally adjusted for age at menarche, number of (selected) diseases at baseline, marital 
status, number of children, age at first birth (centered), hysterectomy/oophorectomy, and oral 
contraceptive use. P-value for nonlinearity was 0.726. (C) Adjusted as in B, and additionally 
adjusted for age at menopause. P-value for nonlinearity was 0.308.  (D) Adjusted as in C, 
P-value for nonlinearity was 0.614.
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Having undergone a hysterectomy and/or oophorectomy was not associated with 
the likelihood of reaching the age of 90 years, compared to women who have 
not undergone hysterectomy and/or oophorectomy (Table 2). Ever use of OC was 
not significantly associated with reaching longevity (RR, 1.16; 95%CI 0.80-1.42). 
A borderline significantly inverse association was observed for duration of OC use 
(RR, 0.92 per year; 95%CI 0.84-1.00). Ever HRT use was significantly associated 
with the likelihood of reaching longevity, compared to never users (RR, 1.20; 
95%CI, 1.03-1.39). Among HRT users, duration of HRT use was not associated with 
reaching longevity.  Age at HRT initiation did point towards a borderline-significant 
inverse association with reaching longevity (RR,0.97 per year; 95%CI 0.94-1.01) 
(Table 2). In additional analyses (Table 5) we observed a significantly positive 
association between HRT use and reaching longevity in women with an early 
menopause (<50 years) (RR,1.32; 95%CI, 1.07-1.61), but not in women with a later 
age at menopause (≥50 years) (RR, 1.09; 95%CI, 0.88-1.36; P-interaction, 0.179).
No significant interaction by smoking status, and disease history was observed 
in the relationship between age at menarche and longevity (Table 3). Smoking 
status also modified the relationship between age at menopause and longevity 
(P-Interaction, <0.001). Ever smokers with a later age at menopause (55-65 year) 
had a higher likelihood to reach longevity, compared to those whose age at 
menopause was between 50-54 years (RR, 1.72; 95%CI, 1.25-2.38). Among never 
smokers, the effect estimate of the same comparison pointed towards an inverse 
association, with a RR of 0.78 (95%CI, 0.60-1.03)(Table 3).
In analyses investigating survival to 80 years, only HRT use was significantly 
associated with reaching longevity (ever vs. never; RR,1.05; 95% CI, 1.00-1.11), but 
the strength of the association was weaker compared to our main analyses (Table 
4). In sensitivity analyses, no significant association was observed between age 
at menarche (<12 vs. ≥12 years) and reaching longevity (data not shown). When 
we did not adjust for disease history at baseline, the association between age at 
menopause and reaching longevity remained non-significant (data not shown). 
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Table 3: Multivariable-adjusted RRs for reaching the age of 90 years according to age at menarche, and age at menopause by 
strata of smoking status, BMI, and disease history in birth cohorts of 1916-17; Netherlands Cohort Study (1986-2007).
   Overall  Smoking status   Body Mass Index (kg/m2)a  Disease historyb  
     Never smokers Ever smokers  18.5-<25 25+  
No history of 
disease
History of 
disease
Age at menarche
9-12 yr
Survivors (90+)/n 270/796 205/545 65/251 143/389 125/396 219/558 51/238
RR (95% CI)c
0.99 (0.88-
1.12) 1.06 (0.92-1.22) 0.80 (0.62-1.04) 0.98 (0.83-1.15) 1.02 (0.85-1.23) 0.99 (0.87-1.13)
1.10 (0.80-
1.51)
13-14 yr
Survivors (90+)/n 452/1,325 339/952 113/373 260/699 186/606 381/973 71/352
RR (95% CI)c Reference Reference Reference Reference Reference Reference Reference
15-16 yr
Survivors (90+)/n 166/459 125/342 41/117 92/253 73/201 135/339 31/120
RR (95% CI)c
1.06 (0.92-
1.22) 1.04 (0.89-1.23) 1.13 (0.85-1.51) 0.98 (0.81-1.19) 1.20 (0.97-1.49) 1.02 (0.87-1.18)
1.26 (0.87-
1.82)
17-22 yr
Survivors (90+)/n 40/117 26/72 14/45 25/72 15/45 30/82 10/35
RR (95% CI)c
1.04 (0.81-
1.35) 1.06 (0.77-1.45) 0.99 (0.63-1.56) 0.97 (0.70-1.35) 1.16 (0.76-1.77) 0.93 (0.69-1.24)
1.46 (0.85-
2.52)
P-trend 0.417 0.872 0.063 0.985 0.242 0.988 0.356
P-interaction 0.301 0.571 0.369 
Continuous (per increment of 1 year)
Survivors (90+)/n 928/2,697 695/1,911 233/786 520/1,413 399/1,248 765/1,952 163/745
RR (95% CI)c
1.00 (0.97-
1.04) 0.99 (0.95-1.03) 1.04 (0.97-1.10) 0.98 (0.94-1.03) 1.03 (0.98-1.09) 0.99 (0.95-1.02)
1.02 (0.94-
1.11)
Fem
ale reproductive factors and reaching longevity
 
155
7
Age at menopause
24-44 yr
Survivors (90+)/n 154/467 114/317 40/150 97/262 54/196 123/323 31/144
RR (95% CI)d
0.99 (0.85-
1.15) 0.97 (0.82-1.15) 1.07 (0.78-1.46) 1.06 (0.88-1.28) 0.88 (0.69-1.13) 0.99 (0.84-1.16)
0.98 (0.66-
1.47)
45-49 yr
Survivors (90+)/n 297/889 222/632 75/257 162/465 133/411 243/630 54/259
RR (95% CI)d
0.95 (0.85-
1.07) 0.90 (0.79-1.03) 1.13 (0.88-1.45) 0.95 (0.81-1.12) 0.97 (0.81-1.16) 0.95 (0.83-1.07)
1.03 (0.74-
1.44)
50-54 yr
Survivors (90+)/n 388/1,067 299/761 89/306 210/555 174/500 332/811 56/256
RR (95% CI)d Reference Reference Reference Reference Reference Reference Reference
55-65 yr
Survivors (90+)/n 68/196 41/143 27/53 37/96 31/99 50/133 18/63
RR (95% CI)d
0.98 (0.80-
1.21) 0.78 (0.60-1.03) 1.72 (1.25-2.38) 1.01 (0.77-1.33) 0.96 (0.71-1.30) 0.90 (0.72-1.14)
1.41 (0.91-
2.19)
P-trend 0.772 0.854 0.302 0.783 0.446 0.983 0.368
P-interaction 0.004 0.501 0.541 
Continuous (per increment of 1 year)
Survivors (90+)/n 907/2,619 676/1,853 231/766 506/1,378 392/1,206 748/1,897 159/722
  RR (95% CI)d
1.00 (0.99-
1.01)  1.00 (0.99-1.01) 1.01 (0.99-1.04)  0.99 (0.98-1.01) 1.01 (0.99-1.03)  1.00 (0.99-1.01)
1.02 (0.99-
1.05)
a Participants with a BMI <18.5 excluded. b Diseases included; heart attack, angina pectoris, stroke, any type of cancer, and diabetes. c Multivariable-adjusted model. d As in 
c, and additionally adjusted  for marital status, number of selected diseases at baseline, number of children, age at first birth (centered), and oral contraceptive use.
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Table 4: Age- and multivariable-adjusted RRs for reaching the age of 80 years 
according to reproductive factors in a female birth cohort of 1916-17; Netherlands 
Cohort Study (1986-2007).
Model 1a Model 2b
median n 80+ RR (95% CI) RR (95% CI)
Age at menarche (years)
9-12 12 796 637 0.99 (0.94-1.03) 0.98 (0.94-1.02)
13-14 13 1,325 1,076 Reference Reference                        
15-16 15 459 378 1.01 (0.96-1.07) 1.01 (0.97-1.07)
17-22 17 117 91 0.96 (0.87-1.06) 0.98 (0.88-1.08)
P for trend 0.705 0.385
Continuous (per increment of 1 year) 1.00 (0.99-1.01) 1.00 (0.99-1.02)
Age at menopause (years) c,d
24-44 42 467 374 0.98 (0.93-1.04) 1.02 (0.97-1.07)
45-49 47 889 711 0.98 (0.94-1.03) 1.00 (0.96-1.04)
50-54 51 1,067 869 Reference Reference
55-65 55 196 166 1.04 (0.97-1.11) 1.05 (0.98-1.12)
P for trend 0.159 0.752
Continuous (per increment of 1 year) 1.00 (1.00-1.01) 1.00 (1.00-1.01)
Age at natural  menopause (years) c
24-44 42 399 323 0.99 (0.93-1.05) 1.02 (0.96-1.08)
45-49 47 773 614 0.97 (0.93-1.02) 0.98 (0.94-1.03)
50-54 51 973 797 Reference Reference
55-65 55 174 145 1.02 (0.95-1.09) 1.03 (0.96-1.11)
P for trend 0.289 0.858
Continuous (per increment of 1 year) 1.00 (1.00-1.01) 1.00 (1.00-1.01)
Age at surgically induced menopause (years) 
c
24-44 42 68 51 0.98 (0.82-1.17) 0.99 (0.83-1.18)
45-49 47 116 97 1.09 (0.95-1.25) 1.10 (0.97-1.26)
50-54 51 94 72 Reference Reference
55-65 56 22 21 1.25 (1.08-1.44) 1.14 (0.96-1.36)
P for trend 0.236 0.652
Continuous (per increment of 1 year) 1.01 (1.00-1.02) 1.01 (0.99-1.02)
P-interaction(natural vs. surgical menopause) 0.039 0.093
Paritye
Nulliparous 477 384 Reference Reference
  Parous 2,142 1,736 1.01 (0.96-1.06) 0.99 (0.93-1.06)
Number of childrene,f,g
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1 1 245 200 Reference Reference
2 2 496 409 1.01 (0.94-1.09) 1.01 (0.94-1.09)
3 3 484 394 1.00 (0.93-1.07) 1.00 (0.92-1.08)
4 4 337 272 0.99 (0.91-1.07) 0.98 (0.90-1.07)
5-10 6 559 444 0.97 (0.90-1.05) 0.97 (0.89-1.05)
11+ 12 21 17 0.99 (0.80-1.23) 0.97 (0.80-1.18)
P for trend 0.248 0.171
Continuous (per increment of 1 child) 1.00 (0.99-1.01) 0.99 (0.98-1.00)
Age at first birth (years)e,g,h
15-19 19 31 19 0.78 (0.58-1.03) 0.79 (0.61-1.03)
20-24 23 468 370 Reference Reference
25-29 27 955 794 1.05 (1.00-1.11) 1.01 (0.96-1.07)
≥30 32 688 553 1.02 (0.96-1.08) 0.98 (0.92-1.04)
P for trend 0.251 0.984
Continuous (per increment of 1 year) 1.00 (1.00-1.00) 1.00 (1.00-1.00)
Hysterectomy/Oophorectomyi
No 2,323 1,882 Reference Reference
Yes 300 241 0.99 (0.93-1.05) 1.00 (0.94-1.06)
Oral contraceptive usej 
Never-users 2,521 2,039 Reference Reference
Ever-users 98 81 1.02 (0.93-1.12) 1.03 (0.94-1.12)
Duration oral contraceptive usek 
Continuous (per increment of 1 year) 3 77 0.97 (0.94-1.01) 0.97 (0.94-1.00)
Hormone Replacement Therapy (HRT) j, l
Never-users 2,260 1,812 Reference
Ever-users 295 248 1.05 (0.99-1.11) 1.05 (1.00-1.11)
Duration HRT usek
Continuous (per increment of 1 year) 3 242 1.01 (1.00-1.01) 1.00 (1.00-1.01)
Age at HRT initiationk
Continuous (per increment of 1 year) 50 247 0.99 (0.98-1.00) 0.99 (0.98-1.00)
Menstrual lifespan (years)m 
<25 23 209 158 0.93 (0.86-1.01) 0.96 (0.89-1.04)
25-<30 28 510 409 0.99 (0.94-1.04) 1.00 (0.95-1.05)
30-<35 33 974 789 Reference Reference
35-<40 37 760 628 1.02 (0.98-1.07) 1.02 (0.97-1.06)
≥40 41 153 127 1.02 (0.95-1.11) 1.03 (0.95-1.11)
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P for trend 0.030 0.155
Continuous (per increment of 1 year) 1.00 (1.00-1.01) 1.00 (1.00-1.01)
a Age-adjusted model.  
b Multivariable-adjusted model. 
c Additionally adjusted for marital status, number of selected diseases at baseline, number of children, age at first 
birth (centered), and oral contraceptive use.  
d Additionally adjusted for hysterectomy/oophorectomy. 
e Additionally adjusted for age at menarche, age at menopause, marital status, number of selected diseases, hyster-
ectomy/oophorectomy, and oral contraceptive use.   
f Additionally adjusted for age at first child (centered).  
g Nulliparous women excluded. 
h Additionally adjusted for number of children.  
i Additionally adjusted for  age at menarche, number of selected diseases, number of children, age at first birth 
(centered), and oral contraceptive use.  
j Additionally adjusted for marital status, number of selected diseases, age at menarche, age at menopause, number 
of children, age at first birth (centered), hysterectomy/oophorectomy.  
k Never users excluded.  
l Additionally adjusted for hypertension. 
m Additonally adjusted for  marital status, number of selected diseases, and hysterectomy/oophorectomy.
Table 5: Ever use of Hormone Replacement Therapy and reaching the age of 90 years by 
onset of menopause, with corresponding test for interaction, in a female birth cohort of 
1916-17; Netherlands Cohort Study (1986-2007).
Overall Age at menopause
     <50 years ≥50 years
Hormone Replacement therapy use
No
Survivors (90+)/n 763/2,260 377/1,161 386/1,099
RR (95% CI)a Reference Reference Reference
Yes
Survivors (90+)/n 119/295 64/158 55/137
RR (95% CI)a 1.20 (1.03-1.39) 1.32 (1.07-1.61) 1.09 (0.88-1.36)
P-interaction 0.179 
a Multivariable-adjusted model additionally adjusted for age at menarche, number of selected diseases, number of 
children, age at first birth (centered), oral contraceptive use, and history of hypertension.
Discussion 
Using data from the Netherlands Cohort Study, no significant associations were 
observed between age at menarche, age at menopause, induction of menopause, 
parity, menstrual lifespan, and OC use in relation to the chance of reaching the 
age of 90 years. The age at which women had their first childbirth was borderline 
significantly associated with the chance of reaching longevity, where a higher age 
at first birth pointed towards a higher likelihood of reaching longevity. In women 
with an early menopause (<50 years), ever HRT was significantly associated with a 
higher chance of reaching longevity, compared to never HRT-use. 
Only one prospective cohort study, the Women’s Health Initiative (WHI), has 
published on the relationship between age at menarche and menopause, and the 
likelihood of reaching longevity thus far(11). It found that a later onset of menarche 
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(≥12 years) was associated with a significantly increased odds of reaching the age 
of 90 years, compared to those who had an earlier menarche (<12 years) (11). In 
our analyses, no association was observed between age at menarche and reaching 
the age of 90 years, also when the same comparison was made (<12 vs. ≥ 12 
years) as in Shadyab et.al. (11) (data not shown). In most studies on mortality, a 
later age at menarche was also found to be associated with a decreased risk for 
all-cause mortality (21, 22). Although most studies found a positive association 
between age at menarche and chances of survival, the strength of these associations 
was modest. One publication indicated that the age at menarche might become less 
important as a risk factor for survival at older ages (19). However, in sensitivity 
analyses investigating survival to 80 years, we also observed no association between 
age at menarche and longevity (Table 4). Alternatively, early menarche has often 
been linked to an increased risk of diabetes and cardiovascular diseases (23, 24). 
In sensitivity analyses, the relationship between age at menarche and longevity was 
not significantly modified by history of (selected) disease status. However, somewhat 
stronger, non-significant, effect estimates were observed in those who had a history 
of disease (Table 3).
In a publication from the WHI age at menopause was positively associated with 
reaching longevity (11), while no associations were observed in the current study. 
A systematic review indicated that women who had an early menopause have 
an increased risk of all-cause mortality (7). However, they concluded that the 
confounder sets used by the included studies varied a lot. It was noted that the 
strength of the effect estimate became weaker when studies adjusted for certain 
factors, i.e. socioeconomic status, and HRT use (7). 
In stratified analyses we observed that smoking status acted as a significant effect-
modifier between age at menopause and longevity, where a later menopause was 
associated with a decreased chance of reaching longevity in never smokers, but 
with an increased chance in ever smokers (Table 3). It is well-known that smoking 
is associated with an increased risk for premature and early menopause (25). 
However, to our knowledge only one study investigated potential effect-modification 
by smoking when studying the relationship between age at menopause and age at 
death thus far (26), showing that age at menopause was not associated with age at 
death in never smokers, while an early age at menopause was associated with an 
earlier age at death in current smokers. This is in line with the results of our study 
(26). It would be interesting to investigate whether these results can be replicated in 
other cohorts as well.  
Only two studies adjusted for history of disease when studying the association 
between age at menopause and longevity/mortality (27, 28) while other studies did 
not e.g. (11, 21), but there was no clear difference in results between them. When 
we did not adjust for history of (selected) diseases the effect estimate became 
somewhat stronger, but not statistically significant (data not shown). Although there 
was no adjustment for history of disease in the main analyses by the WHI, in the 
discussion section it was noted that the association between age at menopause and 
longevity disappeared when adjusting for self-rated health (11). In stratified analyses, 
it was observed that the strength of the association between age at menopause 
and longevity was stronger in women with a history of disease compared to those 
without a history of disease (Table 3). However, the Wald-test for interaction was 
not statistically significant. These findings, together, indicate that smoking and 
disease history potentially influence the relationship between age at menopause and 
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longevity. However, it is still questionable whether they acts as confounder, effect-
modifier or mediator.  
In this study, no association was observed between menstrual lifespan and reaching 
longevity. This is in line with the result of an earlier study, investigating the 
relationship between menstrual lifespan and mortality (15). In a study from the WHI 
(11), reproductive lifespan, defined as the age at menopause minus age at menarche, 
was positively associated with reaching longevity. However, in the WHI study the 
number of pregnancies and the duration of oral contraceptive use were not taken 
into account which makes these results difficult to compare.  
Another possible explanation for the observed differences between the WHI cohort 
and NLCS cohort is the use of a different statistical method. In the analyses by 
Shadyab et.al. (2016), logistic regression analyses were used to calculate ORs of 
reaching longevity (29). However, when the outcome is not rare, as in this case, 
the use of OR can easily overestimate the effect compared to RR. As a result, 
the higher odds of reaching longevity observed in their study might possibly be 
caused by this effect. Additionally, the WHI is a multi-ethnic cohort (11), while the 
NLCS cohort consisted primarily of Caucasian women, which might have also led 
to different results. Similar to the analyses by the WHI, we observed a positive 
association between age at first childbirth and reaching longevity (12). In two recent 
prospective cohort studies similar results were observed, where a later age at first 
childbirth was associated with a decreased risk for all-cause mortality (15, 30). 
However, one should realize that all women in our cohort did survive childbirth. 
Surviving childbirth at an older age might be an indicator of good overall health, 
which might have influenced our results. Consequently, we would not advice to 
delay childbirth giving the increased risk for obstetric complications, and other 
negative consequences known to be associated with a later age at childbirth as well 
(31). 
Parity and number of childbirths were found to be positively associated with 
reaching longevity (12), and inversely associated with all-cause mortality in several 
studies e.g. (15, 32). In our analyses, ever parous and an increased number of 
childbirths were not associated with an increased likelihood of reaching longevity. 
A possible explanation for this difference might lie in the era from which the 
women in our analyses stem. Around 1900, having multiple childbirths has been 
hypothesized to be a commonly used strategy to increase the chance of surviving 
offspring, because childhood mortality was more prevalent (33). With a decreasing 
risk of childhood mortality in the early twentieth century, the average number of 
childbirths also decreased. The generation used for these analyses grew up in a 
period in which these strategies were changing (33). Hypothetically, the choice 
of having multiple children in that time could still have been more common in 
socioeconomically vulnerable families, as suggested by earlier studies (34). Because 
these women might stem from a more vulnerable socio-economic background, their 
own likelihood of reaching an old age might have also been smaller. Unfortunately, 
information on socio-economic vulnerability is not available in our cohort. Although 
most studies observed a beneficial effect of increased childbirths e.g. (12, 15, 30), 
the underlying strategies used in this time period might have counterbalanced the 
effect of these two conflicting effects on longevity. However, this suggestion is 
speculative and should be better explored in future studies. 
Although there are no studies that have assessed the relationship of OC use with 
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longevity yet, several studies have investigated the relation to all-cause mortality, 
and found no, or only a weak protective association between OC-use and mortality 
e.g. (10, 35). In our study we also observed no significant association between OC-
use and reaching longevity, but the number of ever OC users was small (Table 
2). We did observed a significantly inverse association between the duration of 
OC use and the likelihood of reaching longevity among ever users. However, 
because the women in our cohort were already above the age of 45 years when 
oral contraceptives were introduced in the Netherlands, these findings may not be 
representative for typical OC users nowadays.
A large systematic review based on 32 randomized controlled trials indicated that 
there is no association between the use of HRT and mortality risk (9). In cohort 
studies, the use of HRT has been inversely associated with all-cause mortality on 
the short-term (<5 years)e.g. (36), but not on the long-term (≥5 years) (8, 36). In 
the current study, HRT use was significantly positively associated with reaching 
longevity, compared to never users. The age at HRT initiation was inversely 
associated with reaching longevity. This observation raised the hypothesis that the 
use of HRT might be more beneficial for those who had an early menopause in 
terms of reaching longevity, which we therefore decided to further investigate. In 
these additional analyses we indeed observed a significantly positive association 
between ever HRT use and reaching longevity, but this was limited to women who 
had an early menopause (<50 years of age) (Table 5). 
Strengths of the study are the prospective study design which limits the risk for 
information bias and selection bias, the large sample size, and detailed information 
on the main exposures, as well on potential confounders. Furthermore, our study 
population was very homogeneous with respect to age, making confounding by age 
unlikely.
There were some limitations to our study. The women included in these analyses 
already survived to an advanced age (68-70 years). Reproductive factors might 
have played a role in premature mortality before the age of 69 years, but these 
women were not included in the analyses. This might have led to survivorship 
bias.  Furthermore, only limited information was available on the socioeconomic 
circumstances of these women. Although we had data on educational level of these 
women, there is still a possibility of residual confounding by socioeconomic status 
on a household level, which might have influenced our results.
In conclusion, timing of menarche and menopause were not associated with the 
likelihood of reaching the age of 90 years. However, we did observe that the 
relationship between age at menopause and longevity was significantly modified 
by smoking status. Parity and the number of children were also not related to 
the likelihood of reaching longevity. Age at first childbirth did show a positive 
association with the likelihood of reaching the age of 90 years. Ever HRT use also 
showed a significantly positive association with reaching longevity, but in additional 
sensitivity analyses we observed that this was only the case in women who had an 
early age at menopause (<50 years).
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The studies described in this thesis aimed to investigate how several factors relate 
to the probability of reaching longevity, which we defined as reaching the age 
of 90 years. In these studies, we have focused on the association with parental 
lifespan, several lifestyle factors and reproductive factors using detailed questionnaire 
information from the oldest participants (born 1916-17) of the Netherlands Cohort 
Study (NLCS). Furthermore, these studies have tried to formulate an answer to 
several knowledge gaps that we identified in the literature review that we presented 
in chapter 2. Additionally, we were interested whether psychosocial factors were also 
associated with reaching an exceptionally high age. Therefore, we tried to assess 
whether there is a relationship between perceived loneliness and reaching longevity 
using data from the Longitudinal Aging Study Amsterdam (LASA). 
In this chapter, we will provide a brief overview and interpretation of the 
main findings. Although this dissertation focusses mainly on longevity, in this 
chapter, we will also shortly reflect on the concept “healthy lifespan”, and the 
maximum lifespan. Lastly, we provide some methodological considerations, and 
recommendations for future research.    
Summary of the main findings
In chapter 2, we observed that smoking, and a low level of physical activity 
were inversely associated with reaching longevity (1-11). Alcohol intake, and BMI, 
showed limited and/or contradictory associations with reaching longevity (1, 2, 
5, 7, 9, 12). Furthermore, we concluded that parental longevity was significantly 
associated with reaching longevity, primarily through maternal longevity. Some 
studies indicated a stronger effect of parental longevity in female offspring compared 
to male offspring (1, 3, 4). Lastly, we observed a lack of studies investigating the 
relationship between dietary and reproductive factors, and longevity.
In chapter 3, we observed that both male and female offspring of parents who 
survived to ages 80 year and older had an increased likelihood of reaching the 
age of 90 years, compared to those whose parents had died before the age of 80 
years. Longevity in parents will most likely not be a direct cause for their offspring 
to reach longevity. We suggested that this longevity advantage might be passed 
on to later generations by a combination of early environmental influences and 
genetic factors. Therefore, we additionally adjusted for some environmental factors 
that might explain the observed relationship. In these analyses, paternal survival 
in male offspring and maternal survival in female offspring were still significantly 
positively associated with an increased likelihood of reaching the age of 90 years. 
Earlier studies had observed that this association was primarily present for maternal 
longevity, and not for paternal longevity (3, 4), and more pronounced in female 
offspring (1, 4, 5). 
Regarding lifestyle factors, our analyses have focused on smoking behaviour, body 
size, levels of non-occupational physical activity, and alcohol intake. In line with 
the results of chapter 2, our analyses in chapter 4 showed that current and former 
smokers have a significantly reduced probability of reaching the age of 90 years 
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compared to never smokers. Based on our analyses in chapter 5, increased levels 
of non-occupational physical activity seemed to increase the probability of reaching 
the age of 90 years in both men and women. In men, we observed a positive 
linear association, indicating that probabilities of reaching longevity increase with 
increasing levels of physical activity. In women, we observed a plateau, indicating 
that the potential beneficial effect of physical activity is restricted to a certain 
amount in terms of reaching longevity. In earlier studies, BMI showed significant 
inverse associations with longevity in both extremes of the spectrum (<20 kg/
m2 and >30 kg/m2), but the use of varying BMI cut-off points made it difficult 
to draw clear conclusions (2, 5, 7, 9). In the analyses of chapter 5, underweight 
(BMI<18.5 kg/m2), and obesity (BMI ≥30 kg/m2) were associated with a reduced 
probability of reaching 90 years of age, but only in women. In men, no association 
was observed between BMI and reaching longevity. After excluding ex-drinkers, 
moderate alcohol consumption (5-<15 gr. alcohol per day) at the age of 68-70 years 
was associated with the highest probability of reaching the age of 90 years in both 
men and women (chapter 6). Earlier studies found inconsistent results regarding 
the association between alcohol consumption and longevity as presented in chapter 
2. The effect estimates observed in chapter 6 did indicate that binge drinking was 
associated with lower chances of reaching longevity.
Based on the analyses described in chapter 7, we observed no association between 
indicators of menstrual timing (age at menarche, age at menopause, and reproductive 
lifespan) and the likelihood of reaching longevity. We did observe that a later 
age at first childbirth was associated with an increased probability of reaching the 
age of 90 years. The use of Hormone Replacement Therapy was also positively 
associated with reaching longevity, but only in women with an early menopause 
(<age 50 years).
Based on the analyses of chapter 8, no significant associations were observed 
between loneliness and reaching 90 years in both men and women. When we 
considered the sub dimensions of loneliness (emotional and social loneliness) we 
observed that social loneliness was significantly inversely associated with reaching 
90 years in women.
Interpretation of main findings
In line with earlier studies, in chapter 3 we observed that offspring of long-
lived parents have a higher likelihood of becoming long-lived themselves. 
We have hypothesized that this relationship is explained by a combination of 
early environmental influences and genetic factors. After further adjustment of 
environmental factors, we observed strong evidence for the existence of a specific 
mother-daughter longevity relationship. Other studies also observed strong evidence 
for a mother-daughter longevity relationship. These consistent findings could hint 
towards an important role of variations in inherited mitochondrial DNA (mtDNA) 
in the process of reaching longevity, which is transmitted via the maternal germline 
only (13). Indeed, several studies have found an association between longevity 
and mtDNA variants of haplogroup J in several European countries (14-16), and 
with mtDNA variant haplogroup D in Japan (17). In these studies, it was observed 
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that these haplogroups were more common among centenarians than in ethnically 
matched younger controls. Later studies observed that cells that contained mtDNA 
belonging to haplogroup J produced less reactive oxygen species (ROS) and less 
adenosine triphosphate (ATP), compared to cells containing other mtDNA molecules, 
which could explain a decreased rate of somatic aging. However, these findings 
could not be replicated in other geographical populations, which indicates that the 
effect of certain mtDNA variations depend on the individual genetic background 
(18). This hypothesis was later tested and confirmed when looking at specific 
mutation patterns in mtDNA (19). Consequently, more advanced analyses techniques 
are needed to study the interplay between haplogroups and individual mutations to 
adequately assess the relationship between mtDNA and reaching longevity. 
We also observed evidence for the presence of a father-son longevity relationship. 
However, because other studies did not observe such a relationship, this finding 
should be further explored. Although the genetic traits observed in long-lived 
families are beneficial at an individual level, some researchers argue that these 
stable genomes could be disadvantageous for the successful evolution of the 
species, on a population level (20). It has been observed that individuals aged 80 
years and over had a lower percentage of chromosomal aberrations, compared to 
younger controls (21). It seems that the genome of these individuals seems to be 
more resilient against DNA mutations, resulting in a slower rate of cell senescence. 
However, with lower genetic instability, individuals are less adaptable to potential 
environmental changes, which reduces the evolutionary ability of the species (20). 
Therefore, at a population level, lifestyle or environmental modifications could be a 
more favorable strategy to promote longevity.  
As described in chapter 1, environmental factors account for about 75% in the 
process of reaching longevity. Based on earlier studies (1-12) and the result of our 
analyses, smoking seems to be the single most important determinant for reaching 
exceptional ages in both men and women. Men who had never smoked more than 
doubled their chances of reaching 90 years of age compared to men who were 
still smoking at older ages. Quitting smoking seemed to improve the likelihood 
of reaching longevity, but still, the chance of reaching an exceptionally old age 
was smaller compared to those who had never smoked. We also observed that the 
association between smoking and longevity was stronger in men than in women. 
This is most likely explained by differences in smoking behaviour between both 
sexes (e.g. smoking quantity and type of cigarettes). It is hypothesized that exposure 
to tobacco could decrease the likelihood of reaching longevity by acting as an 
accelerator of the aging process, and by increasing the risk for several diseases of 
which smoking is a recognized risk factor (22). It is known that tobacco smoke 
contains high levels of free radicals that are produced in a steady state by the 
oxidation of NO to NO2, which then reacts with reactive species in smoke such as 
isoprene (23). Furthermore, it has been observed that plasma levels of antioxidant 
vitamins were lower in smokers, compared to never smokers, and that  these levels 
increased with smoking cessation (24). The additional accumulation of free radicals, 
in combination with lower plasma levels of antioxidants, may accelerate the aging 
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process by increasing the oxidative stress in somatic cells. Furthermore, it has been 
observed that smoking was associated with shortening of telomeres in circulating 
lymphocytes, which accelerates the deterioration of the immune system associated 
with aging (immunosenescence) (25). Smoking also increases the risk for developing 
several diseases, and thus increases the risk for premature mortality, which might 
also lead to a reduced chance of reaching longevity (26).  
Being underweight (BMI <18.5 kg/m2) or obese (BMI ≥30 kg/m2) seemed to 
reduce the likelihood of reaching longevity in women. Interestingly, in the analyses 
of chapter 5, BMI showed no association with reaching longevity in men. However, 
we did observe that a BMI of 25 kg/m2 and above did reduce the probability of 
reaching 90 years in never and former smoking men, but not in current smokers. 
Furthermore, the test for interaction of smoking on the relationship between BMI 
and longevity was statistically significant. The high proportion of current smokers 
in men, could explain why we did not observe an association between BMI and 
longevity in men. Only one other longevity study has stratified for smoking status 
in men, when investigating the relationship between BMI and reaching the age of 
85 years (2). It found that the inverse relationship between BMI (≥25kg/m2 vs. 
<25 kg/m2) and reaching the age of 85 was stronger in non-smokers, compared 
to current smokers (2). The reason why BMI was not associated with reaching 
longevity in current smokers remains unclear and should be further explored. 
Physical activity was positively associated with reaching longevity in our study, 
and in studies performed earlier. With aging, the risk of developing cognitive and 
physical impairments increases, and there is a decline in cardiorespiratory fitness and 
muscle function (27, 28). It has been shown that regular physical exercise has a 
beneficial effect on maintaining brain function, cardiovascular function, lung function, 
muscle function, body composition, and metabolism, as has been summarised in 
(29). Additionally, physical activity seems to have a positive effect on aging at 
the cellular level, as summarised in (30). Still, there remains some controversy 
regarding the optimal duration and intensity of physical activity. In our analyses, 
the likelihood of reaching 90 years of age increased with an increasing duration 
of non-occupational physical activity in men. However, in women the likelihood of 
reaching 90 years increased until around 60 minutes of non-occupational physical 
activity per day, after which the effect estimates plateaued. Other studies on 
longevity also showed inconsistent result between duration of physical activity and 
longevity. Only one study observed a dose-response relation between duration of 
physical activity and longevity in men (2), while two other studies did not observe 
such a relationship among men (3, 7). Therefore, the effect of increasing exercise 
duration on longevity at an older age remains unclear. Regarding intensity, no study 
has assessed the relationship between the intensity of physical activity and reaching 
longevity thus far. It has been observed that extraordinary peaks in physical 
performance among Olympic athletes in early life was associated with increased 
mortality rates above the age of 50 years (31). Based on these results, the authors 
hypothesized that the investments in physical strength and growth in early life 
come at the cost of somatic maintenance in later life (31). However, this hypothesis 
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remains speculative and should be further examined in future studies.
There has been a lot of controversy surrounding the association between alcohol 
consumption and reaching longevity. We observed that moderate alcohol consumption 
(5-<15 gr. alcohol per day) was associated with the highest probability of reaching 
longevity in both men and women. Other studies observed no relationship (1, 7) 
or an inverse relationship (9, 12) between alcohol intake and reaching longevity. 
Regarding premature mortality, a J-shaped relationship between alcohol intake and 
premature mortality was observed (32). This indicates that the relationship might 
be dose-dependent, with favourable effects at lower alcohol dosages, and negative 
effects at higher alcohol dosages. Heavy alcohol consumption is associated with 
detrimental effects on the brain, cardiotoxicity, and with an increased risk for 
developing several types of cancer and liver disease (33-36). Mild or moderate 
alcohol intake has been associated with a decreased risk for cardiovascular diseases, 
and diabetes type II (37, 38). While alcohol exposure seems to have opposite effects 
on disease development, some animal studies also suggest a direct beneficial effect 
of exposure to alcohol on the aging process. In one study, an association was 
observed between alcohol administration and increased FOXO3A activity in mouse 
liver (39). Single nucleotide polymorphisms in the FOXO3A is one of the most 
important genetic alterations linked with reaching longevity in humans (40, 41). 
Furthermore, one study observed an association between moderate alcohol intake and 
a downregulation of mTOR activity in the myocardium of Yorkshire swine (42). 
The mTOR nutrient sensing pathway is often linked with longevity, but findings are 
inconclusive (40). 
In accordance with the evolutionary theories described in chapter 1, it is 
hypothesized that investments in growth and reproduction would result in a 
decreased maintenance of somatic cells in later life. Several researchers have tried 
to test this hypothesis in humans, but it has led to contradictory results. To date, 
most studies have used historical data to study populations under natural fertility 
conditions (43). Most of these studies looked at the number of childbirths and its 
association with reaching longevity and found no clear evidence for the existence 
of such relationship, as summarised in (43). Regarding evidence from prospective 
cohort studies, there is also no conclusive evidence of an existing reproductive 
trade-off in humans. A study by Shadyab et al. (2016) observed that a later age 
at menarche, a later age at menopause, and a longer reproductive lifespan were 
associated with an increased odds of reaching 90 years, which would conflict with 
the evolutionary theories described earlier (44, 45). Furthermore, in later analyses 
they observed that parity was positively associated with reaching longevity, which 
would also indicate that increased reproductive investments would not reduce 
somatic maintenance leading to a decreased chance of reaching longevity (46). 
In contrast to the findings of Shadyab et al. (2016), in our analyses (chapter 
7), we did not observe any association between timing of menarche, menopause, 
reproductive lifespan and parity and reaching longevity. This illustrates that the 
relationship between reproduction and reaching longevity in humans remains 
inconsistent and needs to be further explored. 
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In our analyses, loneliness was not significantly associated with reaching longevity. 
This was surprising given the observed significant association between loneliness and 
mortality in earlier studies (47). However, the current lack of publications on the 
relationship between loneliness and longevity makes it difficult to reflect on. Our 
finding could illustrate that a risk factor associated with mortality does not have to 
be necessarily associated with longevity as well, as we did explain in Chapter 1. 
Alternatively, there is also the possibility that our observation is a chance finding, 
and replication is desirable.
Old but healthy? 
With an increasing life expectancy, there is also an increasing interest in the 
quality of life during these added years to life. Many elderly people experience an 
increasing burden of disease with aging. As a result, several new concepts have 
been developed that tried to quantify a measure for an increasing lifespan free of 
disease. Terms like healthy life expectancy, healthy aging, or successful aging, have 
incorporated quantitative indicators of disease prevalence, mental functioning and/
or physical functioning together with chronological aging (48, 49) .Even though the 
life expectancy has been increasing, data suggests that increases in healthy lifespan 
are developing more slowly (50). Unlike the treatment of communicable diseases 
in the first half of the twentieth century, improvements in treatment options for 
non-communicable diseases have mostly led to improved survival rates, rather than 
decreases in the prevalence of disease. As a result, the average duration of the 
disease increased, and the prevalence of non-communicable disease increases with 
age (51). Consequently, the increasing life expectancy in the second half of the 
twentieth century was accompanied with an increasing burden of chronic diseases 
(51).
Although the healthy life expectancy seems to increase more slowly compared to 
the period life expectancy, reaching longevity has been associated with a delayed 
occurrence of morbidity (52). It was observed that long-lived individuals (95+ 
years) experienced age-related diseases (incl. cancer, cardiovascular disease, diabetes 
mellitus, hypertension, osteoporosis and stroke) on average 18 to 24 years later 
compared to their younger control group (52). The mechanism behind these findings 
are still unclear, and replication of these findings in a longitudinal setting is needed. 
However, the findings do indicate that long-lived individuals are a potentially 
suitable model to study factors that might contribute to healthy aging. Several 
studies have shown that determinants that are associated with reaching longevity are 
often a good predictor for healthy survival or morbidity-free survival as well (10, 
11, 53). 
Maximum lifespan
Even though more people reach exceptionally high ages, there is still a lot of 
uncertainty whether there is a fixed maximum attainable lifespan, or that this also 
increases. In the literature, there exists a controversy about the upper limit to human 
lifespan. Dong et al. (2016) suggested that there is a natural limit to the human 
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lifespan, which they estimated to be around 115 years (54). This publication has 
led to fierce debates about whether a limit to human lifespan exists. The statistical 
methods used for the publication by Dong et al. has been criticized by other 
researchers (55-58), and another study suggests that there is a plateau, but no limit 
to the human lifespan (59). Predictions and theories about the maximum lifespan, 
are largely influenced by the oldest individuals ever recorded. The oldest “officially” 
documented human individual is Jeanne Calment, who died in 1997 at an age of 
122 years (60). There is still a lot of controversy whether her record is valid, or 
whether this was a case of identity fraud between mother and daughter (61, 62). 
The uncertainty around this influential case (outlier) has a huge impact on the 
debate surrounding the theoretical and statistical modelling of the maximum lifespan. 
Despite the many speculations on whether a maximum lifespan exists, in the end, 
only time will tell whether the current record can be broken. 
Methodological considerations
The analyses presented in this thesis have several strengths and limitations to 
consider that might have influenced the validity of our findings. Furthermore, there 
are some additional methodological points that we have to discuss.
Internal & external validity 
Important strengths of the analyses presented in this thesis are the longitudinal study 
design, the large sample size, and completeness of follow-up. In comparison with 
other observational study designs used before (e.g. historical cohorts, case-control 
design), using a prospective cohort approach reduces the risk for information bias, 
and selection bias because the exposure has been determined independently before 
the outcome was measured. Furthermore, we were able to collect extensive data on 
potential confounding variables, making it possible to adjust for an elaborate set 
of variables, reducing the risk for bias due to confounding. The large sample size 
made it possible to conduct analyses on several lifestyle habits (e.g. smoking and 
drinking habits) in great detail. The high completeness of follow-up decreases the 
risk for selective dropout of participants.
One limitation of the analyses presented in this thesis is that the analyses were 
based on a single baseline measurement. For instance, no information was collected 
on changing smoking habits after baseline measurement. Although few people will 
start smoking at an older age, more people will quit while aging (63). Some cohort 
members might have quit smoking during follow-up, but would still be classified 
as a current smoker in our analyses. This might have led to an underestimation of 
the effect of smoking on longevity. Furthermore, BMI could have varied before and 
after the baseline measurement. Although we expect that our baseline measurement 
is a fairly good representation of weight during most of the lifespan, ideally weight 
should be measured at different time periods. The potential problem of reverse 
causation arises as well. Although we collected information on disease status at 
baseline, some baseline characteristics might be explained by the participants’ 
preclinical disease status. For example, persons who develop a lethal or chronic 
disease in the years after baseline measurement, and therefore are less likely to 
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reach longevity, might already have some preclinical symptoms before or at baseline, 
including changes in weight, or a reduced level of physical activity. In our analyses 
on alcohol consumption, we were able to exclude ex-drinkers who had quit drinking 
alcohol up to five years before the baseline measurement, to account for reverse 
causation.   
It should also be noted that the participants included in most of the analyses 
already survived to advanced ages (e.g. 68-70 years at baseline). This could have 
resulted in potential survivorship bias for some analyses. For instance, those who 
are especially vulnerable for the adverse effects of smoking might already have died 
before reaching the age of 68 years. As a result, the association between smoking 
and reaching longevity might be even stronger in younger cohorts. 
The chance of reaching the age of 90 years (at the age of 68-70 years) in 
the NLCS longevity cohort was 15.5% for men, and 33.4% for women. This 
was slightly higher than the estimations given by Statistics Netherlands. They 
estimated that men and women aged 69 in 1990 had a 12.0%, and 28.0% chance 
to reaching the age of 90 years, respectively (64). As a result, one could argue 
that the participants of the NLCS may have been more healthy, compared to the 
general Dutch population. However, the estimations of Statistics Netherlands were 
based on the current mortality rates of 1990 in a hypothetical cohort. As a result, 
these estimates do not take the improved mortality rates between 1990 and 2011 
into account. This illustrates that the period life expectancy might lead to an 
underestimation of the true survival probabilities, compared to a real cohort that is 
longitudinally followed over time. 
Regarding the analyses on reproductive factors, the prevalence and timing of oral 
contraceptive (OC) use in this study population are not comparable with current 
generations, which limits the external validity of our findings regarding OC use 
and longevity to current generations. In modern generations the use of birth control 
is much more common. The longevity cohort of the NLCS was situated in an 
era where various forms of birth control were gradually introduced, and therefore 
not yet fully integrated. However, later generations have not been able to reach 
longevity yet. Therefore, future studies are needed to investigate the potential impact 
of birth control on the relationship between reproductive factors and reaching 
longevity. 
Regarding the analyses on loneliness, the ages at which the participants were 
included was much broader (ages 64-85). This means that there are some potential 
generational differences between the participants. Furthermore, older individuals 
have a higher (conditional) chance of reaching 90 years of age at baseline. We 
did account for this potential confounding effect by adjusting, and stratifying for 
baseline age in the multivariable-adjusted models. However, because of the limited 
sample size, we were only able to stratify by age categories of 10 years. Therefore, 
residual confounding by baseline age could still have influenced our results. 
Preferably, future studies should use homogenous age groups when the sample 
size allows for that, as we did in the NLCS analyses. This limits the risk for 
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(confounding) bias due to potential age and generational differences. 
Comparison of the statistical analysis techniques 
Earlier studies estimated the association between lifestyle factors and longevity using 
logistic regression analyses. However, given the high proportion of participants 
that have reached longevity (90 years of age) in our study population, odds ratios 
(OR) easily overestimate the effect compared to risk ratios (65). Given the high 
proportion of the outcome and the prospective cohort design, which makes it 
possible to estimate incidences of reaching longevity,  multivariable-adjusted Risk 
Ratios (RR) were preferred over the use of ORs. Therefore, we searched for 
alternatives to calculate RR instead of OR which yielded several options, which we 
have compared (Table 1). 
Firstly, the use of a log-binomial regression model was considered. This is 
“theoretically” the most suitable alternative. However this model often fails 
to converge when analyzing small samples or using multiple confounders. We 
experienced that this model was problematic when analyzing relationships in more 
detail, with smaller sample sizes. 
Secondly, the Poisson regression model was considered. The results of the Poisson 
regression model were identical to the results of the log-binomial regression model 
in larger samples, and the model yielded no problems when analyzing smaller 
sample sizes (Table 1). Lastly, the Cox regression model with a fixed follow-up 
time was considered. This method performed similar to the Poisson regression model 
(Table 1). This technique differs from the Cox proportional hazards model, because 
we use a fixed follow-up time for each participant. When calculating a Hazard 
Ratio (HR), use is being made of an average risk over a certain time period (based 
on person-time). When using a fixed follow-up time, time is not taken into account 
by appointing an equal follow-up time to each participant. As a result a cumulative 
risk is estimated, that can be translated to a Risk Ratio instead of a Hazard Ratio. 
Concluding remarks and future perspectives 
The research presented in this thesis aimed to identify several (modifiable) factors 
that are associated with reaching the age of 90 years. We observed that offspring 
of parents who survived to ages 80 year and older had an increased likelihood 
of reaching the age of 90 years. Furthermore, smoking was the most important 
(modifiable) factor associated with a decreased probability of reaching the age of 
90 years, while being physically active, having a BMI between 18.5 and 25.0 kg/
m2 (in women), and a moderate alcohol consumption (5-<15 gr. alcohol/day) were 
associated with increased probabilities of reaching the age of  90 years. 
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Table 1: Comparison of effect sizes on the relationship between smoking habits and 
reaching longevity, using different statistical analyses techniques.
n 90+ Logistic regression 
(OR)
Log-binomial 
regression (RR)
Poisson regres-
sion (RR)
Cox regression 
(fixed follow-up) 
(RR)
Cigarette smoking status in men (age-adjusted)
Never smoker 305 78 3.35 (2.34-4.83) 2.75 (2.03-3.73) 2.75 (2.03-3.73) 2.75 (2.03-3.73)
Former smoker 955 161 1.98 (1.46-2.70) 1.82 (1.38-2.39) 1.82 (1.38-2.39) 1.82 (1.38-2.39)
Current smoker 679 63 1 1 1 1
Cigarette smoking status in men with higher vocational/ university education (fully-adjusted model)
Never smoker 66 21 2.02 (0.72-5.62) Failed to con-
verge
1.77 (0.87-3.62) 1.77 (0.87-3.62)
Former smoker 111 29 1.60 (0.51-4.98) Failed to con-
verge
1.46 (0.66-3.21) 1.46 (0.66-3.21)
Current smoker 74 10 1 1 1 1
The field of longevity research using individual longitudinal data is relatively 
new and still expanding. Therefore, more research is needed to further identify 
characteristics that are associated with reaching longevity, and to replicate the 
findings we described earlier. Currently, there are only few prospective cohort 
studies that have a sufficiently long follow-up to study longevity of their 
participants. Fortunately, their number is growing, which opens new possibilities to 
study the determinants of reaching longevity.  
Based on the results of this thesis we observed that some modifiable lifestyle 
factors, including smoking and physical activity, show a strong association with 
reaching longevity in our study population. In the past, it has been observed 
that smoking had a strong effect on  life expectancy, especially in men (66). It 
is suggested that the sex difference in life expectancy that was observed in the 
twentieth century is mainly caused by differences in smoking behavior (66). More 
recently, data from the USA and UK suggest that the increase in life expectancy 
has started to plateau (67, 68). It has been suggested that the growing number 
of obese and physically inactive individuals could have caused the stagnating life 
expectancy (69, 70). Longitudinal cohorts using individual data can be used to 
quantify the relationship between such lifestyle factors and lifespan, as we did in 
our analyses for this thesis. Because predictions on the development of the life 
expectancy are often based on simple linear extrapolation of a historical period 
(71), it is difficult to predict the impact of changing lifestyle trends on future life 
expectancy. More recently, efforts have been made to forecast  lifestyle-attributable 
mortality in the future, using epidemiological data e.g. (72). In the long-term, 
these developments might lead to better projections of the future life expectancy, 
considering the influence of changing lifestyle trends.)   
Apart from alcohol intake, little attention has been given to the relationship between 
nutrition and longevity in this dissertation. As described in chapter 2, there is 
a lack of prospective studies investigating the relationship between nutrition and 
longevity in humans. Unfortunately, we  did not have the opportunity to investigate 
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this relationship during the time frame of this PhD project. Interestingly, caloric 
restriction is often mentioned as a potential intervention strategy to prolong the 
lifespan in humans. However, most of these claims are based on the results 
of animal studies (73). There is still a lot of debate whether caloric restriction 
would also prolong the lifespan in humans (74). Studying the effects of caloric 
restriction on longevity in humans is difficult, due to ethical concerns it would 
raise. Furthermore, cohorts that have data on individuals who experienced a period 
of caloric restriction are rare. In some cohorts, including the NLCS, information 
of individuals who experienced a period of caloric restriction is available (75, 
76). Therefore, it would be interesting to evaluate the relationship between caloric 
restriction and longevity using information of these cohorts in future studies. 
Although the number of studies is growing, there is still a lot of inconsistency and 
debate regarding the relationship between reproduction and lifespan in humans. We 
observed that the results of observational studies among humans do not correspond 
with the hypotheses of evolutionary theories of aging, including the disposable soma 
theory, and the theory of antagonistic pleiotropy. Furthermore, the recent advances in 
birth control could also change the relationship between reproduction and lifespan. It 
will be interesting to see how these relationships will evolve in the near future.
In chapter 2, we mentioned that the baseline cut-off ages and longevity cut-off ages 
varied widely across the different longevity studies. In our own analyses, we did 
observe that the effect estimates between a risk factor and longevity, might differ 
using different longevity cut-off ages. For instance, we observed that the strength 
of the association between smoking and longevity became stronger with increasing 
longevity cut-off age (3)(Chapter 4). Furthermore, in the analyses on loneliness and 
longevity using data from the LASA cohort, we also observed that the association 
between loneliness and longevity might differ at different baseline ages. Given the 
long follow-up and complexity it requires to study the etiology of longevity in a 
longitudinal setting, studies are restricted to a certain time window in the lifespan. 
Ideally, one might study longevity using a conception-to-death cohort design that 
starts during pregnancy until death, with multiple follow-up measurements in 
between (77). However, such a study design will not be feasible in the near future, 
given the long follow-up and logistic complexity (77). Alternatively, advances in 
the field of life course epidemiology could provide relevant opportunities to address 
the issues currently experienced with the use of multiple cut-off ages. Life course 
epidemiology aims to study the contribution of early life factors together with later 
life factors to estimate the risk and protective processes on several outcomes across 
the life course (78). For this, (combined) longitudinal information of existing and 
new longitudinal cohorts is needed to cover different time windows during the 
life course. Because prospective cohort studies only provide results on the long 
term, acquiring funding is difficult when competing with different types of studies 
delivering results on the short term (79). This threatens the long-term sustainability 
of existing and newly developed cohorts, and a more strategic approach is needed 
to ensure that there is more support for these types of studies. 
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Summary 
In this dissertation, we have investigated factors that are associated with reaching 
the age of 90 years (longevity). To investigate these relationships, we used data 
from the Netherlands Cohort Study (NLCS) and the Longitudinal Aging Study 
Amsterdam (LASA).
For the analyses in which the association between parental, lifestyle and reproductive 
factors and reaching the age of 90 were investigated, we used data from the NLCS. 
The NLCS was set up in 1986 as a large prospective cohort study, which aimed to 
investigate the relationship between diet and the development of multiple forms of 
cancer in the Netherlands. The NLCS collected data from 120,852 men and women 
(55-69 years) using an 11-page self-administered questionnaire. This questionnaire 
contained questions about demographic factors, dietary habits, smoking habits, 
physical activity, alcohol consumption, anthropometry, medical information and 
family history. Because at the start of these analyzes only a part of the participants 
were able to reach the age of 90, we have limited our analyses to the oldest birth 
cohorts (1916 and 1917) of the NLCS cohort. The participants (68-70 years at the 
start of this study) from these two birth years form the cohort for the analyses in 
this dissertation. Follow-up of this cohort up to the age of 90 was 99.9% complete. 
The analyses in this thesis are based on 7,807 participants (3,646 men and 4,161 
women). Among these participants we observed that 565 men (15.5%) and 1388 
women (33.4%) survived until the age of 90.
In chapter 3 we observed that both male and female descendants of parents who 
survived up to 80 years of age had an increased chance of reaching the age of 
90, compared to those whose parents had died before the age of 80. We suggested 
that this benefit could be passed on to later generations through a combination 
of early environmental influences and genetic factors. We have therefore corrected 
the estimates for some environmental factors that could explain the observed 
relationship. In these analyses, a longer lifespan of fathers in male offspring and a 
longer lifespan of mothers in female offspring was still associated with an increased 
chance of reaching the age of 90.
With regard to lifestyle factors, our analyses focused on smoking behavior, height, 
BMI, non-occupational physical activity and alcohol consumption. Our analyses 
in chapter 4 showed that current and former smokers have a considerably lower 
chance of reaching the age of 90 compared to never-smokers. In addition, we 
observed that this relationship was stronger in men compared to women. In further 
analyses, we found that this difference could possibly be attributed to the differences 
in smoking behavior (incl. smoking quantity, and type of tobacco).
Based on our analyses in chapter 5, an increasing level of (non-occupational) 
physical activity seemed to increase the chance of reaching the age of 90 in both 
men and women. In men, we observed a positive linear association, indicating that 
the chance of reaching longevity increased with an increasing level of physical 
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activity. In women, we saw that the potential beneficial effect of physical activity 
is limited to a certain amount of physical activity (~ 60 min./day) in terms of 
achieving longevity, after which the chances did not increase further. Furthermore, 
in the analyses of chapter 5, underweight (BMI <18.5 kg / m2) and obesity (BMI 
≥30 kg / m2) were associated with a reduced chance of reaching 90 years, but only 
among female participants. In men, no relationship was observed between BMI and 
reaching the age of 90.
After excluding former drinkers, moderate alcohol consumption (5- <15 g alcohol 
per day) at the age of 68-70 years was associated with the highest probability of 
reaching the age of 90 in both men and women (chapter 6). The effect estimates 
observed in chapter 6 further indicated that binge drinking was associated with 
lower chances of achieving longevity.
Based on the analyses described in chapter 7, we did not observe a relationship 
between indicators of the fertile period (age at menarche, age at menopause and 
reproductive life) and the chance of reaching a 90-year-old age among female 
participants. We found that a later age at the first delivery was associated with 
an increased chance of reaching the age of 90. The use of hormone replacement 
therapy was also positively associated with reaching longevity, but only in women 
with early menopause (<50 years).
For the analyses of loneliness in relation to reaching the age of 90, we used data 
from the LASA cohort. LASA is a prospective cohort study that was initiated in 
1992 to study the physical, emotional, cognitive and social functioning of elderly 
people (55-84 years) in the Netherlands. For this, potential participants were 
approached from 11 municipal registers from representative geographical regions 
in the Netherlands for the Living Arrangements and Social Networks of Older 
Adults (LSN) program. Participants recruited for this study were born between 
1908 and 1937 (n = 3,805). From this sample, 3,677 (still living) participants 
were contacted for the first LASA cycle (1992-1993), on average 11 months after 
the LSN interview, with a response rate of 85%. The examinations took place 
at the participants’ home, approximately every three years. Trained interviewers 
conducted interviews and additional data was obtained using a questionnaire. During 
the interviews, the participants were also asked for permission to participate in a 
separate medical interview. Clinical measurements were taken during the medical 
interview and the interviewer asked additional questions. Loneliness was measured 
during the interviews using a validated 11-item De Jong-Gierveld scale. Because 
only a part of the full cohort could have reached the age of 90 at the start of 
these analyses, the analyses were limited to participants born before 2 August 1928. 
Follow-up of this cohort up to the age of 90 was 99.5% complete. After excluding 
participants with missing data on loneliness (n = 62), 1,032 men and 1,078 women 
were used for these analyses. Our follow-up showed that among these participants 
252 men (24.4%) and 413 women (38.3%) have reached the age of 90 years.
Based on the analyses of chapter 8, no significant associations were observed 
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between loneliness and reaching the age of 90 in both men and women. When we 
looked at the subdimensions of loneliness (emotional and social loneliness), we saw 
that social loneliness was significantly negatively associated with reaching 90 years 
in women.
In the systematic literature study from chapter 2, we concluded that smoking and 
a low level of physical activity were associated with a lower chance of achieving 
a long life. This is in line with the results that we observed in chapters 4 and 
5. Alcohol intake and BMI showed limited and / or conflicting associations with 
reaching longevity. In addition, the review revealed that the age at which the 
parents died was positively associated with reaching longevity, with the age at 
which the mother died showing the strongest association. Some studies indicated a 
stronger effect of parental lifespan in female offspring compared to male offspring.
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Nederlandse samenvatting
In dit proefschrift hebben we onderzoek gedaan naar factoren die geassocieerd zijn 
met het bereiken van een 90-jarige leeftijd (langlevendheid). Om deze verbanden te 
onderzoeken hebben we gebruik gemaakt van gegevens afkomstig uit de Nederlandse 
Cohort Studie (NLCS) en de Longitudinal Aging Study Amsterdam (LASA). 
Voor de analyses waarin de associatie tussen ouderlijke-, leefstijl- en reproductieve 
factoren en het bereiken van een 90-jarige leeftijd is onderzocht, hebben we gebruik 
gemaakt van gegevens uit de NLCS. De NLCS is in 1986 opgezet als een groot 
prospectief cohortonderzoek, dat gericht was op het onderzoeken van de relatie 
tussen voeding en de ontwikkeling van meerdere vormen van kanker in Nederland. 
De NLCS heeft daarvoor gegevens verzameld van 120.852 mannen en vrouwen 
(55-69 jaar) met behulp van een zelf gerapporteerde vragenlijst van 11 pagina’s. 
Deze vragenlijst bevatte vragen over demografische factoren, voedingsgewoonten, 
rookgewoonten, lichamelijke activiteit, alcoholgebruik, antropometrie, medische 
informatie en familiegeschiedenis. Omdat bij aanvang van deze analyses slechts 
een deel van de deelnemers in het NLCS cohort de leeftijd van 90 jaar heeft 
kunnen bereiken, hebben we onze analyses beperkt tot de oudste geboortecohorten 
(1916 en 1917) van het NLCS-cohort. De deelnemers (68-70 jaar oud bij aanvang 
van deze studie) uit deze twee geboortejaren vormen het cohort voor de analyses 
in dit proefschrift. Follow-up van dit cohort tot de leeftijd van 90 was voor 
99,9% compleet. De analyses in dit proefschrift zijn dat ook gebaseerd op 7.807 
deelnemers (3.646 mannen en 4.161 vrouwen). Onder deze deelnemers zagen we dat 
565 mannen (15,5%) en 1388 vrouwen (33,4%) overleefden tot de leeftijd van 90 
jaar.
In hoofdstuk 3 zagen we dat zowel mannelijke als vrouwelijke nakomelingen van 
ouders die tot 80 jaar en ouder overleefden een verhoogde kans hadden om de 
leeftijd van 90 jaar te bereiken, in vergelijking met degenen wiens ouders vóór 
de leeftijd van 80 jaar waren overleden. We stelden voor dat dit voordeel zou 
kunnen worden doorgegeven aan latere generaties door een combinatie van vroege 
omgevingsinvloeden en genetische factoren. Daarom hebben we de schattingen 
gecorrigeerd voor enkele omgevingsfactoren die de waargenomen relatie zouden 
kunnen verklaren. In deze analyses was de levensduur van vaders bij mannelijke 
nakomelingen en de levensduur van moeders bij vrouwelijke nakomelingen nog 
steeds significant positief geassocieerd met een verhoogde kans om de leeftijd van 
90 jaar te bereiken. 
Met betrekking tot leefstijlfactoren hebben onze analyses zich gericht op rookgedrag, 
lengte, BMI, niet-beroepsmatige lichamelijke activiteit en alcoholgebruik. Onze 
analyses in hoofdstuk 4 toonden aan dat huidige en voormalige rokers een 
aanzienlijk kleinere kans hebben om de leeftijd van 90 jaar te bereiken in 
vergelijking met nooit-rokers. Daarnaast observeerden we dat deze relatie sterker 
was in mannen ten opzichte van vrouwen. In verdere analyses vonden we dat dit 
verschil mogelijk is toe te wijzen aan de verschillen in rookgedrag (o.a. hoeveelheid 
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en type tabak). 
Op basis van onze analyses in hoofdstuk 5 leek een toenemende mate van (niet-
beroepsmatige) lichamelijke activiteit de kans te vergroten om de leeftijd van 90 
jaar te bereiken bij zowel mannen als vrouwen. Bij mannen zagen we een positieve 
lineaire associatie, wat aangeeft dat de kans om een lange levensduur te bereiken 
toenam met een toenemende mate van fysieke activiteit. Bij vrouwen zagen we 
dat het potentiële gunstige effect van fysieke activiteit beperkt is tot een bepaalde 
hoeveelheid lichamelijke activiteit (~60 min./dag) in termen van het bereiken van 
een lange levensduur, waarna de kansen niet verder toenamen. Verder werden in de 
analyses van hoofdstuk 5 ondergewicht (BMI <18,5 kg/m2) en obesitas (BMI ≥30 
kg/m2) geassocieerd met een verminderde kans om 90 jaar te worden, maar alleen 
bij vrouwelijke deelnemers. Bij mannen werd er geen verband gevonden tussen BMI 
en het bereiken van 90-jarige leeftijd.
 Na uitsluiting van voormalige drinkers werd matig alcoholgebruik (5-<15 gr. 
alcohol per dag) op de leeftijd van 68-70 jaar geassocieerd met de hoogste kans 
om de leeftijd van 90 jaar te bereiken bij zowel mannen als vrouwen (hoofdstuk 
6). De effectschattingen waargenomen in hoofdstuk 6 gaven verder aan dat 
binge-drinken geassocieerd was met lagere kansen op het bereiken van een lange 
levensduur.
Op basis van de analyses beschreven in hoofdstuk 7, hebben we geen verband 
geobserveerd tussen indicatoren van de vruchtbare periode (leeftijd bij menarche, 
leeftijd bij menopauze en reproductieve levensduur) en de kans op het bereiken van 
een 90-jarige leeftijd onder de vrouwelijke deelnemers. We hebben geconstateerd dat 
een latere leeftijd bij de eerste bevalling was geassocieerd met een verhoogde kans 
om de leeftijd van 90 jaar te bereiken. Het gebruik van hormoonsuppletietherapie 
was ook positief geassocieerd met het bereiken van een lange levensduur, maar 
alleen bij vrouwen met een vroege menopauze (<50 jaar).
Voor de analyses naar eenzaamheid in relatie tot het bereiken van de 90-jarige 
leeftijd hebben we gebruikt gemaakt van gegevens afkomstig uit het LASA cohort. 
LASA is een prospectieve cohortstudie die in 1992 is gestart om het fysieke, 
emotionele, cognitieve en sociale functioneren van ouderen (55-84 jaar) in Nederland 
te bestuderen. Hiervoor werden mogelijke deelnemers benaderd uit 11 gemeente 
registers uit representatieve geografische regio’s in Nederland voor het programma 
Living Arrangements and Social Networks of Older Adults (LSN). Deelnemers die 
voor deze studie werden aangeworven, werden geboren tussen 1908 en 1937 (n = 
3.805). Uit deze steekproef werden 3.677 (nog levende) deelnemers gecontacteerd 
voor de eerste LASA-cyclus (1992-1993), gemiddeld 11 maanden na het LSN-
interview, met een responspercentage van 85%. De onderzoeken werden bij de 
deelnemers thuis afgenomen welke ongeveer om de drie jaar plaatsvonden. Getrainde 
interviewers hielden interviews en aanvullende gegevens werden verkregen met 
behulp van een vragenlijst. Tijdens de interviews werd aan de deelnemers ook 
toestemming gevraagd om deel te nemen aan een afzonderlijk medisch interview. 
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Tijdens het medisch interview werden klinische metingen verricht en stelde de 
interviewer aanvullende vragen. Eenzaamheid is gemeten tijdens de interviews 
met behulp van een gevalideerde 11-item De Jong-Gierveld schaal. Omdat slechts 
een deel van het volledige cohort de leeftijd van 90 jaar kon bereiken, waren de 
analyses beperkt tot deelnemers die zijn geboren vóór 2 augustus 1928. Follow-up 
van dit cohort tot de leeftijd van 90 was voor 99,5% compleet. Na uitsluiting van 
deelnemers met ontbrekende gegevens over eenzaamheid (n = 62), werden 1.032 
mannen en 1.078 vrouwen gebruikt voor deze analyses. Onze follow-up toonde aan 
dat onder deze deelnemers 252 mannen (24,4%) en 413 vrouwen (38,3%) de leeftijd 
van 90 jaar hebben bereikt.
Op basis van de analyses van hoofdstuk 8 werden geen significante associaties 
waargenomen tussen eenzaamheid en het bereiken van de 90-jarige leeftijd bij zowel 
mannen als vrouwen. Toen we de subdimensies van eenzaamheid (emotionele en 
sociale eenzaamheid) in ogenschouw namen, zagen we dat sociale eenzaamheid 
significant negatief geassocieerd was met het bereiken van 90 jaar bij vrouwen.
In de systematische literatuur studie uit hoofdstuk 2, concludeerden we dat roken 
en een laag niveau van lichamelijke activiteit geassocieerd waren met een lagere 
kans op het bereiken van een lange levensduur. Dit ligt in lijn met de resultaten 
die wij observeerden in hoofdstuk 4 en 5. Alcoholinname en BMI vertoonden 
beperkte en/ of tegenstrijdige associaties met het bereiken van een lange levensduur. 
Daarnaast kwam uit de review naar voren dat de leeftijd waarop de ouders waren 
gestorven positief geassocieerd was met het bereiken van een hoge leeftijd, waarbij 
de leeftijd waarop de moeder stierf de sterkste associatie liet zien. Sommige studies 
wezen op een sterker effect van ouderlijke levensduur bij vrouwelijke nakomelingen 
in vergelijking met mannelijke nakomelingen. 
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Valorisation 
Introduction
In this chapter we will discuss the relevance, and value of this dissertation for 
society. Valorisation creates value from research by describing how research results 
can be used for economical and/or societal benefit, or by translating the acquired 
knowledge into new products, services, processes, or business (1). 
Valorisation during the PhD trajectory
The study findings presented in this dissertation have not only been published 
in several international scientific journals, but were also communicated to a 
broader audience. In 2017, and 2018, we presented our study results at the 
Dutch Demography Day. This is an annual meeting organized by the Netherlands 
Demographic Society, to communicate the latest research findings in the field of 
demography in the Netherlands. In 2017, 2018, and 2019 our study findings were 
displayed and presented at the Dutch Epidemiological Conference (WEON), to an 
audience consisting mostly of epidemiologists. Our study results were also presented 
at the European Congress of Epidemiology (Lyon, France) in 2018. Additionally, in 
2019 and 2020, our study results on body size, non-occupational physical activity 
and reaching longevity, and alcohol consumption and reaching longevity were 
picked up by several international newspaper, television and radio organizations, 
e.g. Newsweek, CNN, and The Times (of London), and were widely spread in 
printed and online media formats, worldwide. As a result, our research findings 
were spread to a broad (lay) audience worldwide. Communicating our results at 
several (international) conferences and in the media has hopefully contributed to an 
increased awareness of several determinants of reaching (human) longevity among 
professionals and the general public. 
Future Valorisation
The findings presented in this dissertation could contribute to an increased 
understanding of determinants of reaching longevity at an individual level. 
Additionally, the results strengthen the knowledge on the relationship between 
lifestyle and aging, that could be of use in demographic projections, and policy 
making.
Determinants of longevity 
The use of data from long-running prospective cohort studies, has provided a 
unique opportunity to study the determinants of reaching longevity at an individual 
level. As described earlier in the Introduction section, until recently most longevity 
research was performed using population- or retrospective study designs to identify 
how the exceptional old differ from the rest of the population. Individual data that 
is prospectively collected to study determinants of longevity is rare and costly, 
because of the long follow-up it requires until the participants are “at risk” of 
reaching longevity. However, a prospective cohort design has several methodological 
advantages including a selection of participants and data collection independent 
of the outcome, which reduces the risk for selection- and information bias. 
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Furthermore, the detailed information that is collected on other factors makes it 
possible to control for potential confounding.
Some modifiable lifestyle characteristics were strongly related with reaching 
longevity. Smoking was the most important factor associated with a decreased 
chance of reaching longevity, while being physically active, having a BMI between 
18.5 and 25.0 kg/m2 (in women), and a moderate alcohol consumption (5-<15 
gr. alcohol/day) were associated with an increased chance of reaching longevity. 
This indicates that the chance of attaining an exceptionally old age is potentially 
modifiable. As a result, promoting certain lifestyle behaviors (e.g. not smoking, 
increasing physical activity) in later life (65+ years) could add years to life.. 
However, it should be noted that the observed associations do not necessarily 
indicate causation, and replication of these findings in other longitudinal cohorts is 
needed. 
Demographic changes
In the past, it was observed that smoking had a huge negative impact on the 
average life expectancy, especially in men. It is even suggested that the sex 
difference in life expectancy that was observed in the 20th century is mainly caused 
by smoking (2). Our analyses confirm that smoking is indeed strongly associated 
with a shorter lifespan. More recently, data from the USA and UK suggests that 
the increase in life expectancy has started to plateau, but the reasons behind this 
stagnation are still unknown (3, 4). It has been suggested that the growing number 
of obese and physically inactive individuals could have caused the stagnating life 
expectancy (5, 6). Demographers, and epidemiologists, could utilize our findings 
to gain a better understanding of the relationship between lifestyle trends in the 
general population and its potential relationship with demographic changes in the 
upper limits of human lifespan. Furthermore, predictions on the development of the 
life expectancy are often based on simple linear extrapolation of a historical period 
(7). Therefore, it is difficult to predict the impact of changing lifestyle trends on 
future life expectancy. Using epidemiological data to estimate the lifestyle-attributable 
mortality in the future could lead to better projection of the future life expectancy 
in the long-term.   
Societal implications
During the dissemination of our results, we got several responses of people who 
were surprised by the actual probabilities of reaching 90 years, which they had 
underestimated. Other researchers also indicated that there exists a “disbelief in 
aging” e.g. (8), in current societies. They argue that there is a profound mismatch 
between the cultural norms of aging, where most policies are based upon, and 
the actual lifespan. Increasing probabilities of reaching exceptionally old ages are 
a positive development on the individual level. However, on a population level, 
a prolonged lifespan has severe consequences for, for example, existing pension 
schemes, healthcare facilities and costs, and insurance companies. Policy makers 
should be aware of these demographic changes, and act on them. Given the design 
of our study, we were able to present absolute probabilities of reaching 90 years by 
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the long follow-up of a closed cohort. We believe that these absolute probabilities 
can inform policy makers about the potential magnitude of aging in subsequent 
generations, and the potential impact that several determinants might have on these 
probabilities.  
Conclusion
In this dissertation we have performed several quantitative analyses to assess the 
relationship of several lifestyle, parental and reproductive factors with the likelihood 
of reaching the age of 90 years (longevity). During the PhD trajectory, there has 
been a wide dissemination of the results to epidemiologists, demographers, and the 
lay public. The findings of our analyses contribute to a better understanding of the 
determinants of reaching exceptionally old ages, which has several implications for 
the individual and for society. 
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Dankwoord
In de afgelopen vier jaren zijn er verschillende personen geweest die mij hebben 
gesteund en/of een belangrijke bijdrage hebben geleverd waardoor ik dit proefschrift 
in zijn huidige vorm heb kunnen realiseren. Ik wil hiervoor graag een aantal 
mensen in het bijzonder bedanken.  
Piet, wij kwamen elkaar voor het eerst tegen tijdens de Master Epidemiologie 
waar je tutor (en blokcoördinator) was bij het blok “Observational Research”. 
Een blok dat ik destijds met veel plezier heb gevolgd en een blok dat ik later 
meerdere malen heb mogen overdoen in mijn rol als tutor. Ik was dan ook erg 
enthousiast dat ik de basis methoden en technieken die ik in dit blok heb geleerd 
in de praktijk mocht gaan toepassen als PhD student binnen de Nederlandse 
Cohort Studie (NLCS) onder jouw begeleiding. Jouw no-nonsense aanpak, scherpe 
inzichten en directe manier van communiceren, hebben al vanaf het begin van onze 
samenwerking geleid tot een efficiënte en duidelijke manier van werken, welke ik 
erg heb weten te waarderen in de afgelopen jaren. Ik waardeer tevens de ruimte en 
het vertrouwen dat jij mij tijdens dit promotietraject hebt gegeven wanneer ik weer 
met een nieuwe (methodologische) invalshoek op de proppen kwam of een nieuwe 
samenwerking aan wilde gaan, ook al was dit voor de planning van het proefschrift 
soms een risico. Hoewel ons “longevity-onderzoek” in het begin een wat moeilijke 
opstart kende doordat wij onze plek in een nieuw vakgebied nog moesten leren 
kennen, bleef jij altijd vertrouwen houden in onze aanpak. Toen ons onderzoek 
eenmaal aan het rollen kwam, hebben we dit ook gestaag en met de nodige 
succesjes kunnen voortzetten. Ik wil je graag bedanken voor je begeleiding in de 
afgelopen jaren en alle leermomenten die mij hebben gevormd tot de epidemioloog 
die ik vandaag de dag geworden ben. 
Frans, ik wil je graag bedanken voor de tijd en moeite die je hebt gestoken om 
mijn promotieonderzoek naar een hoger niveau te tillen. Door je verdiepende vragen 
en inspirerende anekdotes heb ik geleerd hoe belangrijk het is om de context achter 
de cijfers te bekijken alvorens je duidelijke conclusies kunt trekken. Ik zal deze 
inzichten nooit vergeten en zeker meenemen in de rest van mijn wetenschappelijke 
carrière.  
Ik zou ook Prof. dr. Martijn Huisman en Prof. dr. Theo van Tilburg willen 
bedanken voor het vertrouwen en de mogelijkheid die zij mij hebben gegeven om 
aan de slag te gaan met data van het LASA cohort. Ik denk dat het onderzoek 
naar eenzaamheid en langlevendheid, mede dankzij jullie inbreng, een zeer mooie 
toevoeging is geworden aan dit proefschrift.   
Hans, mijn wetenschappelijke carrière is destijds bij jou gestart toen ik tijdens 
mijn bachelor studie als stagiaire bij jou startte. Wij hebben er destijds een mooi 
artikel over geschreven. Dit was voor mij de eerste zet om een wetenschappelijke 
carrière achterna te gaan. Ik vond het dan ook erg leuk, dat je ook tijdens mijn 
promotietraject nog een zeer relevante bijdrage hebt kunnen leveren aan mijn 
ontwikkeling als onderzoeker.
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Ik zou graag mijn dank willen uitspreken voor de leden van de 
beoordelingscommissie: Prof. Dr. Jos Schols, Prof. dr. Maryska Janssen, Prof. dr. 
Eline Slagboom, Prof dr. Fanny Janssen, en Dr. Ron van Golde voor de tijd en 
moeite die zij hebben vrijgemaakt om dit proefschrift te beoordelen. 
Jolanda, tijdens mijn promotietraject heb ik meerdere malen bij je aangeklopt, 
omdat ik weer extra informatie nodig had voor het een of ander. Niets was voor 
jou teveel, en het was voor mij altijd verrassend en een ware verademing om te 
zien hoe netjes je altijd alles had gestructureerd. Niet alleen organisatorisch, maar 
ook op persoonlijk vlak was je altijd toegewijd en opmerkzaam bij persoonlijke 
gebeurtenissen (bijv. gepersonaliseerde verjaardagsposters, en een geboorte-felicitatie 
kaartje). Hierdoor heb je ervoor gezorgd dat ik mij altijd zeer gewaardeerd voelde 
binnen het team, dank hiervoor.   
Ik zou ook graag de andere collega’s van de NLCS willen bedanken, waaronder 
Leo, Matty, Colinda, Harry en collega-aio’s voor de bijdragen die zij hebben 
geleverd ter voorbereiding van mijn promotieonderzoek, maar ook zeker voor de 
samenwerkingen, steun en/of input die ik tijdens mijn promotietraject van jullie heb 
mogen ontvangen. 
Collega’s van de vakgroep Epidemiologie: Ik heb de afgelopen jaren met veel 
plezier op de afdeling gewerkt, en dit was nooit gelukt zonder omgeven te worden 
door fijne collega’s. Alle ervaring en input die ik van jullie heb meegekregen tijdens 
het (epid) refereren, het verzorgen van onderwijs en de gezellige onderonsjes tijdens 
één of meerdere van de vakgroep-uitjes heb ik altijd zeer weten te waarderen. 
Ik wil graag in het bijzonder Yvonne (Leenders), Mariëlle, Petra, Conny, Irma en 
Yvonne (van den Bergh) bedanken waar ik de afgelopen jaren altijd terecht kon 
voor praktische hulp, alsook Harry en Jos die het leven achter een computerscherm 
een stuk aangenamer wisten te maken.  
Eline, nadat we al meerdere keren hadden samengewerkt tijdens mijn master stage 
bij de EnCoRe-studie, werd je ook mijn eerste kamergenote tijdens mijn PhD 
traject. Ongeveer tegelijkertijd begon jij vol overgave als post-doc. Je gedrevenheid 
in het onderzoek is bewonderenswaardig en je was voor mij dan ook, naast een 
fijne collega, een voorbeeld van een uitstekende onderzoeker waar ik veel van heb 
kunnen leren. 
Ook alle andere (oud) Epi-aio’s wil ik bedanken voor de fijne momenten van 
afgelopen jaren. Ik zal nooit onze gezellige vrijdagmiddagborrels, Fast-Food Friday’s, 
andere lunches (met en zonder Noro-virus), alle leuke momentjes tijdens congres-
bezoeken en de journalclubs vergeten. Ook de afscheidsborrel die jullie voor mij 
hebben georganiseerd heb ik zeer gewaardeerd!  
Tevens wil ik mijn (oud) kamergenoten en paranimfen Jeroen en Lisette bedanken 
voor de leuke jaren die ik samen met jullie heb mogen beleven in de verre uithoek 
Dankwoord
 
213
A
van de vakgroep epidemiologie. Hoewel het werken aan een promotieonderzoek 
gepaard gaat met flink wat ups en downs, denk ik dat ons gezamenlijk relativerend 
vermogen ervoor heeft gezorgd dat de mindere momenten toch een stuk dragelijker 
werden. Jeroen, als ik iets hoop mee te nemen van de afgelopen jaren waarin we 
samen hebben gewerkt is het toch wel je enthousiasme en gedrevenheid die jij in 
werkelijk alle aspecten in je leven naar boven weet te halen (ook al begon dit 
meestal iets later op de dag dan gepland). Gelukkig zal de vakgroep nog jarenlang 
kunnen genieten van ons gezamenlijk (seizoens-gebaseerde) kunstwerk dat nog steeds 
op de gang te bewonderen is. Lisette, het was altijd prettig om samen met jou ’s 
ochtends vroeg rustig aan de werkdag te kunnen beginnen. Ook was het prettig om 
iemand te hebben waarmee ik tips en tricks kon uitwisselen van planten in de tuin 
tot aan de ellende van het verbouwen en opknappen van een huis. Ik denk ook 
dat ik je bij deze officieel moet uitroepen tot winnares van de kamelenrace van de 
afgelopen jaren!  
(Schoon)familie en vrienden, bedankt voor jullie belangstelling in mijn 
promotieonderzoek. Mijn ouders: Hoewel het voor jullie niet altijd duidelijk was wat 
ik nu precies deed en wat epidemiologie precies inhield, ben ik blij dat het woord 
“e-pi-de-mio-lo-gie” ondertussen al in één vloeiende “epidemiologie” kan worden 
uitgesproken. Ik wil jullie ook bedanken voor het enthousiasme dat jullie hebben 
getoond voor mijn onderzoek en alle hulp die ik van jullie heb mogen ontvangen 
op persoonlijk vlak. Opa Jo en Opa Bert, helaas heb ik tijdens het schrijven van 
dit proefschrift afscheid van jullie moeten nemen. Mijn herinneringen met jullie zal 
ik nooit vergeten, en altijd koesteren.
Lieve Audrey, buiten het werk aan dit proefschrift, hebben wij gedurende de 
afgelopen jaren op persoonlijk vlak samen toch ook op een “rollercoaster van life 
changing events” gezeten, waarbij gevoelens van geluk, stress en verdriet zich 
onherroepelijk wisten af te wisselen. Helaas hebben we afscheid moeten nemen 
van verschillende dierbare personen om ons heen, maar hebben we zeker ook een 
heleboel mooie dingen samen weten te verwezenlijken. Zo was er de aankoop van 
ons eerste eigen huisje, alle (niet altijd even gemakkelijke) verbouwingen die daarop 
volgden en uiteraard de komst van onze lieve Amber als hoogtepunt. Hoewel deze 
stortvloed van gebeurtenissen voor jou ook niet altijd even gemakkelijk was, ben jij 
wel altijd mijn “reddingsvestje” geweest, waardoor ik mijn hoofd altijd boven water 
heb kunnen houden. Amber, je bent nog maar zo kort in mijn leven, maar je hebt 
nu al een ontzettend grote plek in mijn hartje weten te veroveren. Ik ben dan ook 
heel erg trots om jouw papa te mogen zijn! Ik hou zo ontzettend veel van mijn 
lieve dames, en ik kijk met veel enthousiasme uit naar ons verdere leven samen! 
Addendum
 
214
Curriculum Vitae
About the Author
Lloyd Brandts was born on October 7th 1989, in Maastricht, 
the Netherlands. After graduating from secondary school 
(Bonnefanten college, Maastricht) in 2008, he studied Applied 
Psychology at Fontys Hogeschool in Eindhoven. In 2011, 
he started with the bachelor study Health Sciences, with 
specialization “Prevention and Health” at Maastricht University, 
which he completed in 2014. During his bachelor study he 
also participated in the FHML excellence program Maastricht 
Research Based Learning for Excellence (MaRBLe+) in 
2014. Lloyd wrote his bachelor’s thesis “The socioeconomic 
roots of shame and perceptions of social inadequacy” under 
supervision of Prof. dr. Hans Bosma. Afterwards he started to 
study Epidemiology at Maastricht University, which he completed in 2015. Lloyd wrote 
his master’s thesis “Associations of muscle composition with short- and long-term 
treatment complications among colorectal cancer survivors: Findings from the EnCoRe 
study” under supervision of Dr. Martijn Bours and Prof. Dr. Ir. Matty Weijenberg. 
After obtaining a MSc degree in Epidemiology he started as a PhD student at the 
Department of Epidemiology (Maastricht University). He was supervised by Prof. dr. 
ir. Piet A. van den Brandt, and Prof. dr. Frans W.A. van Poppel to study determinants 
of reaching human longevity, which resulted in the work presented in this dissertation. 
The work presented in this dissertation has been published in several international 
scientific journals and was presented at several national and international conferences. 
Alongside this research, he was able to gain experience in teaching Epidemiology and 
Statistics to Bachelor and Master students of Maastricht University. Lloyd currently 
works as a clinical epidemiologist at Maastricht UMC+ (KEMTA) in Maastricht.
Curriculum Vitae
 
215
A
List of Publications
Bosma, H., Brandts, L., Simons, A., Groffen, D., & van den Akker, M. (2014). 
Low socioeconomic status and perceptions of social inadequacy and shame: findings 
from the Dutch SMILE study. The European Journal of Public Health, 25(2), 311-
313.
Brandts, L., & van den Brandt, P. A. (2018). Sex‐specific associations between 
smoking habits and reaching longevity: Netherlands Cohort Study. Geriatrics & 
Gerontology International, 18(8), 1249-1258.
Brandts, L., & van den Brandt, P. A. (2019). Body size, non-occupational physical 
activity and the chance of reaching longevity in men and women: findings from the 
Netherlands Cohort Study. J Epidemiol Community Health, 73(3), 239-249.
Brandts, L., van Poppel, F. W.A., & van den Brandt, P. A. (2019). Female 
reproductive factors and the likelihood of reaching the age of 90 years. The 
Netherlands Cohort Study. Maturitas, 125, 70-80.
van den Brandt, P.A., Brandts, L. (2020). Alcohol consumption and reaching 
longevity: the Netherlands Cohort Study. Age & Ageing, 49(3), 395-402.  
 
Submitted:
Brandts, L., van Poppel, F.W.A., van den Brandt, P.A. Parental lifespan and the 
likelihood of reaching the age of 90 years in the Netherlands Cohort Study (NLCS). 
Brandts, L., van Tilburg, T.G., Huisman, M., Bosma, H. & van den Brandt, P.A. 
Loneliness in later life and reaching longevity. Findings from the Longitudinal Aging 
Study Amsterdam (LASA). 
Oral Presentations:
Parental longevity and the likelihood of reaching longevity in the Netherlands. 
Cohort Study (NLCS). – WEON 2019, Groningen.
Female reproductive factors and the likelihood of reaching the age of 90 years: The 
Netherlands Cohort Study – Dutch Demography Day 2018, Utrecht.
Body size, non-occupational physical activity and the chance of reaching longevity 
in men and women: Findings from the Netherlands Cohort Study. WEON 2018, 
Bilthoven. 
Smoking habits and the chance of reaching longevity in men and women: the 
Netherlands Cohort Study. Dutch Demography Day 2017, Utrecht.
Poster presentations: 
Body size, non-occupational physical activity and the chance of reaching longevity 
in men and women: Findings from the Netherlands Cohort Study. – European 
Congress of Epidemiology, Lyon (France).
Smoking habits and the chance of reaching longevity in men and women: the 
Netherlands Cohort Study. GROW Science Day 2017, Maastricht.
Smoking habits and the chance of reaching longevity in men and women: the 
Netherlands Cohort Study. WEON 2017, Antwerp (Belgium).
